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Abstract 
Enterohaemorrhagic Escherichia coli (EHEC) are of great public health importance, 
causing diarrhoea, haemorrhagic colitis and haemolytic uraemic syndrome. A wealth 
of evidence from cell line and animal studies has linked colonic pathogenesis with 
EHEC induction of mucosal attaching/effacing (A/E) lesions, which are 
characterised by intimate bacterial attachment to intestinal epithelial cells (IECs), 
microvillous effacement and actin polymerisation. However, the clinical relevance of 
A/E lesions has been called into question by the fact that adherent bacteria have not 
been located on colonic biopsies taken from EHEC-infected patients. In addition, in 
vitro organ culture (IVOC) of human intestinal biopsies with EHEC has not yielded 
signs of bacterial colonisation or A/E lesion formation. In this study, we have re-
evaluated the colonic IVOC model and demonstrated for the first time that EHEC 
colonise the colonic epithelium ex vivo and induce A/E lesion formation. High levels 
of oxygen, as used in previous IVOC studies, were found to inhibit EHEC-IEC 
interactions. Adherence was dependent on expression of the bacterial adhesin intimin 
and the type III secretion system (T3SS). In contrast, EHEC adherence to the widely-
used T84 colonic carcinoma cell line was associated with microvillous effacement 
but not actin polymerisation, and was not dependent on intimin or the T3SS, 
highlighting the importance of using physiologically relevant intestinal models when 
conducting EHEC research. 
EHEC pathogenesis has also been linked to induction of an inflammatory response in 
the colonic mucosa, characterised by recruitment of neutrophils to the epithelium. 
This process has been associated with expression of the neutrophil chemokine 
interleukin-8 (IL-8) by cultured IECs following exposure to EHEC flagellin. 
However, other aspects of the innate immune system, such as expression of 
antimicrobial peptides (AMPs), have been neglected. We have demonstrated that 
EHEC induces expression of the AMP human β-defensin-2 (hBD2) and IL-8 in 
human colonic IECs both in vitro and ex vivo. Induction was dependent on exposure 
of IECs to flagellin, and was mediated by mitogen activated protein kinase (MAPK) 
signalling. Furthermore, we present evidence that IL-8 is secreted apically in 
polarised T84 cells following apical stimulation, suggesting that this cytokine may be 
secreted into the lumen during infection. Put together, this PhD project has shed new 
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light on EHEC-IEC interactions and has re-established the IVOC model as an 
important tool for future EHEC research.  
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CHAPTER ONE 
vvvvvvvvv 
INTRODUCTION 
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1.1 | Enterohaemorrhagic E. coli 
The life of humans would be very different without the existence of Escherichia coli. 
E. coli bacteria colonise the gastrointestinal (GI) tract within hours of birth and 
establish themselves as the predominant facultative anaerobe of the microbiota. The 
majority of E. coli strains engage in a mutually beneficial relationship with the host 
that provides a stable environment for the bacteria and improved digestion and 
protection from pathogenic infection for the host (Bentley and Meganathan, 1982; 
Reid et al., 2001). However, a number of strains have acquired genes that confer the 
ability to cause disease in humans. Since the isolation of the first pathogenic E. coli 
type in 1945 (Bray, 1945), the species has emerged as one of the largest contributors 
to food-borne illness worldwide. E. coli strains are genetically diverse and confer a 
range of diseases including diarrhoea, meningitis, urinary tract infections and 
haemolytic uraemic syndrome (HUS). Hundreds of millions of people are now 
estimated to be affected by pathogenic E. coli every year (Croxen and Finlay, 2010). 
Thus, in the past seventy years, our regard for this species has shifted from harmless 
commensal to dangerous pathogen that constitutes a huge public health and 
economic burden worldwide. 
Pathogenic E. coli strains are broadly classified into nine pathotypes, each colonising 
a specific niche in the human body (Figure 1.1). Five of these pathotypes – 
Enterohaemorrhagic E. coli (EHEC), Enteropathogenic E coli (EPEC), 
Enteroaggregative E. coli (EAEC), Enteroinvasive E. coli (EIEC), and Diffusely-
adherent E. coli (DAEC) – colonise the GI tract and induce diarrhoea. Uropathogenic 
E. coli (UPEC) and Neonatal meningitis E. coli (NMEC) are extra-intestinal 
pathotypes that are the leading cause of urinary tract infections and neonatal 
meningitis, respectively. Finally, adherent-invasive E. coli (AIEC) colonise the small 
intestine and are thought to play a role in Crohn’s Disease (CD) pathogenesis 
(Strober, 2011). 
Of the hundreds of pathogenic E. coli strains that affect humans, those belonging to 
the EHEC pathotype pose the largest public health threat in the developed world. 
EHEC are the fourth most commonly reported bacterial cause of enteric infection in 
the UK (ECDC, 2014). It is considered a colonic pathogen that causes diarrhoea by  
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Figure 1.1. Sites of pathogenic E. coli colonisation. Modified from Croxen and 
Finlay, 2010. 
 
forming attaching and effacing (A/E) lesions on intestinal epithelial cells (IECs). 
EHEC bacteria also produce Shiga toxins (Stxs), which damage cells of the colonic 
and renal microvasculature to induce haemorrhagic colitis (HC) and HUS, 
respectively. EHEC-associated HUS is the leading cause of acute kidney failure in 
children in the United Kingdom (UK), and can be fatal (Lynn et al., 2005). 
Furthermore, there is no treatment for EHEC infection or HUS, and the use of 
antibiotics is contraindicated (Goldwater and Bettelheim, 2012). Therefore, EHEC 
research is crucial in order to develop an effective means to combat infection. This 
chapter provides an overview of our current understanding of EHEC infection 
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biology, with emphasis on intestinal pathogenesis and the innate immune response to 
infection. 
 
1.2 | Emergence and evolutionary origin 
In 1983, Riley and colleagues investigated a large food-poisoning outbreak in the 
United States of America (USA) that was associated with an unusual form of 
gastrointestinal illness, characterised by severe abdominal pain and HC (Riley et al., 
1983). They identified the causative agent as an E. coli strain belonging to the 
serotype O157:H7, which had only once before been isolated from a case of HC in 
1975. Retrospective analysis of historical isolates did not implicate E. coli O157:H7 
in any other past cases (Day et al., 1983; Johnson et al., 1983), indicating that this 
serotype was an emerging pathogen. Konowalchuk and co-workers reported that 
EHEC O157:H7 produced a substance that had a cytotoxic effect on Vero African 
Monkey kidney cells, which they termed verotoxin (Konowalchuk et al., 1977). 
O’Brien et al. also discovered this toxin and demonstrated that it showed sequence 
homology to Shiga toxin (Stx), which is produced by Shigella dysenteriae type 1, 
and thus named it Shiga-like toxin (O'Brien et al., 1983). Both verotoxin and Shiga 
toxin are still used to describe this particular type of EHEC toxin, but only the latter 
term will be used in this thesis. Later that same year, Karmali et al., reported an 
association between HUS and the presence of Stx and Stx-producing E .coli (STEC) 
in the stools of sufferers (Karmali et al., 1983), providing the first indication of a 
causal role for Stx in development of HUS. 
Since the discovery of E. coli O157:H7, more than 500 other STEC serotypes have 
been identified (Blanco et al., 2004). However, not all STEC serotypes are capable of 
causing disease in humans; only those which harbour additional virulence 
determinants are considered pathogenic (Nataro and Kaper, 1998). The most 
important of these is the locus of enterocyte effacement (LEE), a large genetic region 
that encodes most of the genes necessary for the A/E phenotype (McDaniel et al., 
1995). This has led to the use of the term STEC to denote any E. coli strain 
containing stx genes and EHEC for those that harbour both stx and the LEE (Nataro 
and Kaper, 1998). 
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EHEC appears to have evolved from EPEC, since phylogenetic data shows that 
EHEC O157:H7 and EPEC O55:H7 share a recent common ancestor (Whittam et al., 
1993). EPEC also possesses the LEE and triggers A/E lesion formation upon 
infection of IECs (McDaniel et al., 1995), but does not harbour stx genes. Stxs are 
encoded on lambdoid prophages incorporated into the bacterial chromosome 
(Makino et al., 1999; Yokoyama et al., 2000), indicating that evolution from EPEC 
to EHEC likely resulted from horizontal gene transfer (HGT) of stx following 
prophage infection. Interestingly, acquisition of stx appears to have occurred several 
times in evolutionary history, as EHEC strains do not fall into a single phylogenetic 
group (Reid et al., 2000). This indicates that the EHEC pathotype represents a 
collection of genetically diverse strains that confer a similar virulence phenotype. 
The acquisition of stx is not the only example of EHEC gaining virulence through 
HGT. Indeed, the genomes of pathogenic E. coli are striking in that many virulence-
associated genes are located in regions of DNA originating from other organisms, 
termed pathogenicity islands (PAIs). PAIs, such as the LEE in EHEC, are discernible 
from native genetic material in that they harbour markedly different G+C contents 
and are found in association with mobile genetic elements (e.g. bacteriophages, 
plasmids, transposons, insertion sequences). The high level of HGT in E. coli drives 
the continuous emergence of new strains, each harbouring a unique repertoire of 
virulence genes (Bugarel et al., 2010). This diversity between strains complicates the 
study of EHEC virulence as it is difficult to infer meaning from analysis of a small 
number of isolates. Researchers therefore tend to focus their attention on O157:H7 
strains (e.g. EDL933, 86-24) as this serotype is most associated with disease in 
humans. As a result, non-O157:H7 strains are less well-characterised. 
The O157:H7 serogroup comprises hundreds of genetically distinct strains, and 
studies have shown that certain strain types are more associated with disease in 
humans. In their phylogenetic study, Manning et al. developed a system for 
classifying O157 strains based on detection of single nucleotide polymorphisms 
(SNPs) in 96 loci in 83 genes (Manning et al., 2008). Using this method, they 
classified over 500 strains isolated from clinical cases in the USA into a total of 9 
clades, and found that strains belonging to clade 8 were significantly associated with 
severe disease presentation (i.e. development of HUS). These clades also differed in 
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the frequency and distribution of stx genes: 100% and 57.6% of clade 8 strains 
harboured the stx2 and stx2c genes, respectively (Manning et al., 2008), which 
encode the Stx subtypes most associated with severe disease (Karch et al., 2006; 
Orth et al., 2007). 
Analysis of EHEC O157:H7 isolates from cases in Europe has revealed an 
association between virulence and bacterial phage type (PT). Phage typing has been 
used since the late eighties as a method of distinguishing between individual EHEC 
strains, and is based on characterising the susceptibility profile of an isolate to a 
panel of 16 bacteriophages (Ahmed et al., 1987; Khakhria et al., 1990). In the UK 
and Ireland, the chance of developing infantile HUS is significantly greater if the 
patient is infected with a strain belonging to PT21/28 compared with other PTs 
(Lynn et al., 2005). Furthermore, PT21/28 accounts for more cases of human illness 
in Scotland compared with other PTs (57% of all cases between 1998 and 2008) 
(Health Protection Scotland, 2009). It has been suggested that the increased virulence 
of PT21/28 is attributable to the fact that this PT is shed from cattle at higher levels 
than other PTs (a so-called ‘supershedder’), which would lead to higher levels of 
these strains in the environment and therefore increased chances of transmission to 
humans (Chase-Topping et al., 2007; 2008). In addition, the number of PT21/28 
strains harbouring both stx2 and stx2c is relatively high compared with PT32, the 
second-most prevalent PT (90% and 28%, respectively) (Xu et al., 2012), which may 
explain the increased disease severity in patients infected with PT21/28. 
 
1.3 | Epidemiology 
EHEC is one of the most common food-borne pathogens in the developed world. It is 
estimated that approximately 265,000 EHEC infections occur every year in the USA 
(CDC, 2015), whilst around 3,500 confirmed cases are reported annually in the 
European Economic Area (EEA) (ECDC, 2014). The actual number of cases in the 
EEA is likely to be higher, since not all cases are reported and therefore cannot be 
included in epidemiological analyses (ECDC, 2014). EHEC is the fourth most 
reported bacterial cause of food- and water-borne zoonosis in the EEA, after 
Campylobacter spp., Salmonella enterica and Shigella spp. (ECDC, 2014).  
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Figure 1.2. Incidence of EHEC infections in the EEA. (A) Proportion of total 
cases reported by individual countries between 2008 and 2012. (B) Median annual 
notification rates for the years 2008-2012. Some EEA countries are excluded due to 
insufficient data. Based on data from ECDC, 2014. 
 
Interestingly, the UK accounts for approximately 25% of the total number of EHEC 
cases reported in the EEA (6,448 of 25,864 cases reported between 2008 and 2012) 
and has one of the highest notification rates of all EEA countries (Figure 1.2). This 
suggests that EHEC infection is particularly prevalent in the UK, although it should 
be noted that differences in diagnostic methods between countries may influence this 
data (ECDC, 2014). EHEC is common in other developed countries including 
Canada, Japan and Australia, as well as in developing countries such as Argentina 
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(Croxen et al., 2013). Sporadic infection accounts for the majority of EHEC cases, 
although epidemic infections also occur (Byrne et al., 2015). 
Public Health England (PHE) recently published an epidemiological report on EHEC 
infections in England based on data collected since the introduction of the National 
Enhanced Surveillance System for STEC (NESSS) in 2009 (Byrne et al., 2015). The 
NESSS is designed to collate microbiological, demographic, clinical and exposure 
data in order to inform epidemiology and improve outbreak detection. The NESSS 
report shows that more than 40% of the total confirmed EHEC cases occurred in 
children <15 years of age, with the highest incidence observed in 1-4 year olds. This 
age group was not found to be disproportionately affected by Campylobacter or 
Salmonella (7.0 and 17.8% of total cases, respectively), indicating that the trend does 
not apply to all food-borne illnesses. The high rate of infantile EHEC illnesses was 
attributed to the infectious nature of EHEC, which is thought to facilitate 
transmission among children via person to person contact at schools and childcare 
facilities. Serogroup O157 was responsible for 98.8% of EHEC cases in England 
(Byrne et al., 2015), which is notably high when compared with figures reported for 
the EEA as a whole (34%) and the USA (36%) (CDC, 2015; ECDC, 2014). 
However, standard diagnostic testing for STEC in England often does not include 
screening for non-O157 strains (Byrne et al., 2015), and so it is possible that non-
O157 cases are under-represented. As mentioned in the previous section, the most 
common O157:H7 phage type is PT21/28 (50% of all cases in Scotland in 2008), 
followed by PT8 and PT32 (both 11%) (Health Protection Scotland, 2009). 
According to the ECDC (2014), the most commonly isolated non-O157 serogroups 
in the EEA are O26, O91, O103 and O145; whilst the US Department of Agriculture 
(USDA) has named O26, O45, O103, O111, O121 and O145 as the most important 
non-O157 disease-causing serogroups in the USA (USDA, 2012). 
The transmission route of EHEC is faecal-oral, with an estimated infectious dose of 
<100 organisms (Tuttle et al., 1999). Cattle and other farm animals often serve as a 
reservoir host for EHEC. Accordingly, the most common route of human exposure to 
EHEC is through consumption of food products contaminated with infectious 
livestock faeces. Foods that have been implicated in EHEC transmission include 
ground beef, sausage, unpasteurised milk and apple juice, and a variety of vegetables 
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(Chauret, 2011). Exposure by direct contact with reservoir hosts in petting zoos, 
agricultural shows and farm settings is also an important mode of transmission, 
accounting for 34.8% of EHEC cases in England between 2009 and 2012 (Byrne et 
al., 2015). As mentioned above, person to person transmission is also common, 
particularly during outbreaks. 
 
1.4 | Disease symptoms and treatment 
The progression of EHEC-associated disease from ingestion to clinical outcome is 
summarised in Figure 1.3. Diarrhoea is reported in most cases (92.8% in England 
between 2009 and 2012), and is often accompanied by other complaints such as 
abdominal cramps, fever and vomiting (79.2, 32 and 37.3%, respectively) (Byrne et 
al., 2015). These symptoms typically ensue within 3-4 days of ingesting the infective 
dose. Bloody diarrhoea, a sign of HC, develops in around 61% of cases around 3 
days later. It is the detection of blood in the stool that causes most patients to seek 
medical attention. In most cases, symptoms will begin to improve 4-10 days after the 
onset of illness. However, in 5-15 of cases, alleviation of gastrointestinal symptoms 
is followed by development of HUS (Byrne et al., 2015; Trachtman et al., 2012). 
HUS is characterised by haemolytic anaemia, thrombocytopaenia, and acute kidney 
failure. The syndrome is more likely to develop in children, and is the leading cause 
of acute infantile kidney dysfunction. There is no treatment for HUS other than 
dialysis, which is performed in 30-40% of cases for approximately 10 days 
(Trachtman et al., 2012). Approximately 1 in 4 HUS sufferers also develop 
neurological dysfunction leading to apnoea, coma, seizures, cortical blindness and 
haemiparesis (Trachtman et al., 2012). Additional sequelae of HUS include chronic 
renal dysfunction, colonic strictures, hypertension, stroke, gallstones and diabetes 
mellitus. (Byrne et al., 2015; ECDC, 2014; Lynn et al., 2005; Spinale et al., 2013; 
Tarr et al., 2005). HUS carries a mortality rate of up to 5%, with death usually 
resulting from the aforementioned neurological complications (Kavanagh et al., 
2014; Trachtman et al., 2012). 
There is currently no effective treatment for EHEC infection. The use of antibiotics 
is not recommended, as some clinical studies have indicated that antibiotic treatment  
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Figure 1.3. Progression of clinical symptoms over time (days) following EHEC 
infection. Adapted from Tarr et al. (2005). Percentages represent proportion of 
individuals presenting symptom relative to total number of cases (Byrne et al., 2015). 
 
is a risk factor for HUS (Smith et al., 2012; Wong et al., 2000). This has been 
attributed to antibiotics triggering the expression and release of Stx in bacteria via 
activation of the stress-induced Stx phage lytic cycle (Tarr et al., 2005; Zhang et al., 
2000). However, other studies show no negative correlation between antibiotic 
therapy and HUS (Bielaszewska et al., 2012; Safdar et al., 2002), and so the use of 
antibiotics to treat STEC infection remains controversial. Much effort has been 
applied to developing a vaccine against EHEC, and several candidates have 
performed well in animal studies (Bentancor et al., 2009; Gu et al., 2009). 
Vaccination of cattle has also been explored as a method of preventing transmission 
to humans (McNeilly et al., 2010; McNeilly et al., 2008; Potter et al., 2004; Tahoun 
et al., 2015). Many vaccine candidates target Stx and/or bovine IEC adherence 
factors such as intimin, translocated intimin receptor (Tir), E. coli secreted protein A 
(EspA) and flagellin; or a combination of the above. The economic cost of producing 
any successful vaccine is likely to influence the extent of its use. 
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Many alternative therapies are being investigated, which have recently been 
reviewed by Goldwater and Bettelheim (2012). Several studies have focussed on 
development of antibodies or synthetic molecules that bind to Stx and prevent it from 
binding to host cells, thereby inhibiting its pathological effects (Islam and Stimson, 
1990; Trachtman et al., 2003; Watanabe-Takahashi et al., 2010). Others have 
identified molecules, such as manganese and compound 75, which inhibit 
intracellular transport of Stx and cytotoxicity in host cells (Mukhopadhyay and 
Linstedt, 2012; Saenz et al., 2007). Another strategy being investigated is the use of 
probiotic bacteria such as Lactobacillus and Bifidobacterium spp. to prevent EHEC 
growth or interaction with the intestinal epithelium (Medellin-Pena and Griffiths, 
2009; Mogna et al., 2012; Sherman et al., 2005). Research into these potential 
therapies is still rudimentary, with few having progressed to clinical trials and none 
demonstrating a protective effect in humans. 
 
1.5 | Virulence 
EHEC possesses two main virulence traits: A/E lesion formation and Stx production. 
Our current understanding of the mechanisms underlying each of these is reviewed in 
this section. 
 
1.5.1 | A/E lesion formation 
EHEC belongs to a family of pathogens, referred to as attaching and effacing (A/E) 
bacteria, that forms distinctive histopathological A/E lesions on IECs. Other 
members of the family include the closely-related human pathogen enteropathogenic 
E. coli (EPEC), rabbit diarrhoeagenic E. coli (RDEC-1), and the murine pathogen 
Citrobacter rodentium. A/E lesions were first described by Staley and colleagues 
following infection of newborn piglets with EPEC (Staley et al., 1969), and are 
distinguishable on IECs by the presence of intimately adherent bacteria and loss of 
microvilli around the attachment site. However, our understanding of the 
mechanisms underlying A/E lesion formation was minimal until the late eighties, 
when Knutton and colleagues developed a simple in vitro test for detecting A/E 
lesions. Using transmission electron microscopy (TEM) to visualise bacteria adhered  
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Figure 1.4. A/E lesion formation on IECs. 
 
to cultured cell lines, the authors showed that A/E lesions were associated with 
polymerised actin beneath the site of bacterial attachment (Knutton et al., 1987). 
Soon afterwards, the same group introduced the fluorescent actin stain (FAS) as a 
new method for detecting polymerised actin that was less labour-some than TEM.  
(Knutton et al., 1989). The FAS test subsequently became the standard diagnostic 
test for A/E bacteria and provided researchers with a tool with which to identify the 
virulence factors necessary for A/E pathogenesis in vitro. 
The events leading to A/E lesion formation have been well-characterised using 
cultured cell lines (Nataro and Kaper, 1998), and are outlined in Figure 1.4. First, 
EHEC forms an initial attachment to an IEC via one or more adhesins (1). The 
bacterium then inserts its type III secretion system (T3SS) into the host cell, which is 
used to inject a barrage of ‘effector’ proteins into the cytosol. These effectors subvert 
host cell processes resulting in several morphological changes, which include the 
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localised effacement of microvilli (2). Microvillous effacement likely facilitates 
bacterial adhesion to the IEC surface, and also plays a role in induction of diarrhoea 
by reducing the absorptive surface area of the epithelium (Viswanathan et al., 2009). 
EHEC also secretes its own receptor, the translocated intimin receptor (Tir), into the 
host cell. Tir inserts into the IEC plasma membrane, where it binds to intimin on the 
bacterial outer membrane to form an intimate attachment (3). Tir then works with 
other effector proteins to recruit polymerised actin (4), which elevates the bacterium 
on an actin-rich pedestal-like structure. Several effector proteins also disrupt 
epithelial barrier function and subvert the transport of ion and water across the 
epithelium, which also contributes to the onset of diarrhoea (Viswanathan et al., 
2009). 
Most of the proteins involved in T3S and A/E lesion formation are encoded on the 
LEE (Mellies et al., 2007). Several effector proteins are also encoded on this PAI, 
although an increasing number of non-LEE-encoded effectors (Nle) are being 
discovered (Wong et al., 2011). The role of these virulence factors in each stage of 
A/E lesion formation on human model epithelia is reviewed below. 
 
1.5.1.1 | Initial attachment 
The mechanisms of EHEC initial attachment to IECs are poorly defined. In EPEC, 
adherence is thought to be primarily mediated by binding of the bundle-forming pilus 
(Bfp), a class of type-IV pilus, to an unidentified host receptor (Cleary et al., 2004; 
Giron et al., 1991). However, EHEC does not possess the plasmid encoding Bfp and 
must therefore associate with IECs via a different mechanism. A whole host of 
putative adhesins has been described (Table 1.1), many of which were identified by 
screening the sequenced genome of EHEC O157:H7 for homologues to known 
adherence factors. Two long polar fimbriae genes (lpfA1 and lpfA2), showing 
sequence homology to the Lpf operon in Salmonella enterica serovar Typhimurium 
(Perna et al., 2001), have been characterised in some detail. Double deletion of lpfA1 
and lpfA2 leads to partially reduced EHEC adherence to HeLa cervical carcinoma 
cells, but only when the regulators histone-like nucleoid structuring protein (HN-S) 
and Ler are also deleted (Torres et al., 2008). Significantly reduced EHEC adherence 
to T84 cells was also observed following deletion of lpf1 or lpf2 in a later study   
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Table 1.1. List of putative adhesion factors expressed by EHEC.  
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(Farfan et al., 2013). It has been proposed that Lpf may confer bacterial adherence to 
IECs by binding to extracellular matrix (ECM) proteins, as EHEC has been shown to 
attach to surfaces coated with fibronectin, laminin and collagen IV in an Lpf-
dependent manner (Farfan et al., 2011). However, EHEC adherence to human small 
intestinal biopsies during in vitro organ culture (IVOC) was actually enhanced in lpf-
deficient mutants compared with wild-type (Fitzhenry et al., 2006), and so the role of 
these fimbriae in adherence to IECs remains unclear. 
Several other fimbrial adhesins have been identified in EHEC. The haemorrhagic 
coli pilus (HCP) is a type IV pilus that binds to ECM proteins and has been shown to 
facilitate EHEC biofilm formation and adherence to several human epithelial cell 
lines (Xicohtencatl-Cortes et al., 2009; Xicohtencatl-Cortes et al., 2007). The E. coli 
common pilus (ECP) is a type I pilus found in both commensal and pathogenic 
bacteria, and has been shown to play a role in EHEC O157:H7 adherence to HeLa 
cells (Rendón et al., 2007). E. coli YcbQ laminin-binding fimbriae (ELF) bind to 
laminin (but not fibronectin or collagen IV) and are also involved in EHEC 
adherence to HeLa cells (Samadder et al., 2009). Finally, signature-tagged 
mutagenesis screening for bovine colonisation factors has led to discovery of novel 
‘F9’ fimbrial adhesins in EHEC serotypes O157:H7 (Dziva et al., 2004) and O26:H- 
(van Diemen et al., 2005). F9 was found to bind fibronectin (but not fibrinogen, 
elastin or hyaluronic acid) and promote adherence to bovine epithelial cells (Low et 
al., 2006); however, the role of F9 fimbriae in adherence to human IECs has not been 
reported. 
Many non-fimbrial bacterial factors have also been linked to initial attachment of 
EHEC to human IECs. The outer membrane protein intimin serves as an essential 
mediator of intimate attachment (see section 1.5.1.2), providing a ligand for the 
bacterial receptor Tir. However, this adhesin has also been shown to interact with 
host proteins. The IEC surface molecule β1-integrin anchors the intestinal epithelium 
to the underlying basement membrane (Humphries et al., 1993). Solid-phase binding 
analysis of EPEC intimin has revealed an interaction between its cell-binding domain 
and β1-integrins (Frankel et al., 1996). In addition, it has been demonstrated that 
EPEC infection of T84 human colonic carcinoma cells triggers a disruption of cell 
polarity, resulting in redistribution of basolaterally-localised β1-integrin to the apical 
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membrane, allowing bacterial access (Muza-Moons et al., 2003). In vitro binding of 
EHEC O157:H7 intimin to the host laminin receptor, nucleolin, has also been 
demonstrated (Sinclair and O'Brien, 2002). Antibodies raised against nucleolin 
inhibited EHEC adherence to HeLa cells (Sinclair and O'Brien, 2002), and nucleolin 
was detected beneath EHEC adhered to intestinal epithelium of piglets, neonatal 
calves and mice (Sinclair et al., 2006). Exposure of HeLa cells to Stx increased 
surface expression of nucleolin, which resulted in increased EHEC adherence 
(Robinson et al., 2006). These studies suggest that intimin may mediate the initial 
attachment of EHEC to IECs via binding to β1-integrin and/or nucleolin. Further 
studies using human intestinal cell lines and/or tissue are necessary to confirm a role 
for these interactions during intestinal EHEC infection. 
E. coli secreted protein A (EspA) is the main constituent of the T3SS translocation 
filament, which is fundamental for intimate attachment (section 1.5.1.2) and may 
also play a role in initial attachment. Ebel and colleagues (1998) showed that 
deletion of espA completely abrogated adherence of EHEC O26:H- to HeLa cells. 
Furthermore, microscopic analysis of wild type EHEC revealed the presence of vast 
numbers of EspA-rich filaments connecting the bacteria to the brush border surface. 
Importantly, these filaments were particularly numerous on bacteria that had not yet 
induced actin pedestal formation, which suggests that EspA-rich filaments are 
involved in the early stages of attachment (Ebel et al., 1998). However, a definitive 
role for the EspA filament in initial attachment has not been demonstrated, although 
this could be due to the difficulty in distinguishing between events leading to initial 
and intimate attachment. 
Autotransporters are a group of proteins found on the outer membrane of Gram-
negative bacteria (Henderson et al., 2004). Enterohaemorrhagic E. coli 
autotransporters (Eha) A, B and J promote biofilm formation and bind to ECM 
proteins. However, although EhaA may play a role in EHEC adherence to bovine 
rectal IECs, all three Eha proteins have failed to mediate adherence to human 
epithelial cells. (Easton et al., 2011; Wells et al., 2009; Wells et al., 2008). E. coli 
secreted protein P (EspP) is a serine protease autotransporter that promotes biofilm 
formation by EHEC and mediates adherence to T84 cells and bovine IECs (Dziva et 
al., 2007; Puttamreddy et al., 2010). Finally, the calcium-binding antigen 43 
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homologue (Cah) autotransporter expressed by EHEC O157:H7 promotes cell-to-cell 
aggregation and biofilm formation but confers a decrease in adherence to HeLa cells 
(Torres et al., 2002). Cah also failed to influence EHEC adherence to Caco-2 cells 
(Torres et al., 2005a), suggesting that this autotransporter does not play a role in 
initial attachment. 
Other putative adhesins include flagellin, outer membrane protein A (OmpA), Vibrio 
cholerae iron-regulated gene A homologue adhesin (Iha), and ToxB. Whilst EPEC 
(H6) flagellin mediates adherence of EPEC to HeLa cells (Girón et al., 2002), EHEC 
adherence was not influenced by antibody-mediated blocking of H7 flagellin 
(Sherman and Soni, 1988). Conversely, a role for H7 flagellin in EHEC adherence to 
bovine IECs and mucus has been demonstrated in several studies (Erdem et al., 
2007; Mahajan et al., 2009). Both OmpA and Iha enhance EHEC adherence to HeLa 
cells (Tarr et al., 2000; Torres et al., 2005a; Torres and Kaper, 2003). ToxB 
contributes to EHEC O157:H7 adherence to Caco-2 cells, although this appears to 
occur indirectly through enhancement of T3S (Tatsuno et al., 2001), which is 
essential for the intimate adherence phenotype (see section 1.5.1.2). ToxB is not 
required for EHEC intestinal colonisation of cattle or sheep (Stevens et al., 2004). 
Interestingly, the host cell membrane phospholipid, phosphatidylethanolamine (PE), 
has been shown to play a role in EHEC adherence to human epithelial cells. Using 
solid phase and liposome aggregation assays, Barnett-Foster and colleagues (1999) 
demonstrated that EHEC and EPEC preferentially bind to PE on the surface of HeLa 
cells. The same research group later showed that EHEC adherence triggered an 
increase in surface expression of PE via induction of apoptosis (Barnett Foster et al., 
2000). This data suggests that EHEC may use PE as a receptor for attaching to 
human epithelial cells. It remains to be determined whether EHEC interacts with PE 
on intestinal epithelial cells. Whilst EPEC binding to PE appears to involve Bfp 
(Barnett Foster et al., 1999), no PE binding partners have thus far been described in 
EHEC. 
Despite the large number of bacterial factors implicated in EHEC initial attachment 
to host cells, none except intimin and EspA (which are also involved in intimate 
attachment) have proven to be essential for adherence. One possible explanation for 
this could be that EHEC uses several adhesins that together confer a cumulative 
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effect on adherence. In addition, the majority of functional EHEC adhesin studies 
have been performed using non-intestinal cell lines (i.e. HeLa cells), so the potential 
influence of host intestinal factors has not been taken into account. More research 
using physiological IEC models is needed in order to elucidate the role of these 
adhesins during infection, as well as the factors influencing their expression and 
function. 
 
1.5.1.2 | Intimate attachment 
Intimin was the first bacterial protein found to be involved in EPEC-mediated  A/E 
lesion formation (Jerse et al., 1990), and an EHEC homologue was identified soon 
after (Yu and Kaper, 1992). This 102 kDa protein consists of an N-terminus that is 
conserved across EHEC and EPEC strains, and a variable C-terminus that confers 
receptor binding activity (Batchelor et al., 2000). Five intimin types have been 
described (α, β, γ, δ and ε), based on antigenic differences in the C-terminus region. 
The most common subtypes found in EHEC are γ, expressed by EHEC O157; and β, 
expressed by some non-O157 serogroups including O26 (McGraw et al., 1999). 
Intimin is essential for EHEC A/E lesion formation on HeLa cells (McKee et al., 
1995) and for in vivo colonisation of infant rabbits, gnotobiotic piglets and neonatal 
calves (Dean-Nystrom et al., 1998b; Donnenberg et al., 1993; Ritchie et al., 2003). 
Furthermore, IVOC experiments using human intestinal tissue have shown that 
intimin is required for EHEC A/E lesion formation on small intestinal epithelium 
(Fitzhenry et al., 2002), although no adherence to colonic epithelium (the site of 
EHEC-associated pathology) was observed using this model (Phillips et al., 2000). 
Initially, it was assumed that intimin mediated intimate attachment of A/E bacteria 
by interacting with a host cell receptor. Rosenshine and colleagues were the first to 
identify a 90 kDa protein on the host epithelial cell surface, which they termed Hp90, 
interacting with intimin during EPEC infection of HeLa cells (Rosenshine et al., 
1992; Rosenshine et al., 1996). However, in 1997, Kenny et al. discovered that Hp90 
was not a host derived-receptor but a bacterial protein translocated into the host cell 
via the T3SS, and thus renamed the protein translocated intimin receptor (Tir) 
(Kenny et al., 1997). This was the first recorded example of a bacterium injecting its 
own receptor into a host cell to mediate adherence. Tir has since been described in  
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Figure 1.5. Structure of T3SS in A/E pathogens. Based on Pallen et al. (2005) and 
Garmendia et al. (2005) 
 
EHEC (Deibel et al., 1998), and the protein is essential for A/E lesion formation 
during infection of HeLa cells (DeVinney et al., 1999) and IVOC of human small 
intestinal tissue (Schüller et al., 2007). Following translocation into the host cytosol, 
Tir inserts into the host plasma membrane in a hairpin loop topology, such that the 
N- and C-terminal portions are cytosolic whilst the central region traverses the 
membrane for intimin binding (Luo et al., 2000). Binding of Tir to intimin mediates 
intimate attachment of the bacterium to within 10 nm of the host cell membrane 
(Frankel et al., 2001). 
The T3SS is a 3.5 MDa complex found in many Gram-negative bacterial species. It 
is comprised of approximately 25 proteins that span the inner and outer membrane 
and mediate secretion of proteins out of the organism (Puhar and Sansonetti, 2014). 
The structure comprises a cytoplasmic domain containing an ATPase known as 
EscN; a trans-membrane ‘needle’ complex made from many proteins such as EscF, 
EscC, EscJ and EscD; and an extracellular translocon consisting of a hollow EspA-   
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Table 1.2. Function of EHEC-secreted effectors. Only effectors with known 
functions in EPEC or EHEC are included. 
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Figure 1.6. Actin pedestals in EPEC-infected Caco-2 cells. Taken from Knutton et 
al. (1989). 
 
rich filament and a terminal EspB-EspD pore (Figure 1.5). The translocation pore 
inserts into the host plasma membrane and bacterial proteins are passed through the 
translocon into the cytosol. In addition to Tir, the T3SS secretes a barrage of effector 
proteins, which have a wide range of effects on the host cell (Table 1.2). 
 
1.5.1.3 | Pedestal formation 
TEM analysis of EPEC- and EHEC-infected IECs reveals a dense actin-rich region 
beneath the site of bacterial attachment (Knutton et al., 1989; Knutton et al., 1987). 
This actin-rich region often extends out of the cell by up to 10 µm, elevating the 
bacterium on a pedestal-like structure (Figure 1.6). Using HeLa cells as an in vitro 
model, scientists discovered that actin recruitment was mediated by the action of Tir 
(Kenny, 1999). Tir indirectly recruits host-derived neuronal Wiskott-Aldrich 
syndrome protein (N-WASP) to the site of adherence, which in turn recruits actin-
related protein-2/3 (Arp2/3) complex to nucleate actin polymerisation (Campellone 
et al., 2004; Garmendia et al., 2004). EPEC and EHEC Tir recruit N-WASP via 
different signalling pathways. EPEC O127:H6 Tir is phosphorylated and binds to the 
host adaptor protein, Nck, to mediate activation of N-WASP (Kenny, 1999). In 
contrast, EHEC O157:H7 Tir stimulates a second secreted bacterial effector protein, 
Tir-cytoskeleton coupling protein (TccP), also known as EspFU, to recruit N-WASP 
(Campellone et al., 2004; Garmendia et al., 2004). Activation of TccP by EHEC Tir  
41 
 
 
Figure 1.7. Actin recruitment pathways employed by EPEC and EHEC 
 
also occurs indirectly via a host linker protein known as insulin receptor tyrosine 
kinase substrate (IRTKS) (Vingadassalom et al., 2009; Weiss et al., 2009) (Figure 
1.7). TccP is the only EHEC effector protein other than Tir that is essential for actin 
recruitment. Since these initial studies, it has emerged that most non-O157 EHEC 
strains are able to utilise both the Nck and TccP pathways to recruit N-WASP and 
induce actin pedestal formation (Frankel and Phillips, 2008; Ogura et al., 2007). The 
existence of several mechanisms for actin recruitment in A/E pathogens suggests that 
strong selective pressure is exerted on expression of this phenotype. 
Several effector proteins have been shown to influence pedestal formation. 
Overexpression of espH in EHEC results in dramatic elongation of pedestals during 
infection of HeLa cells, and deletion of espH in EPEC inhibits pedestal formation 
(Tu et al., 2003). Conversely, ΔespM EHEC and Δmap EPEC form elongated actin 
pedestals on HeLa cells (Kenny et al., 2002; Simovitch et al., 2010), suggesting that 
these two effectors may attenuate pedestal formation. The relevance of effector-
mediated control of pedestal formation is yet to be elucidated. 
Since the discovery of EHEC/EPEC-associated actin pedestals (Knutton et al., 1989), 
this phenotype has served as the primary marker for A/E lesions. However, data from 
studies using human small intestinal IVOC has put into question the importance of 
actin pedestals in A/E lesion formation. In 2004, Garmendia et al. reported that, 
although infection of small intestinal biopsies with EHEC O157:H7 ΔtccP resulted in 
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impaired recruitment of N-WASP and α-actinin (another constituent of actin 
pedestals), mutants were still capable of forming intimate attachments and inducing 
microvillous effacement (Garmendia et al., 2004). Furthermore, it has been shown 
that atypical EPEC serotype O125:H6, which is unable to recruit actin, is able to 
form A/E lesions that are indistinguishable from those induced by EHEC O157:H7 
during small intestinal IVOC (Bai et al., 2008). Moreover, T84 human colonic 
carcinoma cells infected with EHEC show signs of intimate attachment but not 
pedestal formation (Ismaili et al., 1995). These studies indicate that actin recruitment 
is not required for formation of A/E lesions. However, inhibition of Tir 
phosphorylation (i.e. actin recruitment) in C. rodentium resulted in impaired 
colonisation and mucosal attachment during infection of mice (Mallick et al., 2014). 
In addition, TccP/EspFU EHEC mutants demonstrated attenuated colonisation and 
expansion at later stages of infection of rabbits and gnotobiotic piglets (Ritchie et al., 
2008). These data suggest that actin pedestal formation, whilst not essential for A/E 
lesion formation, may stabilise adherence to the intestinal epithelium and promote 
expansion of bacterial colonisation. Another hypothesis is that actin pedestals serve 
as a localised signalling hub that coordinates spatial and temporal control of effector 
protein activity (Lai et al., 2013), since many effectors are known to congregate at 
this site following translocation (Munera et al., 2012). More studies are warranted in 
order to fully elucidate the role of actin pedestal formation during EHEC infection. 
 
1.5.1.4 | Microvillous effacement 
Micovillous effacement on IECs is thought to contribute to diarrhoea by reducing the 
surface area available for nutrient absorption and thereby increasing the osmolarity 
of the intestinal lumen (Hodges and Gill, 2010). Despite its important role in A/E 
pathogenesis, the cause of microvillous effacement has not been elucidated. EPEC-
induced microvillous effacement on human small intestinal mucosa appears to be 
dependent on expression of the T3SS (Shaw et al., 2005), suggesting that one or 
more effectors are involved. EPEC Tir has been implicated, although conflicting data 
exists depending on model system used: Tir was found to be essential for 
microvillous effacement in Caco-2 cells (Dean et al., 2006; Dean et al., 2013) but not 
during human or porcine IVOC (Girard et al., 2005; Shaw et al., 2005). Furthermore, 
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whilst EPEC-associated microvillous effacement on Caco-2 cells has been attributed 
to concerted action of Tir, Map and EspF (Dean et al., 2006), induction of the same 
phenotype on human small intestinal mucosa was attenuated by deletion of espF and 
espH but not not tir or map (Shaw et al., 2005). To the best of our knowledge, the 
cause of microvillous effacement by EHEC has yet to be investigated. 
 
1.5.1.5 | Disruption of IEC function 
In addition to microvillous effacement, EHEC and EPEC employ other strategies to 
induce diarrhoea such as disruption of epithelial barrier function, ion transport and 
water transport (Figure 1.8). Induction of diarrhoea is likely to benefit EHEC 
colonisation by displacement of resident microflora and also facilitates host 
transmission (Lupp et al., 2007). These interferences with host cell processes are 
mediated by the action of effector proteins and require a functional T3SS (Gill et al., 
2007), and so the ability to induce diarrhoea is inexorably linked to A/E lesion 
formation. Most of the data on effector function are based on EPEC studies, with 
relatively little experimental work conducted using EHEC strains. Although all A/E 
pathogens share a core repertoire of 21 effectors, the number expressed by EHEC is 
thought to be almost three times that of EPEC (Tobe et al., 2006). Therefore, it is 
difficult to ascertain how much of the data on EPEC can be applied to EHEC. 
Moreover, few studies have been verified ex vivo or in vivo using human intestinal 
tissue or animal models, respectively. 
 
1.5.1.5.1 | Epithelial barrier function 
The intestinal epithelium acts as a physical barrier between the external environment 
and the internal tissues. The selective permeability of this cell-thick layer is mediated 
by tight junctions (TJ), intercellular complexes formed by interaction of 
transmembrane proteins (i.e. occludins, claudins and zonula occludens proteins) with 
the actin cytoskeleton. TJs serve a dual purpose; they seal the intercellular space and 
selectively permit migration of lymphocytes and solutes across the epithelium, and 
they also maintain the spatial segregation of apical and basolateral membrane-bound  
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Figure 1.8. Mechanisms contributing to diarrhoea during EPEC/EHEC 
infection. 
 
molecules (Turner, 2009). Thus, TJs play an essential role in host defence against 
enteric infection. Several studies have reported that EHEC impairs epithelial barrier 
function, determined by a reduction in transepithelial electrical resistance (TER), 
during infection of polarised T84 and Caco-2 cells (Li et al., 1999; Philpott et al., 
1997; Viswanathan et al., 2004). Interestingly, whilst EPEC-mediated disruption of 
barrier function has been attributed solely to the action of the effector protein EspF, 
EHEC employs TccP/EspFU as well as EspF to induce this effect in both cell lines 
(Viswanathan et al., 2004). Barrier function is impaired by EspF- and TccP-mediated 
redistribution of occludin away from TJs (Viswanathan et al., 2004). EspM, found in 
EHEC but not EPEC, induced loss of zonula occludens protein 1 (ZO-1) from TJs in 
HeLa cells but did not influence TER in MDCK canine kidney cells (Simovitch et 
al., 2010). In EPEC, NleA and Map contribute to TJ disfunction in T84 and Caco-2 
cells by interfering with COPII-dependent cell protein trafficking pathways 
(Thanabalasuriar et al., 2010). Furthermore, EPEC interferes with the actomyosin 
ring that controls TJ activity (Yuhan et al., 1997). These additional mechanisms for 
altering barrier function have yet to be investigated in EHEC. 
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1.5.1.5.2 | Ion transport 
Secreted EPEC effectors impair the activity of both chloride and sodium exchangers. 
This results in a rise in luminal ion concentrations, which hinders water uptake by the 
epithelium. Sodium ions typically enter IECs via one of two membrane-bound 
exchangers: Na+/H+ exchangers (NHEs) or sodium-dependent glucose transporter 1 
(SGLT1). Hecht and colleagues (2004) have demonstrated that infection of Caco-2, 
T84 and HT-29 cells with EPEC results in varying effects on NHE channelling; 
reporting enhanced activity for NHEs 1 and 2 and reduced activity for NHE3. This 
reduction in NHE3 activity is mediated by EspF (Hodges et al., 2008). SGLT1 
channelling in Caco-2 cells is reduced during EPEC infection via an unknown 
mechanism that requires expression of Tir, Map, EspF and intimin (Dean et al., 
2006). Choride uptake in Caco-2 and T84 cells is also inhibited by EPEC infection 
via EspG-mediated internalisation of the Cl–/OH– exchanger, downregulated in 
adenoma (DRA), into the cytoplasm (Gill et al., 2007). Disruption of anion secretion 
has been reported in T84 cells during infection with EHEC O157:H7, as assessed by 
voltage clamp analysis (Li et al., 1999). Aside from this study, EHEC-mediated 
subversion of ion channel activity has not been investigated. 
 
1.5.1.5.3 | Water transport 
Aquaporins (AQPs) are membrane-bound protein channels that transport water 
across epithelia. At least thirteen AQPs are present in mammals, with AQP1, 3, 4 and 
7 known to be expressed in the human colon (Abascal et al., 2014). At present, little 
is known about regulation of aquaporins during enteric infection. However, infection 
of mice with C. rodentium triggered redistribution of AQP2 and 3 from the plasma 
membrane to the cytoplasm of colonocytes (Guttman et al., 2007). Surface 
expression of AQPs was re-established in mice that recovered from infection. This 
redistribution of AQPs was partially dependent on expression of EspF and EspG, 
since AQP2 and 3 remained on the surface of colonocytes following infection with 
∆espF and ∆espG mutant strains. It is yet to be established whether EHEC infection 
affects water transport by aquaporins in humans. 
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1.5.1.6 | Regulation of A/E gene expression 
Most of the genes involved in A/E lesion formation are located in the locus of 
enterocyte effacement (LEE). The LEE consists of 41 genes arranged across five 
transcriptional units (LEE1-5); with LEE1, LEE2 and LEE3 encoding structural 
components of the T3SS, LEE4 encoding the translocation pore, and LEE5 encoding 
intimin and Tir (Elliott et al., 1998). Transcriptional regulation of the LEE is 
orchestrated by three self-encoded core regulators and an array of non-LEE-encoded 
proteins (Figure 1.9) (reviewed in Connolly et al., 2015; Mellies et al., 2007). The 
LEE-encoded regulator (Ler) is found on LEE1 and is the master regulator of LEE2-
5 transcription. Deletion of ler compromises EHEC virulence, demonstrated by 
reduced effector secretion and actin pedestal formation during infection of HeLa 
cells (Elliott et al., 2000). Ler activates LEE transcription by antagonising the 
activities of the global gene repressor, HN-S (Bustamante et al., 2001). Also encoded 
on the LEE are the global regulators of Ler, GrlA and GrlR, which activate and 
repress ler activity, respectively (Iyoda et al., 2006). Non-LEE encoded regulators of 
LEE transcription include the Pch proteins (Iyoda and Watanabe, 2004), quorum-
sensing in E. coli (Qse) signalling proteins (Reading et al., 2007; Sperandio et al., 
2002), and GadE, a regulator involved in resistance to acid stress (Kailasan Vanaja et 
al., 2009). Interestingly, bacteriophage-derived proteins have also been shown to 
influence LEE expression. Xu and colleagues (2012) have reported that the Stx2 
prophage regulator cII, found in most virulent EHEC strains, is capable of inhibiting 
ler activity and expression of LEE-encoded effectors, suggesting that Stx2 lysogeny 
may suppress A/E lesion formation in EHEC. Thus, the mechanisms controlling the 
A/E phenotype are manifold. 
In recent years, it has become increasingly clear that a vast array of external cues 
influences A/E gene expression in EHEC. Many of these cues have been shown to 
interact with the regulatory mechanisms described above to promote or repress 
transcription of A/E genes. These interactions are summarised in Figure 1.9B and 
discussed in more detail below. 
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Figure 1.9. Regulation of the LEE in EHEC. (A) Core regulation by LEE-encoded 
regulators. (B) Influence of external cues on LEE transcription and the regulatory 
pathways involved. Pointed and blunt arrows denote positive and negative 
regulation, respectively. 
 
1.5.1.6.1 | Acid stress 
EHEC are exposed to rapidly increasing and decreasing acidity as they enter and 
leave the stomach. House and colleagues (2009) have postulated that acid stress 
triggers virulence gene expression in EHEC O157:H7. The authors reported that 
exposure to buffered-adaptive acid stress (incubation for a brief period at pH 5.0 
followed by pH 3.0 for 30 minutes) significantly enhanced the ability of EHEC to 
adhere to Caco-2 and HeLa cells. However, this adherence was not intimin-
dependent, and microarray analysis revealed variable effects on LEE-encoded T3SS 
genes, suggesting that acid stress did not induce A/E-associated virulence. 
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Conversely, several other research groups have demonstrated that acid stress 
negatively regulates A/E lesion gene expression. It has been shown that inactivation 
of GadE, one of the two main proteins known to mediate acid resistance (AR) in 
response to acidic conditions, results in up-regulation of many LEE-encoded genes 
and enhanced adherence to Caco-2 cells (Kailasan Vanaja et al., 2009; Tatsuno et al., 
2003). GadE-mediated inhibition of LEE gene expression was dependent on Ler 
(Kailasan Vanaja et al., 2009), and a later study confirmed that GadE binds to 
promoter regions on both LEE1 and LEE2 (Tree et al., 2011). This data suggests that 
GadE inversely coordinates AR and LEE gene expression depending on 
environmental pH levels; acting to inhibit LEE expression in favour of AR during 
acid stress, and vice versa in times of low acid stress (Kailasan Vanaja et al., 2009). 
Interestingly, a recent study has demonstrated that EHEC activates GadE-mediated 
repression of LEE expression in response to nitric oxide (NO) (Branchu et al., 2014), 
which is found in gastric juices, further highlighting the important role of GadE in 
regulation of A/E pathogenesis. 
 
1.5.1.6.2 | Butyrate 
During passage through the intestine, EHEC encounters a vast array of molecules 
produced by the resident microflora and the host. Bacterial metabolites include the 
short chain fatty acids (SCFA); of which acetate, propionate and butyrate are most 
abundant in the GI tract (Cummings et al., 1987). SCFAs are utilised by the host to 
promote normal bowel function; in particular, butyrate is the preferred energy source 
for colonocytes and is thought to be protective against colitis and colorectal cancer 
(Hamer et al., 2008). Interestingly, Nakanishi and colleagues (2009) have shown that 
EHEC uses butyrate to stimulate virulence gene expression. EHEC exposure to 
butyrate at levels comparable to those found in the terminal ileum (1.25 to 40 mM) 
resulted in enhanced adherence to Caco-2 cells and increased expression of LEE-
encoded genes tir and espB. Induction of these genes by butyrate was dependent on 
expression of ler, as well as the gene encoding PchA. PchA is a known positive 
regulator of ler expression (Iyoda and Watanabe, 2004) and shares sequence 
homology to the Per regulators of LEE transcription found in EPEC (Porter et al., 
2004). In addition, the protein responsible for sensing butyrate in EHEC has been 
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identified as the global regulator, leucine-responsive regulatory protein (Lrp) 
(Nakanishi et al., 2009). As no recognition site for Lrp could be identified in or 
around the pchA gene sequence, the authors concluded that Lrp must induce LEE 
expression via indirect regulation of pchA. Butyrate has also been shown to induce 
EHEC production of flagella (Tobe et al., 2011). 
 
1.5.1.6.3 | Quorum-sensing signalling molecules 
The idea that quorum-sensing (QS) plays a role in A/E virulence gene regulation was 
first proposed by Sperandio and colleagues, who found that exposure of EHEC to 
preconditioned medium containing EHEC secreted products resulted in induction of 
ler and other LEE-encoded genes. (Sperandio et al., 2002; Sperandio et al., 1999). 
This effect was mediated by the action of a novel regulatory protein, which the 
authors named quorum-sensing E. coli regulator A (QseA). This discovery 
stimulated a wave of research into QS-mediated control of EHEC virulence, and 
several additional regulatory cascades have been discovered. A two-component 
system, involving the sensory kinase QseE and the response regulator QseF, induces 
expression of the non-LEE-encoded gene tccP (Reading et al., 2007); whilst a 
second two component system, involving QseC and QseB, triggers expression of 
genes encoding Ler, flagellin, and other motility factors (Clarke and Sperandio, 
2005; Hughes et al., 2009). These two regulatory systems appear to be linked, since 
stimulation of QseC results in activation of QseE (Reading et al., 2007). 
Furthermore, both systems are triggered upon detection of the host hormones 
adrenaline and noradrenaline, and the QseCB pathway is also responsive to the 
bacterial signalling molecule, autoinducer-3 (AI-3) (Clarke et al., 2006; Reading et 
al., 2007). AI-3 is abundant in the intestines, as it is secreted by the resident 
microflora (Sperandio et al., 2003; Walters et al., 2006). Both adrenaline and 
noradrenaline are also found in the GI tract, where they modulate smooth muscle 
contraction, submucosal blood flow, and ion secretion (Furness, 2000; Horger et al., 
1998). Based on these data, it appears that EHEC uses host hormones and/or secreted 
bacterial signalling molecules as a spatial cue to stimulate expression of the LEE, 
tccP and flagella genes upon entry into the intestine. At present, the external cue(s) 
responsible for QseA-mediated regulation of the LEE have not been resolved. 
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Recently, ethanolamine (EA) has been highlighted as another stimulus for A/E gene 
regulation via the QS pathways. EA, the breakdown product of 
phosphatidylethanolamine (PE), is an essential constituent of all cell membranes and 
is abundant in the intestinal lumen due to the constant shedding of IECs (Cotton, 
1972). EHEC possesses an operon (the eut operon) that allows it to utilise EA as a 
nitrogen source, which gives it a competitive advantage over other bacterial species 
(Bertin et al., 2011). In a study by Kendall et al. (2012), EHEC exposure to EA 
triggered expression of ler, eae, and espA; as well as enhanced actin pedestal 
formation on HeLa cells. EA exposure was also associated with higher transcript 
levels of qseA, qseE and qseC, suggesting that EA induces the A/E phenotype via 
QS. Deletion of the eutB gene did not affect EA-mediated induction of ler 
expression, indicating that EA-mediated induction of A/E gene expression is not the 
indirect result of EA metabolism. 
 
1.5.1.6.4 | Fucose 
Fucose is one of the preferred carbon sources for E. coli in the human gut (Fabich et 
al., 2008). It is made abundantly available in the intestinal mucus by the commensal 
bacterium Bacteroides thetaiotaomicron, due to its ability to cleave fucose from 
mucin glycoproteins (Fischbach and Sonnenburg, 2011). In a recent study, Pacheco 
et al. (2012) reported that EHEC exposure to fucose at levels found in the mucus 
layer resulted in direct suppression of ler transcription via the action of a novel two-
component signalling system, termed FusKR. In the same study, FusKR activity was 
inhibited by the aforementioned QseBC and QseEF regulatory pathways, thereby 
demonstrating another mechanism for QS-mediated induction of A/E genes. Based 
on this data, the authors proposed a model whereby EHEC uses fucose as a cue to 
suppress A/E gene expression whilst in the mucus via FusKR; once at the intestinal 
epithelium, exposure to reduced fucose levels and/or induction of Qse signalling 
results in the lifting of FusKR-mediated repression of LEE transcription, allowing 
expression of A/E genes to ensue. 
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1.5.1.6.5 | Biotin 
Biotin is an essential nutrient for maintaining cellular function in all living 
organisms. Bacteria are able to obtain biotin either from the environment or by 
synthesising it themselves, whereas humans lack the biotin synthesis machinery and 
must therefore rely on intestinal absorption (Said, 2009). The extent of biotin 
absorption in the small intestine leads to relatively low levels of biotin present in the 
colon (Yang et al., 2015). In a recent study by Yang and colleagues (2015), the role 
of biotin in EHEC virulence gene expression was examined. The study showed that 
exposure of EHEC to high levels of biotin abrogated adherence to HeLa and Caco-2 
cells, colonisation of mice, and expression of ler, eae, tir, and genes encoding T3S 
apparatus proteins. This effect was dependent on bacterial expression of birA, a 
regulatory protein that represses biotin synthesis when the nutrient is abundant in the 
environment. BirA was found to negatively regulate the global regulator protein, Fur, 
which in turn was shown to stimulate LEE gene expression. The authors proposed a 
model whereby EHEC exposure to reduced biotin levels in the colon leads to a 
reduction in BirA-mediated repression of Fur, enabling Fur to stimulate expression 
of LEE genes encoding A/E lesion formation. Interestingly, A/E gene expression in 
EPEC was unaffected by biotin, and it was suggested by the authors that this may 
account for the difference in tissue tropism exhibited between EPEC and EHEC 
(Yang et al., 2015). No evidence for Fur binding to promoter regions on the LEE, nor 
to those on regulatory genes such as GrlA/R or QseA, was observed; indicating that 
Fur likely induces LEE expression indirectly via an unidentified regulator. 
 
1.5.1.6.6 | Oxygen 
Upon entry into the GI tract, EHEC is exposed to rapidly decreasing oxygen 
concentrations. Non-invasive imaging of oxygen in mice suggests that colonic 
oxygen concentrations are around 1.4% of atmospheric pressure, which is considered 
microaerobic (MA) (He et al., 1999). To investigate the effect of microaerobiosis on 
EHEC expression of A/E lesion genes, Schüller and Philips (2010) developed a 
vertical diffusion chamber (VDC) system to perform infections under MA 
conditions. The authors found that EHEC displayed enhanced adherence to polarised 
T84 cells and production of Tir, EspA and EspB in MA conditions compared with 
52 
 
aerobic (AE) conditions. Increased Tir translocation into the host membrane, a 
marker for intimate attachment and A/E lesion formation, was also observed during 
MA infection of Caco-2 cells. Adherence of an espA mutant was not affected by 
microaerobiosis, suggesting that oxygen regulates expression of LEE-encoded genes. 
Girard and colleagues (2007) also reported a positive effect of reduced oxygen levels 
on EHEC adherence during bovine intestinal IVOC. Put together, it appears that the 
reduction in environmental oxygen concentration experienced upon entry into the 
intestine triggers expression of the A/E phenotype by EHEC. To date, the 
mechanisms underlying this effect are yet to be explored. 
 
1.5.1.6.7 | Contact with IECs 
During their study of oxygen-mediated effects on the A/E lesion phenotype, Schüller 
and Phillips (2010) noted that EHEC expression of the T3S proteins Tir, EspA and 
EspB was induced only in the presence of an IEC monolayer. Moreover, incubation 
with preconditioned T84 cell medium was not sufficient to induce T3SS activity, 
suggesting that physical contact with host IECs was required. In agreement with 
these findings, Roe et al. (2004) have shown that centrifugation of EHEC bacteria 
onto embryonic bovine lung (EBL) epithelial cells is sufficient to induce bacterial 
expression of Tir in an environment where T3SS expression is usually repressed (i.e. 
during incubation in M9 medium). The impact of host cell contact on A/E virulence 
gene expression has recently been studied in detail by Alsharif and colleagues 
(2015), who reported that EHEC exhibited higher levels of LEE1 promoter activity 
when adhered to HeLa cells compared with glass slides. Induction of LEE1 
expression and actin pedestal formation was dependent on GrlA, and was not 
affected by inhibition of host cell signalling. In addition, the authors demonstrated 
that exposure of EHEC to fluid shear, at levels comparable to those found at the 
exposed brush border (up to 5 dynes/cm3), further induced LEE1 activation. These 
data suggest that EHEC are able to sense physical contact with IECs and mechanical 
fluctuations associated with peristalsis as a cue for enhancing expression of genes 
responsible for A/E lesion formation. At present, it is not known how GrlA is 
activated in response to these cues, although it has been established that GrlR is not 
involved. 
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It is clear from the available data that regulation of A/E lesion formation in EHEC is 
a complex process that involves sensing of a variety of environmental cues using 
several regulatory pathways. The challenge remains to unravel how these pathways 
interact to coordinate spatial and temporal expression of the A/E lesion phenotype as 
EHEC travels through the GI tract. 
 
1.5.1.7 | Clinical relevance of A/E lesion formation 
Although A/E lesion formation has been well-characterised using human carcinoma 
cell lines such as HeLa, very few studies have examined EHEC pathogenesis on 
human intestinal tissue. In 2000, Phillips et al. employed the IVOC model to 
investigate A/E lesion formation by EHEC strain 85-170 and EPEC strain E2348/69 
at various human intestinal sites (Phillips et al., 2000). The authors reported that, 
whilst EPEC triggered A/E lesion formation on biopsies from the proximal and distal 
small intestine, EHEC-induced A/E lesions were restricted to the follicular-
associated epithelium (FAE) of Peyer’s patches in small intestinal biopsies. No 
EHEC adherence to colonic biopsies was observed, which is striking as EHEC-
induced intestinal damage is localised to the transverse colon (Griffin et al., 1990; 
Kelly et al., 1987; Malyukova et al., 2009; Shigeno et al., 2002). To address this 
discrepancy, the same research group extended the scope of their initial study by 
performing IVOC on biopsies from a wider range of colonic sites (caecum to rectum) 
and using several different EHEC strains. However, A/E lesions were observed in 
only 4 out of 113 colonic IVOCs (Chong et al., 2007). To determine whether 
adherence to FAE was required to prime EHEC for colonic colonisation, a two-step 
IVOC experiment was performed in which FAE-containing terminal ileal biopsies 
were infected with EHEC and then co-cultured with colonic biopsies. Results 
showed that priming of EHEC on FAE enhanced colonic colonisation. However, 
bacteria bound to colonic biopsies exhibited a non-intimate adherence phenotype 
inconsistent with A/E lesions (Chong et al., 2007). Put together, these data indicate 
that EHEC do not form A/E lesions on human colonic epithelium ex vivo, and 
therefore cast doubt on their role in colonic pathogenesis in vivo. 
Several limitations to the aforementioned studies exist, which may have affected the 
ability of EHEC to form A/E lesions on colonic biopsies. Firstly, all of the EHEC 
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strains tested were Stx-negative, which may be relevant as Stx has been shown to 
enhance EHEC adherence to HeLa cells and colonisation of mice (Robinson et al., 
2006; section 1.5.2.3). Secondly, these IVOC experiments were performed under 
95% oxygen in order to maintain oxygenation of the explanted intestinal tissue, 
which may have inhibited expression of A/E genes (section 1.5.1.6.6). Thirdly, only 
biopsies derived from paediatric donors have been used for IVOC, and so it is 
currently undetermined whether EHEC colonise intestinal biopsies isolated from 
adults. To date, the effect of age on EHEC adherence has not been studied. 
In vivo animal studies have shown that EHEC forms colonic A/E lesions following 
infection of gnotobiotic piglets, infant rabbits and neonatal calves (Dean-Nystrom et 
al., 1997; Francis et al., 1986; Pai et al., 1986; Tzipori et al., 1986). These studies 
were performed using young animals, which lack an intestinal microbiota, in order to 
avoid the effects of colonisation resistance. In contrast, clinical examination of 
human intestinal samples from EHEC-infected patients has not yielded evidence of 
adherent bacteria (Kelly et al., 1987; Malyukova et al., 2009), although it should be 
noted that samples are generally taken at a progressed stage of disease when 
colonisation may have diminished or be obscured. More ex vivo human tissue studies 
are needed in order to clarify whether A/E lesions have clinical relevance to human 
disease during EHEC infection. 
 
1.5.2 | Shiga toxin production 
Shiga toxin (Stx) production distinguishes EHEC from all other A/E pathogens. Stxs 
are a family of exotoxins whose name derives from the first bacterial species found 
to produce the toxin, Shigella dysenteriae type I (Olitsky and Kligler, 1920). Whilst 
Stx from Shigella is considered the prototype, EHEC produce two antigenically and 
structurally distinct toxins termed Stx1 and Stx2 (Bergan et al., 2012). Stx1 exhibits 
99% sequence homology to Stx produced by S. dysenteriae, whereas Stx2 shares 
approximately 56% homology (Jackson et al., 1987a; Jackson et al., 1987b; 
Strockbine et al., 1986). Several Stx1 and Stx2 subtypes exist (see Table 1.3), and 
EHEC are capable of harbouring one or several of these subtypes. Stx2 is more 
closely associated with disease in humans compared with Stx1 (Boerlin et al., 1999; 
Werber et al., 2003). Whilst the characteristics of each individual subtype are yet to   
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Table 1.3. List of Stx subtypes. Adapted from Bergan et al. (2012)  
 
be elucidated in detail, all Stx2 subtypes have been found in human EHEC isolates 
except for Stx2g, which was derived from a cattle isolate (Bergan et al., 2012; Leung 
et al., 2003). Stx2a- and Stx2c-producing strains are most often associated with HUS 
compared with strains producing other Stx subtypes (Karch et al., 2006; Orth et al., 
2007). Stx2e has been linked to oedema disease in pigs (Weinstein et al., 1988). 
Interestingly, Stx2d cytotoxicity is enhanced by exposure to human and mouse 
intestinal mucus (Melton-Celsa et al., 1996) suggesting that Stx activity may be 
modulated by external cues. 
Stx is a holotoxin with an AB5 molecular structure. The 32-kDa A subunit is located 
in the centre of a doughnut-shaped ring of five identical 7.7-kDa B subunits (Fraser 
et al., 1994). The A subunit is responsible for the toxin’s enzymatic activity, whilst 
the B subunits mediate binding to the host cell surface glycolipid, 
globotriaosylceramide (Gb3; also known as CD77) (Lindberg et al., 1987). Stx 
binding to Gb3 triggers internalisation of the toxin, retrograde transport through the 
cell, and inhibition of protein synthesis and apoptosis (Figure 1.10). Gb3 is highly 
expressed in the microvasculature of the colon and the kidney, and it is thought that  
 
Subtype 
 
Source 
A subunit 
homology 
B subunit 
homology 
 
Reference(s) 
Stx S. dysenteriae Type 
1 
prototype prototype Strockbine et al., 1988 
Stx1(a) E. coli O157:H7 99% 100% Calderwood et al., 1987; 
Jackson et al., 1987b 
Stx1c E. coli O128:H2 97% 97% Zhang et al., 2002 
Stx1d E. coli ONT:H19 94% 92% Bürk et al., 2003 
     
Stx2(a) E. coli O157:H7 prototype prototype Jackson et al., 1987a 
Stx2b E. coli O118:H12 94% 89% Piérard et al., 1998 
Stx2c E. coli O157:H7 100% 97% Schmitt et al., 1991 
Stx2d E. coli O91:H21 99% 97% Teel et al., 2002 
Stx2e E. coli O139 94% 87% Gyles et al., 1988; Weinstein et 
al., 1988 
Stx2f E. coli O128:H2 71% 83% Schmidt et al., 2000 
Stx2g E. coli O2:H25 96% 94% Leung et al., 2003 
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Figure 1.10. Intracellular Stx transport within Gb3-positive cells. (1) The B 
subunits (blue) of Stx bind to host cell receptor Gb3; (2) the B subunits trigger 
membrane invagination leading to internalisation of the toxin into an early 
endosome; (3) Stx is transferred from the endosome to the Golgi apparatus, where it 
begins its migration to the endoplasmic reticulum (ER) via the retrograde transport 
pathway; (4) once in the ER, the A subunit (red) dissociates from the B subunits and 
is targeted for ER-associated degradation (ERAD); (5) the ERAD pathway releases 
the A subunit into the cytosol, at which point the subunit refolds, thus preventing 
proteasomal degradation. This is followed by ribosomal binding and cleavage of a 
single adenine residue of the 28S rRNA by N-glycosidase activity. Disruption of 
protein synthesis leads to activation of a ribotoxic response and subsequent apoptosis 
(Johannes and Romer, 2010; Pacheco and Sperandio, 2012). 
 
Stx-mediated cytotoxic action at these sites is responsible for the onset of HC and 
HUS, respectively (Tarr et al., 2005). Stx2 exhibits 400 times greater renal toxicity in 
mice compared with Stx1 (Tesh et al., 1993), which may explain the closer 
association of Stx2-producing strains with HUS. 
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1.5.2.1 | Regulation of Stx expression and release 
Stx is encoded within the late genes of lambdoid prophages integrated into the EHEC 
chromosome (Johansen et al., 2001). Expression of stx is controlled by phage-
encoded promoters: the pstx promoter induces expression of stx genes only, whereas 
PR and PR’ control expression of all phage genes including stx and the genes involved 
in bacterial cell lysis (Figure 1.11). Induction of stx1 expression is mainly mediated 
by pstx, which is subject to negative regulation by the global regulator protein Fur 
(Calderwood and Mekalanos, 1987). In contrast, stx2 expression is regulated by PR 
and PR’ without the involvement of pstx (Wagner et al., 2001b). PR and PR’ expression 
are repressed in homeostatic conditions by the regulatory protein cI, which binds to 
an ‘operator site’ (OR) upstream of the promoters (Waldor and Friedman, 2005). 
Removal of cI-mediated repression results in activation of PR and PR’, which in turn 
induce expression of stx2 (Tyler et al., 2004). This process also leads to expression 
of genes involved in the phage lytic cycle, meaning that induction of stx2 is 
inexorably linked to bacterial cell lysis (Neely and Friedman, 1998; Wagner et al., 
2001b). This differential regulation of stx1 and stx2 expression results in different 
cellular localisation: whereas Stx1 remains predominantly intracellular within the 
periplasmic space, Stx2 is mainly found extracellularly in bacterial supernatants 
(Shimizu et al., 2009; Strockbine et al., 1986). However, both Stx1 and Stx2 have 
been identified within outer membrane vesicles (OMVs) secreted by EHEC (Kolling 
and Matthews, 1999), indicating an alternative pathway of toxin release to cell lysis. 
Once released into the intestinal lumen, Stx traverses the epithelium by one or more 
putative mechanisms (reviewed in Schüller, 2011) and interacts with Gb3-positive 
cells in the colon and kidney, leading to systemic disease. 
Bacterial expression of stx1 and stx2 is induced a by a number of external cues, 
which are discussed below. 
 
1.5.2.1.1 | Iron 
Iron is an essential nutrient for all living organisms, and enteric pathogens must 
acquire iron from the external GI environment in order to survive (Skaar, 2010). In 
1982, O’Brien and colleagues reported that incubation of certain E. coli strains in 
iron-depleted broth resulted in production of a toxin that could be neutralised with  
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Figure 1.11. Regulation of Stx expression. (A) Repression of Stx phage during 
lysogeny (B) Induction of stx1 expression (based on Wagner et al., 2002) (C) 
Induction of stx2 expression (based on Pacheco and Sperandio et al., 2012). Phage 
encoded and native regulators are shown in red and grey, respectively. Pointed and 
blunt arrows denote positive and negative regulation, respectively. 
 
antibodies raised against the Shigella dysenteriae type I toxin (O'Brien et al., 1982). 
Following the subsequent discovery of the EHEC pathotype, it was demonstrated 
that low iron concentrations induces expression of stx1 in EHEC by releasing Fur-
mediated repression of pstx (Calderwood and Mekalanos, 1987). As Stx-mediated 
damage to the colonic microvasculature is thought to cause HC, it is possible that 
EHEC produces Stx1 under low iron conditions as a means of triggering the 
migration of iron-rich blood into the lumen. However, this strategy would require a 
mechanism for Stx1 release from the bacteria, which is yet to be presented. Iron does 
not appear to play a role in regulation of Stx2 expression (Sung et al., 1990). 
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1.5.2.1.2 | DNA damage 
In the years following the discovery of EHEC, several research groups noted that 
EHEC production of Stx2 was enhanced by DNA-damaging agents such as UV 
radiation, mitomycin C and antibiotics (Acheson and Donohue-Rolfe, 1989; Al-
Jumaili et al., 1992; Muhldorfer et al., 1996). Mühldorfer and colleagues (1996) 
demonstrated that mitomycin C-mediated induction of stx2 expression was 
dependent on RecA, a protein involved in the SOS response. The SOS response is a 
conserved bacterial mechanism for coping with conditions that cause DNA damage, 
and mediates DNA repair, inhibition of cell division and induction of prophages 
(Little and Mount, 1982). Upon induction of the SOS response, RecA cleaves cI to 
de-repress PR and PR’, resulting in expression of stx2 and the rest of the phage 
genome (Koudelka et al., 2004). This association between the SOS response and stx2 
expression is thought to explain why treatment of EHEC infections with certain 
antibiotics increases the risk of developing HUS (Pacheco and Sperandio, 2012). 
 
1.5.2.1.3 | QS signalling ligands 
In addition to its effect on LEE and flagellar gene expression (section 1.5.1.6.3), 
adrenergic QS signalling has been shown to regulate stx2 expression. In 2001, 
Sperandio and colleagues reported that inhibition of QS pathways in EHEC results in 
reduced expression of stx2, as well as recA and other SOS response regulators 
(Sperandio et al., 2001). Hughes et al. (2009) later confirmed the role for QS in stx2 
regulation by showing that exposure to adrenaline or AI-3 results in expression of 
stx2 in wild-type but not ΔqseC EHEC. The authors also found that QseC-mediated 
induction of stx2 expression occurs via QseF. In addition, EA triggers expression of 
stx2, together with qseC, qseF and qseA (Kendall et al., 2012). Put together, these 
studies indicate that EHEC detection of adrenaline, AI-3 and EA by QS results in 
induction of SOS response proteins, which in turn trigger production of Stx2. It is 
currently unclear whether detection of these external stimuli leads to induction of 
other SOS response-associated effects. 
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1.5.2.1.4 | Hydrogen peroxide and NO 
Neutrophils produce DNA damaging agents such as hydrogen peroxide (H2O2) and 
NO (Carreras et al., 1996), and so investigators have examined the role of these 
molecules in Stx regulation. Wagner and colleagues (2001a) showed that incubation 
of EHEC with human neutrophils or H2O2 resulted in enhanced stx2 expression. This 
effect has since been corroborated by Los et al. (2010), who suggested that oxidative 
stress conditions in the GI tract may contribute to Stx production by EHEC. In 
contrast, NO has been shown to inhibit stx2 expression in EHEC exposed to 
mitomycin C. This effect was associated with a reduction in recA expression, 
indicating that NO negatively affects stx2 expression by repressing the SOS response 
(Vareille et al., 2007). Put together, this data suggests that neutrophils can modulate 
stx2 expression during EHEC infection by secretion of H2O2 or NO, respectively. 
However, a role for neutrophils or secreted factors on Stx production during in vivo 
infection has not been demonstrated. 
 
1.5.2.1.5 | Regulation of Stx expression levels 
A seminal paper by Wagner et al. has shed light on possible mechanisms by which 
the Stx-encoding bacteriophage itself may influence the level of Stx expressed in the 
bacterial host (Wagner et al., 2002). By constructing lysogens containing mutant H-
19B prophages (a Stx1-encoding prophage isolated from O26:H11 strain H19), the 
authors demonstrated several key findings. One of these was that mutation of the P 
gene, which is essential for prophage replication, resulted in a significant reduction 
in Stx1 production following mitomycin C-mediated induction. This indicated that 
prophage replication is a major contributor to phage-regulated Stx1 production, 
likely by increasing the copy number of stx1 and therefore the amount expressed 
following induction. This was corroborated by the observation that prophage 
induction by mitomycin C results in increased detection of stx1A by Southern 
hybridisation in wt but not ΔP H19. More recently, a study by Fogg et al. confirmed 
a cumulative effect of prophage burden on Stx production in EHEC by comparing stx 
transcription and translation in E. coli K12 single and double isogenic lysogens of 
Stx phage φ24B (Fogg et al., 2012). Not only did the double lysogen express higher 
levels of toxin compared with the single lysogen, but they were also more sensitive 
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to induction by the antibiotic norfloxacin. These data indicate that prophage/stx copy 
number is likely to influence both the degree of induction and the level of Stx 
produced by induced bacteria. 
A second key finding from the study by Wagner and colleagues was that deletion of 
the S gene involved in phage-mediated lysis resulted in prolonged accumulation of 
Stx1 relative to wt cells, indicating that the timing of cell lysis (and therefore Stx 
release) is also likely to influence the quantity of Stx produced (Wagner et al., 2002). 
In many lambdoid phages, the S gene can be translated in one of two methionine start 
sites, yielding either a short product that induces lysis or a longer product that 
inhibits lysis (Neely and Friedman, 1998). It is thought that the relative concentration 
of these two products dictates the time of bacterial lysis, which would in turn affect 
the amount of Stx produced before lysis. However, genetic analysis of the S gene 
located on the H19B prophage did not reveal the same conserved dual translational 
start site found in the S gene of other start sites (Neely and Friedman, 1998), and it 
remains to be determined whether this prophage possesses another mechanism for S-
mediated control of cell lysis. 
Further investigation into how prophage-mediated control of stx expression and cell 
lysis may influence Stx expression levels is of great interest in that it may yield 
knowledge of prophage-specific molecular interactions that can be exploited for 
therapeutic inhibition of Stx expression. In this regard, it would prove particularly 
useful to shed light on how this phenomenon is influenced by external stimulatory or 
inhibitory factors. 
 
1.5.2.2 | Stx interaction with the human intestinal epithelium 
Most functional Stx research has focussed on its effect on Gb3-expressing cells, as 
Stx-mediated damage to these cells is linked to development of HC and HUS 
(Johannes and Römer, 2010). However, Gb3-negative IECs represent the first point 
of contact between Stx and the host, and so may play an equally important role in 
EHEC pathogenesis. 
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1.5.2.2.1 | Internalisation of Stx into IECs 
Analysis of human intestinal tissue has revealed that IECs do not express Gb3 on 
their surface (Björk et al., 1987; Holgersson et al., 1991; Miyamoto et al., 2006; 
Schüller et al., 2004). This lies in contrast to most commonly-used colonic 
carcinoma cell lines (e.g. Caco-2, HT-29), which express Gb3 and are susceptible to 
Stx cytotoxicity (Jacewicz et al., 1995; Schüller et al., 2004). On the other hand, T84 
colonic carcinoma cells do not express Gb3 (Jacewicz et al., 1995; Miyamoto et al., 
2006; Schüller et al., 2004), which makes them the most physiologically accurate in 
vitro model with which to study Stx interactions with the human intestinal 
epithelium. 
Interestingly, it has been reported that incubation of T84 cells with Stx results in 
internalisation of the toxin, despite the absence of the Gb3 receptor (Philpott et al., 
1997; Schüller et al., 2004). Intracellular Stx was visualised in association with the 
Golgi apparatus and the ER, suggesting intracellular toxin trafficking via retrograde 
transport (Philpott et al., 1997) similar to that described in Gb3-positive cells (Figure 
1.10; Johannes and Römer, 2010). However, T84 cells do not show reduced protein 
synthesis or apoptosis following Stx internalisation, indicating that ERAD 
retrotranslocation of the toxin from the ER to the cytosol is likely disrupted (Schüller 
et al., 2004). Importantly, addition of Stx to the apical side of polarised T84 cell 
monolayers results in translocation to the basolateral compartment without affecting 
epithelial barrier function (Maluykova et al., 2008; Philpott et al., 1997; Tran et al., 
2014). Further characterisation of Stx internalisation in these cells has implicated a 
role for a clathrin-independent endocytosis pathway resembling macropinocytosis 
(MPC), a non-receptor-mediated method of taking up extracellular solute 
macromolecules within large actin-coated vesicles (Malyukova et al., 2009). Toxin 
uptake was significantly reduced by known inhibitors of MPC during incubation of 
T84 cells with purified Stx and Stx-negative EHEC, and the bacterial serine protease 
EspP was found to be sufficient to stimulate toxin internalisation via this route 
(Malyukova et al., 2009; In et al., 2013). However, a recent study of Stx 
translocation using a wild-type EHEC infection model reported no effect of MPC 
inhibition on toxin transport through T84 cells (Tran et al., 2014), thereby casting 
uncertainty about the physiological relevance of this transport route. Nevertheless, it 
is clear that Gb3-independent Stx translocation through IECs is a reproducible 
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phenomenon in vitro, which may explain how Stx traverses the epithelium and 
causes systemic pathology during infection (Schüller, 2011). 
 
1.5.2.2.2 | Stx and EHEC adherence 
A role for Stx in EHEC adherence to epithelial cells has been postulated by Robinson 
and colleagues (2006), who showed that infection of HeLa cells with Stx-negative 
EHEC strain TUV 89-2 resulted in reduced adherence compared with the Stx-
producing 86-24 wild-type strain. In the same study, TUV 89-2 colonisation of mice 
was also significantly lower than that of 86-24. The authors hypothesised that host 
cell exposure to Stx induced surface expression of the putative intimin receptor 
nucleolin, which in turn promoted bacterial adherence. This theory was supported by 
data showing that incubation of HeLa cells with Stx resulted in increased surface 
expression of nucleolin (Robinson et al., 2006). Stx-enhanced EHEC adherence has 
also been demonstrated in HT-29 cells (Xicohtencatl-Cortes et al., 2007). However, 
infection of infant rabbits with an Δstx2 mutant of EHEC 905 resulted in similar 
levels of intestinal colonisation to the wild type, suggesting that Stx2 does not 
influence EHEC adherence to the intestinal epithelium in this model (Ritchie et al., 
2003). Therefore, the role of Stx in EHEC adherence remains controversial. 
 
1.5.2.2.3 | Stx and the innate immune response 
Many studies have examined the role of Stx in regulation of the innate immune 
response by IECs, with data supporting both stimulatory and inhibitory effects. This 
data is discussed in more detail in section 1.6.1.2. 
 
1.5.2.3 | Role of Stx outside the human host 
Despite a wealth of research into the role of Stx during EHEC infection of humans, 
there is very little evidence from these studies to suggest where the evolutionary 
advantage for Stx prophage carriage actually lies. EHEC infection of humans is a 
relatively rare occurrence compared to infection of cattle. Indeed, it is generally 
accepted that ruminants represent the primary hosts for EHEC and that infection of 
humans is an incidental occurrence (Dean-Nystrom et al., 1998a; Hancock et al., 
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1998). Therefore, the role of Stx prophage carriage in EHEC survival is most likely 
related to life within the ruminant host or in the external environment. Interestingly, 
EHEC infection of cattle is generally asymptomatic and does not result in the Stx-
associated pathology (i.e. HC, HUS) that arises during human infection (reviewed in 
Smith et al., 2002), despite the fact that Stx is present in cow pats at detectable levels 
(Ball et al., 1994; Hyatt et al., 2001) and that Stx expression in EHEC O157:H7 has 
been linked with increased faecal shedding in cattle (Hoffman et al., 2006). This 
suggests that Stx interacts differently with cattle compared with humans, perhaps in a 
way that confers a selective advantage to the host bacterium. 
 
One hypothesis for the selective advantage of the Stx prophage is that it facilitates 
EHEC transmission, colonisation and/or survival within the ruminant host. As 
previously mentioned in section 1.5.2.2.2, Stx has been shown to promote 
colonisation of mice and adherence to immortalised epithelial cells (Robinson et al., 
2006), and so it is possible that Stx may also facilitate colonisation of the lower 
intestinal epithelium in ruminants. In addition, Stx has been shown to modulate 
various aspects of the bovine immune system. Menge et al. reported that purified 
Stx1 induced apoptosis in stimulated immortalised bovine B cells and hindered 
activation of peripheral blood mononuclear cells isolated from bovine blood (Menge 
et al., 1999). In a later study, the same group demonstrated that ileal intraepithelial 
lymphocytes (IELs) were also affected by Stx: exposure to purified Stx1 resulted in 
significant loss of the Gb3+ subset of IELs and reduced mitogen-mediated activation 
in the remaining cells (Menge et al., 2004). Ileal IELs have also been shown to 
exhibit elevated expression of interleukin 4 (IL-4) in the presence of Stx1 (Moussay 
et al., 2006), and primary bovine mucosal macrophages show reduced surface 
expression of CD14 and CD172a and elevated expression of a range of cytokines 
(Menge et al., 2015). All of these cell types have been shown to express Gb3 on their 
surface and bind Stx1 (Stamm et al., 2002; Menge et al., 2004; 2015). Put together, 
these findings suggest that Stx1 impairs the initiation of the adaptive and/or 
inflammatory response in cattle by targeting a range of immune cells including 
lymphocytes and macrophages. This likely benefits EHEC by preventing immune-
mediate killing, and therefore may represent the selective force behind EHEC 
retention of the Stx prophage. 
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Aside from the advantages conferred by direct interactions with the ruminant host, it 
has been suggested that the Stx prophage may confer protection against predation by 
other inhabitants of the GI tract. For example, the rumen is populated by a range of 
protozoan species that graze on bacteria, including those from the genera 
Eudiplodinium, Metadinium, Polyplastron, Isotrichia, Entodinium and Diplodinium 
(Rasmussen et al., 2005). Interestingly, Steinberg and Levin reported that lysogeny 
of E. coli K12 with a Stx2-producing prophage resulted in augmented survival within 
the food vacuoles of the ciliated protozoan, Tetrahymena pyriformis (Steinberg and 
Levin, 2007). In addition, intracellular survival of EHEC O157:H7 harbouring stx1 
and stx2 was higher compared with K12, but O157:H7 strains containing stx1 alone 
or no stx genes showed no observable fitness advantage over K12 following 
ingestion by the ciliate. Lysogeny of K12 with a Stx2 prophage encoding a non-
functional stx2 gene resulted in enhanced survival compared with K12 but to a lesser 
extent than that observed with the lysogen containing functional stx2. Further to this 
study, Stoffa and Koudelka showed that Stx2 produced by EHEC EDL933 whilst 
encapsulated within Tetrahymena thermophila phagocytic vesicles resulted in killing 
of the protozoan cell by inhibition of protein synthesis (similar to its effect on 
mammalian cells), but only when the toxin was released via prophage-mediated lysis 
of the bacterium and not as a result of bacterial digestion by the host (2012). This 
suggests a possible explanation as to why stx is almost exclusively retained within a 
lytic prophage in EHEC, since phage-mediated lysis appears to be essential for toxin-
mediated attack on bacteriophagic protozoa (Stoffa and Kouldelka, 2012). 
 
This data suggests that possession of Stx-producing prophages confers protection 
against bacteriophagic protozoa, which could lead to increased success within the 
ruminant host (Steinberg and Levin, 2007). Furthermore, residing within protozoa 
could also result in sheltering from other hazards associated with the GI tract (e.g. 
predation, microbial toxins, host immune response) or the external environment (e.g. 
desiccation, predation, biocides) (Brandl, 2006). Thus, it seems that the selective 
advantage of harbouring the Stx prophage may be driven by its ability to enhance 
survival in environments other than the human host.  
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1.6 | Interaction with the innate immune system 
Enteric innate immune defences play a pivotal role in protecting humans from 
microbial infection, and many of these defences are orchestrated by the intestinal 
epithelium (Figure 1.12A). Specialised goblet cells secrete heavily-glycosylated 
proteins, called mucins, into the lumen, which form a dense layer of gel-like mucus 
that lines the epithelium (Linden et al., 2008). The mucus layer serves the dual 
purpose of providing a niche for the commensal microflora and forming a physical 
barrier between luminal microbes and the intestinal epithelium (Birchenough et al., 
2015; Juge, 2012). Intestinal epithelial enterocytes secrete a range of microbicidal 
molecules, called antimicrobial peptides (AMPs), into the lumen. Some of these 
AMPs (e.g. human β-defensin (hBD)-1) are constitutively produced and retained in 
the mucus layer, forming a biochemical barrier (Dommett et al., 2005; Mukherjee 
and Hooper, 2015). These preventative measures represent the front line of defence 
against infection by pathogenic microbes. 
The intestinal epithelium is also capable of mounting further innate immune defence 
mechanisms in the event of microbial attack (Figure 1.12B). IECs express pattern 
recognition receptors (PRRs), such as Toll-like receptors (TLRs) and NOD-like 
receptors (NLRs), which recognise microbe-associated molecular patterns (MAMPs) 
associated with bacterial cell walls or membranes (e.g. lipopolysaccharide (LPS), 
peptidoglycan, flagella or nucleic acids). Stimulation of PRRs by MAMPs triggers a 
cascade of pro-inflammatory signal transduction pathways. These include the nuclear 
factor κB (NF-κB) and mitogen-activated protein kinase (MAPK) pathways, which 
lead to activation of the transcription factors activator protein-1 (AP-1) and NF-κB, 
respectively (Li and Verma, 2002; Morrison, 2012). These transcription factors 
stimulate expression of a range of genes such as those encoding cytokines (e.g. 
interleukin (IL)-8, interferon (IFN)-γ, tumour necrosis factor (TNF)-α) and inducible 
AMPs (e.g. hBD2, LL-37). AMP production results in direct microbial killing via 
cell lysis, whilst secretion of cytokines leads to recruitment of specialised innate 
immune cells (e.g. dendritic cells (DCs), neutrophils, macrophages) that phagocytose 
microbes and secrete DNA-damaging agents (e.g. NO, H2O2). These immune cells 
migrate across the epithelium through TJs and attack invading microbes in the  
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Figure 1.12. Innate immune defence in the colon. (A) Mechanisms employed 
during homeostasis. IECs secrete mucins and AMPs to form a dense sterile inner 
mucus layer and a loose microbiota-rich outer layer. (B) Mechanisms employed 
during microbial attack. Detection of MAMPs by PRRs induces an inflammatory 
response characterised by production of inducible AMPs and recruitment of 
lymphocytes. 
 
68 
 
lumen. These defence measures are collectively termed the inflammatory response 
(Bergstrom et al., 2012; Brown et al., 2013). 
In addition to inducing inflammation, infected IECs are capable of undergoing cell 
death via apoptosis as a mechanism of killing and/or displacing invading bacteria. 
Apoptosis is induced following microbial stimulation of ‘death receptors’ on the IEC 
membrane (Wong Fok Lung et al., 2014). 
The multitude of antimicrobial defence mechanisms at the disposal of IECs 
highlights the importance of the intestinal epithelium in preventing and fighting 
enteric infection. As the intestinal epithelium also serves as the target site for EHEC 
colonisation, innate immune interactions between IECs and EHEC are likely to play 
a key role in the outcome of infection. The rest of this section summarises our 
current knowledge of these interactions. 
 
1.6.1 | Innate immune response to EHEC infection 
Intestinal biopsies from EHEC-infected patients display signs of moderate 
inflammation, characterised by neutrophil infiltration into the lamina propria (Griffin 
et al., 1990; Kelly et al., 1990). Using an in vitro model system involving polarised 
T84 cells and isolated human neutrophils, Savkovic and colleagues (1996) showed 
that EPEC-associated neutrophil transmigration across the epithelium is mediated by 
the chemokine, IL-8. Since then, many studies have reported elevated IL-8 
expression levels in human IEC lines (i.e. T84, Caco-2, HT-29) following infection 
with both EPEC (Khan et al., 2008; Ruchaud-Sparagano et al., 2007; Sharma et al., 
2006; Zhou et al., 2003) and EHEC (Bellmeyer et al., 2009; Berin et al., 2002; 
Dahan et al., 2002; Farfan et al., 2013; Gobert et al., 2008; Ledesma et al., 2010; 
Miyamoto et al., 2006). EHEC-induced IL-8 expression in T84 cells is dependent on 
both MAPK and NF-κB signalling pathways (Dahan et al., 2002). In addition, IL-8 
has been detected in the blood of EHEC-infected patients suffering from HUS 
(Fitzpatrick et al., 1992; Murata et al., 1998). These data highlight IL-8 as an 
important mediator of the innate immune response to EHEC. As such, many 
researchers use this cytokine as a marker for inflammation when examining EHEC-
IEC interactions. To date, EHEC-IEC innate immune interactions have only been 
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investigated using cultured epithelial cell lines, although EPEC induction of IL-8 in 
human small intestinal biopsies has been demonstrated (Schüller et al., 2009). 
Several bacterial factors have been implicated in stimulating the innate immune 
response during EHEC infection, as discussed below. 
 
1.6.1.1 | Flagellin 
Flagellin, a protein that forms part of the flagellum, is considered the primary inducer 
of the innate immune response during EHEC infection. The flagellum itself is 
comprised of a long extracellular flagellin-rich filament attached to a molecular 
motor that is embedded in the bacterial outer membrane(s) (Jarrel and McBride, 
2008). This filament is composed of 11 protofilaments, which wrap together to form 
the final structure. Each protofilament is almost entirely composed of stacked 
flagellin monomers. Flagellin consists of four linearly connected domains (termed 
D0-D4) which together form a structure that resembles an upper case greek gamma 
(Γ) (Yonekura et al., 2003) (Figure 1.13). The first two of these domains (D0 and 
D1) are highly conserved and are embedded within the filament structure, whilst D3 
and D4 are more variable and form the external part of the filament (Bardoel and 
Strijp, 2011). Flagellin is detected exclusively by TLR5, which recognises a discrete 
conserved site on the D1 domain (Smith et al., 2003). As the D1 domain of flagellin 
is buried within the filament core and therefore inaccessible to TLR5 when in its 
polymeric state, it is assumed that TLR5 is only capable of recognising monomeric 
flagellin (Smith et al., 2003). 
Purified H7 flagellin is capable of inducing IL-8 expression in T84 and Caco-2 cells, 
as well as in human colonic xenografts (Berin et al., 2002; Miyamoto et al., 2006; 
Zhou et al., 2003). Moreover, deletion of fliC, the gene encoding flagellin, 
significantly attenuated the IL-8 response to EHEC in T84 and Caco-2 cells 
(Bellmeyer et al., 2009; Miyamoto et al., 2006). However, it should be noted that 
deletion of fliC did not completely abolish the IL-8 response in T84 cells (Bellmeyer 
et al., 2009), suggesting that other factors may also play a role. Partial abrogation of 
the IL-8 response by deletion of fliC has also been reported for EPEC (Khan et al., 
2008; Schüller et al., 2009). Bocking TLR5 activity in intestinal cell lines inhibited  
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Figure 1.13. Flagellin domain organisation and TLR5 binding region. Adapted 
from RCSB Protein Data Bank (URL: 
http://www.rcsb.org/pdb/results/results.do?outformat=&qrid=8FB40A8F&tabtoshow
=Current). 
 
the inflammatory response to flagellin from Salmonella dublin and E. coli K12 
(Bambou et al., 2004; Eaves-Pyles et al., 2011). It is therefore assumed that 
stimulation of IL-8 by EHEC flagellin is also mediated by TLR5, although this has 
not been confirmed experimentally. 
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1.6.1.2 | Stx 
Yamasaki and colleagues (1999) were the first to implicate Stx in innate immune 
gene regulation, showing that recombinant Stx1 induced IL-8 expression in Caco-2 
cells. Although a stimulatory effect of purified Stx1 and Stx2 has since been 
demonstrated on HCT-8 and T84 cells (Bellmeyer et al., 2009; Thorpe et al., 2001), 
this was not confirmed by other studies on Caco-2 cells (Berin et al., 2002; 
Miyamoto et al., 2006). Similarly, whilst deletion of stx in EHEC resulted in reduced 
IL-8 and NF-κB expression in T84 cells (Bellmeyer et al., 2009), other studies on 
Caco-2 cells reported no effect of stx deletion on the IL-8 response (Berin et al., 
2002; Miyamoto et al., 2006). Moreover, Δstx mutants have even been shown to 
enhance IL-8 and MIP3α expression in T84 cells relative to wild-type bacteria 
(Gobert et al., 2007). It is difficult to determine the cause of the varying effects of 
Stx, since contrasting results have been observed from studies using the same cell 
line and similar Stx concentrations. It is possible that different cell culture methods 
may lead to differences in internalisation of Stx and/or expression of any Stx-
responsive innate immune receptors, which would likely affect the IL-8 response to 
the toxin. However, the influence of cell culture methods on Stx-IEC interactions has 
not been examined. Thus, the role of Stx in innate immune gene regulation remains 
unclear. 
 
1.6.1.3 | Fimbriae 
Two EHEC fimbriae, HCP and Lpf, have been associated with the innate immune 
response to EHEC. Ledesma and colleagues (2010) have shown that purified HCP 
and recombinant HcpA (the main constituent of HCP) induce expression of IL-8 and 
TNF-α in T84 and HT-29 cells via activation of MAPK signalling proteins p38, 
ERK1/2 and JNK. However, deletion of hcpA did not significantly affect IL-8 
expression in HT-29 cells compared with the wild-type strain. In a recent study by 
Farfan et al. (2013), double deletion of the genes encoding Lpf1 and Lpf2 resulted in 
significantly lower T84 cell expression of IL-8, as well as several other cytokines 
(IL-6, IL-15. FGF, GM-CSF and IP-10). 
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1.6.2 | Immune evasion mechanisms 
The innate immune response creates a hostile environment in which EHEC must 
survive and proliferate. The concept that EHEC might secrete effector proteins that 
subvert the innate immune response first arose from reports stating that inhibition of 
T3S in EHEC and EPEC resulted in an enhanced IL-8 response to infection (Hauf 
and Chakraborty, 2003; Khan et al., 2008; Ruchaud-Sparagano et al., 2007). Since 
then, many effectors have been discovered that interfere with host cell control of 
inflammation, apoptosis and phagocytosis (Table 1.2) (Santos and Finlay, 2015). 
Those effectors targeting inflammatory signalling are discussed in more detail below. 
EPEC and EHEC effectors repress the inflammatory response by targeting both the 
NF-κB and MAPK signalling pathways. NF-κB is a transcription factor that 
comprises a dimer of two Rel homology protein subunits, p50 and p65, together with 
one or more non-Rel homology proteins. In its inactivated state, NF-κB resides in the 
cytoplasm bound to the inhibitory protein, IκB. Upon stimulation of the NF-κB pro-
inflammatory signalling cascade, the enzyme IκB kinase (IKK) is activated, which in 
turn acts to dissociate IκB from NF-κB. The de-repressed NF-κB then translocates to 
the nucleus, where it binds DNA sequences called response elements to induce 
transcription of inflammatory genes such as IL-8 (Figure 1.14) (Lawrence, 2009). 
NleE has been shown to suppress the IL-8 response to EPEC and EHEC in several 
cell lines by preventing degradation of IκB, thereby inhibiting NF-κB activation 
(Nadler et al., 2010; Newton et al., 2010; Yen et al., 2010). NleB has the same effect 
during EPEC infection of HeLa and Caco-2 cells, although this effector is thought to 
play a lesser role compared with NleE (Li et al., 2013; Newton et al., 2010; Pearson 
et al., 2013). NleH1 and NleH2 both interact with ribosomal protein S3 (RPS3), a 
non-Rel homology subunit of NF-κB that confers gene regulation specificity. Whilst 
NleH1 inhibits translocation of RPS3 into the nucleus, NleH2 increases translocation 
of the subunit (Gao et al., 2009; Pham et al., 2012). Furthermore, these two effectors 
interact with each other, with relative levels of each determining the overall net 
effect on RPS3 translocation (Pham et al., 2012). Infection of gnotobiotic piglets 
with a ΔnleH1 EHEC mutant resulted in greater disease severity, whilst no effect was 
observed with the ΔnleH2 mutant (Gao et al., 2009). Finally, EPEC and EHEC NleC 
have been shown to cleave the p65 subunit of NF-κB, leading to degradation of NF- 
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Figure 1.14. NF-κB and MAPK signalling pathways. Transcription factors are 
shown in green ovals. Positive and negative regulatory proteins are shown in purple 
and grey ovals, respectively. MAPK pathway based on Morrison et al. (2012). 
 
2011; Yen et al., 2010). Ectopically-expressed NleC also targets the p50 and c-Rel 
subunits in HeLa cells, conferring the same effect on IL-8 expression (Mühlen et al., 
2011). 
Several different MAPK pathways regulate gene transcription in humans, and two of 
these – the p38 and JNK pathways – are pro-inflammatory. PRR stimulation initiates 
the activation of a phosphorylation cascade involving various kinases, beginning 
with a MAPK kinase kinase (MAPKKK). The activated MAPKKK phosphorylates a 
MAPK kinase (MAPKK), which in turn phosphorylates either the p38 or JNK 
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MAPKs (Morrison, 2012). Both of these MAPKs stimulate transcription factors such 
as AP-1 to induce transcription of pro-inflammatory genes including IL-8 (Figure 
1.14) (Pramanik et al., 2003). Baruch and colleagues (2011) have demonstrated that 
EPEC NleD cleaves both p38 and JNK, which prevents activation of AP-1 during 
infection of HeLa cells. However, deletion of nleD did not reduce the ability of 
EPEC to repress IL-8 expression. EPEC NleC is capable of inhibiting 
phosphorylation of p38 in Caco-2 and HT-29 cells, leading to reduced IL-8 
production (Sham et al., 2011). Conversely, ectopically-expressed NleH2 has been 
shown to enhance AP-1-dependent transcription in HeLa cells (Gao et al., 2009), 
although the mechanism underlying this effect has not been investigated. 
 
1.6.3 | Antimicrobial peptides 
Antimicrobial peptides (AMPs) are important components of the enteric innate 
immune system. These small cationic peptides are capable of directly killing 
microorganisms by attacking their cell membrane and/or wall (Mukherjee and 
Hooper, 2015). AMPs are also becoming increasingly recognised as important 
inflammatory signalling molecules (Yang et al., 2004), and inflammatory bowel 
disease (IBD) has been associated with enhanced AMP production (Fahlgren et al., 
2003; Zilbauer et al., 2010). Whilst some AMPs are constitutively expressed by 
IECs, others are induced by the presence of microbes or inflammatory stimuli 
(Dommett et al., 2005). Infection of IECs with a range of pathogens leads to 
production of inducible AMPs, suggesting that they play an important role in 
resisting pathogen attack. Despite this, the effect of EHEC infection on AMP 
production in IECs has not been investigated. 
Several AMPs are expressed by IECs in the human colon: lysozyme, human β-
defensins (hBDs) 1-4, and LL-37. The mode of action and expression pattern of each 
of these is summarised below. 
 
1.6.3.1 | Lysozyme 
Lysozyme is a glycosidase that damages bacterial cell walls by hydrolysis of 
peptidoglycans (Callewaert and Michiels, 2010). It is more effective at killing Gram-
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positive than Gram-negative bacteria, as peptidoglycans are shielded by the outer cell 
membrane of the latter (Mukherjee et al., 2008). However, E. coli susceptibility to 
lysozyme-mediated lysis has been demonstrated (Sedov et al., 2011). Lysozyme is 
expressed in large amounts by specialised Paneth cells found at the base of small 
intestinal crypts (Peeters and Vantrappen, 1975). Colonic expression of lysozyme is 
thought to be generally low but elevated levels are found in individuals suffering 
from CD-associated colitis (Fahlgren et al., 2003). To the best of our knowledge, no 
data showing an effect of microbial infection on lysozyme production has been 
published (Mukherjee et al., 2008). 
 
1.6.3.2 | Defensins 
Defensins are small peptides (2-6 kDa) that kill bacteria by forming pores across 
plasma membranes, leading to a loss of membrane potential and cell lysis 
(Mukherjee and Hooper, 2015). Human defensins are classified into α and β-
defensins based on differences in disulphide bond arrangements and spacing of 
cysteine residues (Selsted and Ouellette, 2005). Whilst enteric α-defensin expression 
is restricted to Paneth cells (Putsep et al., 2000), β-defensins (hBDs) are expressed 
by IECs in the small intestine and the colon. Four types of hBDs (hBD1-4) have been 
identified in colonic IECs, all of which exert microbicidal activity against a range of 
bacterial species including E. coli (Dhople et al., 2006; Estrela et al., 2013; Pazgier 
et al., 2006). 
 
1.6.3.2.1 | hBD1 
hBD1 is constitutively expressed in the small intestine and the colon (Zilbauer et al., 
2010) and is not responsive to pro-inflammatory stimuli (Fahlgren et al., 2003). No 
changes in hBD1 expression have been reported in IECs following infection with 
Salmonella spp., EIEC, Campylobacter jejuni, and Helicobacter pylori (Chakraborty 
et al., 2008; Fahlgren et al., 2003; O'Neil et al., 1999; Ou et al., 2009; Zilbauer et al., 
2005). However, Shigella infection resulted in down-regulation of hBD1 expression 
in human intestinal biopsies, xenografts and HT-29 cells (Chakraborty et al., 2008; 
Islam et al., 2001; Sperandio et al., 2008). The same effect has also been observed 
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following Vibrio cholerae and ETEC infection of HT-29 cells (Chakraborty et al., 
2008). This likely represents a bacterial survival strategy to avoid hBD1-mediated 
lysis or immune detection.  
 
1.6.3.2.2 | hBD2 
hBD2 is not detected in the intestine of healthy individuals but is expressed in the 
colonic epithelium of CD and ulcerative colitis (UC) patients (Fahlgren et al., 2003; 
Zilbauer et al., 2010). Accordingly, hBD2 expression is enhanced by pro-
inflammatory stimuli (IL-1α and IL-1β) in Caco-2 and HT-29 cells (Fahlgren et al., 
2003; O'Neil et al., 1999; Schlee et al., 2007). hBD2 is also expressed during in vitro 
infection with pathogenic bacteria including EPEC, EIEC, Salmonella spp., Shigella 
spp., and Campylobacter jejuni (Fahlgren et al., 2003; Hase et al., 2002; Khan et al., 
2008; O'Neil et al., 1999; Ogushi et al., 2001; Ou et al., 2009; Sperandio et al., 2008; 
Zilbauer et al., 2005). Furthermore, commensal bacteria such as E. coli Nissle 1917 
also trigger an hBD2 response in IECs in vitro (Schlee et al., 2007; Wehkamp et al., 
2004). 
 
1.6.3.2.3 | hBD3 
Similarly to hBD2, hBD3 is expressed in the colonic epithelium of IBD patients but 
not in healthy individuals (Fahlgren et al., 2003; Zilbauer et al., 2010). The pro-
inflammatory cytokines IFN-γ and IL-1β enhance hBD3 expression in LS174T 
human colonic cells (Fahlgren et al., 2004). Little is known about bacterial regulation 
of hBD3: whilst Campylobacter jejuni induced hBD3 expression in Caco-2 and HT-
29 cells (Zilbauer et al., 2005), Shigella flexneri triggered both up- and down-
regulation depending on the IEC model used (Sperandio et al., 2008). On the other 
hand, Salmonella enterica Serovar Typhimurium infection conferred no effect on 
hBD3 expression in T84 and Caco-2 cells (Ou et al., 2009). 
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1.6.3.2.4 | hBD4 
hBD4 is expressed in the small intestine and the colon at a relatively low level 
compared with other defensins (Fahlgren et al., 2004). There is currently no evidence 
for microbial regulation of hBD4 in the intestine, although expression in lung 
epithelial cells is induced by infection with Pseudomonas aeriginosa and 
Streptococcus pneumoniae (Conejo García et al., 2001). hBD4 does not appear to be 
responsive to inflammatory stimuli (Conejo García et al., 2001; Fahlgren et al., 
2003). 
 
1.6.3.3 | LL-37 
LL-37 belongs to the cathelicidin family of AMPs, a structurally heterogeneous 
group that associates with a ‘cathelicidin domain’ during intracellular storage 
(Zanetti, 2004). It is the only cathelicidin currently described in humans, and 
expression has been localised to the colon but not the small intestine (Hase et al., 
2002). LL-37 expression in human colonic cell lines is enhanced upon infection with 
Salmonella spp. and EIEC (Chakraborty et al., 2008; Hase et al., 2002). As with 
hBD1, LL-37 production is repressed during Shigella-infection of human intestinal 
tissue (Islam et al., 2001; Sperandio et al., 2008) and in cell lines infected with 
Vibrio cholerae and ETEC (Chakraborty et al., 2008). However, it should be noted 
that the inhibitory effect of Shigella spp. on LL-37 expression is not reproduced in 
vitro using cell lines (Hase et al., 2002; Sperandio et al., 2008). LL-37 exerts 
bactericidal activity against E. coli, as well as many other bacterial species (Turner et 
al., 1998; Yan and Hancock, 2001). Although the mechanism for LL-37-mediated 
bacterial killing has not been completely defined (Ho et al., 2013), it is known that 
the peptide can form pores in bacterial membranes (Lee et al., 2011). 
 
 
1.7 | Models used to study EHEC-IEC interactions 
Cultured epithelial cell lines have been widely applied in the study of EHEC 
infection biology and have played an indispensable role in some of the most seminal 
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discoveries in the field. In particular, the HeLa cell model has contributed greatly to 
our understanding of the mechanisms underlying actin pedestal formation during 
EHEC and EPEC infection. Furthermore, polarised intestinal epithelial cell lines 
such as T84 and Caco-2 cells have enabled in vitro analysis of the innate immune 
response to infection. However, it is well established that pathogen interactions with 
cancer-derived cell lines often differ from those taking place on native host tissue 
(Law et al., 2013). This is due to the fact that cancer-derived cells often carry 
mutations which change their properties. Cultured IEC monolayers also lack several 
important factors compared with their in vivo counterparts: cross-talk with cells of 
the surrounding tissue and the immune system, resident microflora, and other 
specific environmental stimuli that may influence gene regulation. Therefore, it is 
desirable to confirm results obtained from cell lines by using more physiologically 
accurate infection models. 
One major obstacle in the progression of EHEC research is the lack of a suitable in 
vivo host model. Human infection studies are unethical due to the severity of disease 
caused by EHEC, and intestinal biopsy samples should not be taken from naturally-
infected individuals due to the high risk of perforation (Nataro and Kaper, 1998). 
Critically, EHEC infection of standard mice leads to low levels of intestinal 
colonisation and no disease symptoms (Mundy et al., 2006). Germ-free (i.e. no 
indigenous microflora) and streptomycin-treated (i.e. reduced microflora) are 
amenable to colonisation by EHEC, although extremely high infectious doses are 
required to generate disease-like symptoms in these animals (Mohawk and O'Brien, 
2011). Furthermore, investigation of EHEC colonisation patterns using these models 
has yielded conflicting data: whilst infection of streptomycin-treated mice leads to 
predominantly colonic colonisation (Wadolkowski et al., 1990), infected germ-free 
mice show signs of colonisation in the ileum and caecum but not the colon (Eaton et 
al., 2008). Some research has been performed on the natural murine A/E pathogen, 
C. rodentium. Citrobacter infection of mice results in loose stools, intestinal 
inflammation and colonic hyperplasia but does not fully resemble the spectrum of 
disease caused by EHEC in humans, mainly due to the lack of Stx production 
(Mohawk and O'Brien, 2011). Mallick and colleagues (2014) have recently 
constructed an Stxd-producing strain of C. rodentium, which induces A/E lesions and 
Stx-mediated intestinal and kidney damage in mice, and therefore may represent a 
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more physiologically relevant model of infection than conventional C. rodentium. 
Other investigators have utilised gnotobiotic piglets and infant rabbits as in vivo host 
models for EHEC (Pai et al., 1986; Ritchie et al., 2003; Tzipori et al., 1986). Both 
animals develop A/E lesions, watery diarrhoea and inflammation upon infection with 
EHEC. Gnotobiotic piglets also develop neurological HUS-like symptoms, and are 
therefore currently the best animal model for EHEC infection. However, it is 
generally difficult to ascertain whether animal infections simulate human infection 
due to the chance that species-specific interactions may generate confounding data 
(Fang et al., 2013). Furthermore, the routine use of larger animals is limited by high 
maintenance requirements and low genetic tractability. 
The absence of a suitable in vivo model has led to the development of innovative 
alternatives. In vitro organ culture (IVOC) was developed as a means of maintaining 
human intestinal tissue biopsies in the laboratory, and has also been used for 
infection studies (Fang et al., 2013). IVOC has a major advantage over cell line 
models in that the former uses healthy native epithelium that consists of all the major 
cell types, together with an in-tact mucus layer and microbiota. As such, IVOC has 
become the gold-standard model for studying EPEC/EHEC-IEC interactions, having 
contributed to re-evaluation of the role of actin pedestals in A/E pathogenesis 
(section 1.5.1.3) (Bai et al., 2008; Garmendia et al., 2004; Schüller et al., 2007). A 
polarised version of the IVOC model (pIVOC) has also been effectively applied to 
characterise the innate immune response to EPEC infection (Schüller et al., 2009). 
However, the apparent tissue tropism of EHEC for the distal small intestine and lack 
of colonic colonisation has been puzzling (Chong et al., 2007; Phillips et al., 2000), 
and it remains unclear whether this represents the genuine in vivo situation (in 
contrast to data obtained from certain animal studies) or is an artefact arising from 
experimental factors. 
An alternative ex vivo model system involves implantation of human foetal intestinal 
tissue into severe-combined immuno-deficient (SCID) mice. This murine xenograft 
model has been employed to study EHEC A/E lesion formation (Golan et al., 2011), 
as well as the role of EHEC flagellin in regulation of IL-8 expression (Miyamoto et 
al., 2006). Although this model has the potential to greatly contribute to the field, it 
is currently unclear whether EHEC-xenograft interactions are confounded by murine 
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factors. Furthermore, this model system lacks resident microbiota and, as with the 
IVOC model, a functional adaptive immune system. Both IVOC and xenograft 
models are not suitable for routine laboratory use due to high technical standards and 
access limitations to human tissues. 
 
1.8 | Summary 
EHEC is regarded as a pathogen of great public health importance, causing 
debilitating and potentially fatal disease for which there is currently no effective 
treatment. Since its discovery in 1983, great advances in our understanding of EHEC 
infection biology have been made. The intestinal epithelium plays a crucial role in 
the events leading to pathogenesis: IECs are the site of EHEC colonisation and A/E 
lesion pathology; EHEC modulation of IEC signalling leads to diarrhoea; IECs 
trigger inflammation in response to EHEC proteins, and IECs mediate Stx access to 
host internal tissue, leading to HC and HUS. Despite a wealth of research in these 
areas, several of the underlying molecular mechanisms involved in EHEC-IEC 
interactions remain unclear. Examples include the role of Stx in EHEC adherence 
and the innate immune reponse, the role of adhesins in initial attachment, and the 
role of effectors in microvillous effacement. In many cases, our understanding is 
clouded by the generation of conflicting data, which is a result of the use of artificial 
experimental model systems. In addition, ex vivo analysis of EHEC adherence to 
IECs using IVOC has thrown into question the clinical relevance of A/E lesions, 
further prompting the need for new or improved models that allow a closer 
simulation of the in vivo situation. Finally, whilst the discovery of numerous EHEC 
mechanisms for innate immune suppression has highlighted the importance of 
immune responses during EHEC infection, the breadth of our knowledge in this area 
does not extend further than the expression of a few select cytokines. Therefore, it 
would be beneficial for future EHEC research to focus on (1) further elucidation of 
processes underlying A/E lesion formation using physiologically relevant infection 
models and (2) expansion of our knowledge of the innate immune response to EHEC 
infection. 
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1.9 | Aims and objectives 
The overarching aim of this PhD project was to characterise EHEC interactions with 
the human colonic epithelium by using physiologically relevant IEC models: human 
intestinal IVOC and polarised T84 cells. The objectives were to: 
1. Determine whether EHEC colonises human colonic IECs and produces A/E 
lesions 
2. Characterise the innate immune response to EHEC infection in human 
colonic IECs 
3. Identify the bacterial factors involved in the interactions specified in 
objective 1 and 2  
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CHAPTER TWO 
 
MATERIALS AND METHODS 
  
83 
 
All reagents were obtained from Sigma-Aldrich, unless otherwise stated. Incubations 
were conducted at 19-23°C (room temperature), unless indicated otherwise. 
 
2.1 | Bacterial strains and growth conditions 
A list of E. coli strains used in this study is presented in Table 2.1. All work 
involving Shiga toxin-producing EHEC strains was conducted at containment level 
(CL) 3, whilst Stx-negative EHEC and EPEC were handled at CL2. Bacterial stocks 
were generated from standing overnight cultures grown in 2 mL Luria Bertani 
Lennox (LB) broth at 37°C. Cryotubes (Sarstedt) were loaded with 700 µL overnight 
culture and 300 µL autoclaved 50% glycerol (in distilled deionised water (ddH20), 
Thermo Fisher Scientific) and stored at -80°C. To initiate a culture, cryotubes were 
placed on dry ice until a thin upper layer of stock (approximately 1 mm) had thawed. 
A pipette tip was used to transfer some of the liquid stock onto an LB-agar 
(Formedium) plate, which was then incubated overnight at 37°C and stored at 4°C 
for up to 1 month. LB-agar plates were prepared by mixing LB and 1.5% w/v agar 
with ddH20. Once autoclaved, approximately 20 mL LB-agar solution was poured 
into petri dishes and left at room temperature to set and dry. For infection assays, 
bacteria from several colonies were taken from an agar plate and grown overnight 
without agitation in 2 mL LB broth at 37°C. Deletion mutants (except EDL933 
ΔespA) were selected in 50 µg/mL kanamycin or 30 µg/mL chloramphenicol (see 
Table 2.1). Overnight cultures were spun down at 18,000 x g for 5 minutes and 
resuspended in serum-free culture medium before inoculation. 
 
2.2 | Cell culture and infection 
2.2.1 | General cell culture methods 
Cell lines were cultured in 25 cm2 or 75 cm2 culture flasks (Sarstedt) at 37°C in a 5% 
CO2 atmosphere. Vero African Green Monkey kidney cells (ATCC CCL-81) were 
cultured in Dulbecco’s modified Eagle’s medium (DMEM) containing 4500 mg/L 
glucose and sodium bicarbonate, supplemented with 4 mM L-glutamine (20 mL/L of 
200 mM stock solution) and 10% foetal bovine serum (FBS; non-US origin). Caco-2   
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Table 2.1 | List of E. coli strains used in this study. All EHEC strains are Stx-
positive unless stated otherwise.  
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human colonic carcinoma cells (ATCC HTB-37) were cultured in DMEM 
supplemented with L-glutamine and FBS as described above but with the additional 
supplement of 1x non-essential amino acids (10 mL/L of 100x stock solution). T84 
human colonic carcinoma cells (ATCC CCL-248) were cultured in DMEM/Nutrient 
F12 Ham medium (1:1 mixture) containing 15mM HEPES and sodium bicarbonate, 
supplemented with 2.5 mM L-glutamine (12.4 mL/L of 200 mM stock solution) and 
10% FBS. Cells cultured in 25 cm2 flasks were provided with 5 mL culture medium, 
whilst those in 75 cm2 flasks were cultured in 15 mL medium. Cells were passaged 
approximately every 7 days. Culture medium was aspirated from the flask and cells 
were rinsed with PBS to remove residual medium. Cells were then incubated in 0.5-1 
mL 0.25% trypsin-0.02% EDTA at 37°C until they had detached from the base of the 
culture flask. After vigorous resuspension of cells in culture medium (at least 5 mL 
to neutralise trypsin activity), cells were transferred into new culture flasks at a 
dilution ratio of 1:10 (Caco-2), 1:20 (Vero) or 1:5 (T84) relative to the concentration 
before passage. 
 
2.2.2 | Cryopreservation of cell lines 
For long-term storage, cells were cryopreserved in liquid nitrogen. Cells were 
suspended at a high density (2-4 x 106 cells) in 1 mL culture medium containing 
dimethyl sulphoxide (DMSO, 5% v/v for T84 cells and 10% for all other cell lines) 
and transferred into cryotubes. To avoid cell damage by formation of ice crystals, 
cryotubes were placed in a Mr Frosty Freezing Container (Nalgene) containing 
isopropanol and frozen to -80°C overnight before being transferred to liquid nitrogen 
storage (vapour phase). To initiate a culture from frozen stocks, cells were thawed at 
37°C, diluted in 9 mL warm culture medium and spun at 100 x g for 10 minutes to 
remove DMSO. Cell pellets were resuspended in 7 mL medium, transferred to a 25 
cm2 culture flask and cultured until confluent. Medium was exchanged the day after 
thawing. 
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2.2.3 | Seeding cells for infection assays 
For infection assays, cells were seeded into cell culture plates (Sarstedt and Greiner 
Bio-One) during the passage process. After resuspension of trypsinised cells in 
culture medium, approximately 50 µL cell suspension was diluted 1:1 with trypan 
blue solution and 10 µL of this mixture was loaded into a Neubauer cell counting 
chamber (Hawksley; depth 0.1 mm) and examined using an inverted light 
microscope (Zeiss Invertoskop ID03). The number of viable cells (distinguishable by 
their lack of blue staining) within each of the 4 counting areas of the cell counting 
chamber (Figure 2.1) was determined, and the number of cells per mL (x) was 
calculated using the following equation: 
   x = (average number of cells counted per counting area * 2) * 104 
The proportion of dead (blue) cells within the entire cell population was also 
calculated as an indication of the viability of the culture. A proportion of <10% dead 
cells was deemed acceptable for use in experiments. The amount of cell suspension 
needed for seeding (x) was then determined using the following equation: 
             x = total number of cells needed / cell count per mL 
The necessary amount of cell suspension was then transferred into a fresh tube and 
culture medium was added in order to achieve the correct volume required for seeding. 
Cells were then administered into wells of a cell culture plate. 
 
2.2.4 | T84 cell infection 
T84 cells were used for experiments during passages 49-65. For infection assays on 
semi-polarised monolayers, cells were seeded out in 24-well plates containing sterile 
coverslips at a density of 105 cells/well and grown for 7 days until fully confluent. 
Cells were infected with 2 x 107 EPEC bacteria or 4 x 107 EHEC bacteria for 3 or 5 
hours, respectively. To prevent bacterial overgrowth and acidification, media in 
EHEC-infected cells was exchanged after 3 hours. 
For infection assays requiring a fully polarised cell monolayer, cells were seeded out 
into collagen-coated Transwell permeable filter inserts (12 mm diameter, polyester  
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Figure 2.1. Layout of a Neubauer cell counting chamber. Cell counting regions 
are indicated by red boxes. The volume of cell suspension that fits within each of 
these regions is 0.1 mm3, i.e. 10-4 mL. 
 
membrane, 0.4 µm pore size, Corning) at a density of 5 x 105 cells/insert. Rat tail 
collagen type I was stored as a stock solution at a concentration of 1.25 mg/mL in 0.1 
M acetic acid and working solutions of 50 µg/mL were prepared by diluting the stock 
by a factor of 1:25 in 62.5% ethanol (in ddH20). Transwell insert membranes were 
coated with 200 µL collagen working solution (i.e. 10 µg/insert) and left at room 
temperature in sterile conditions for 3-4 hours until the liquid had evaporated. Cells 
were cultured until the transepithelial electrical resistance (TER) of the monolayer 
exceeded 1500 Ω x cm2 (7-10 days), which served as an indication that epithelial 
barrier function had been established. TER was measured using an EVOM2 
resistance meter with an STX2 electrode (WPI). Culture medium was exchanged on 
day 4 post-seeding and every 2 days thereafter. For infection assays, cells were 
inoculated with 6 x 107 EHEC bacteria, 10 ng/ml interleukin (IL)-1β, 25 µM 
inflammatory signalling inhibitor (MG-132, SB203580, SP600125, PD98059; 
Calbiochem) or purified H7 flagellin monomers (various concentrations; David 
Gally, University of Edinburgh, UK) in DMEM/F12 medium without supplements 
and incubated at 37°C in a 5% CO2 atmosphere. For infection assays designed for 
analysis of bacterial colonisation or T84 mRNA expression, bacterial inocula were 
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left for 3 hours. To prevent bacterial overgrowth and acidification, media were then 
exchanged hourly for a further 3 hours (colonisation) or up to 9 hours (mRNA). For 
analysis of protein expression, bacteria were killed 1 hour post-infection by addition 
of gentamicin (200 µg/ml) to the apical and basal medium and incubations were 
continued for a further 24 hours. For experiments using IL-1β, inflammatory 
signalling inhibitors and flagellin, treatments were left on the cells for the duration of 
the assay with no medium exchanges. 
 
2.2.5 | Vero cell infection 
Cells were seeded out into 24-well plates at a density of 1.5 x 105 cells/well and 
cultured overnight. Cells were incubated for 4 hours with 1 x 107 EHEC bacteria or 
100 ng/ml purified Stx2 (Anne Kane, Tufts Medical Centre). 
 
2.2.6 | Caco-2 cell infection 
Cells cultured to passage 8-15 were seeded into 24-well plates containing sterile 
coverslips (microscopy) or 6-well-plates (protein quantification) at a density of 1.2 x 
105 or 2 x 105 cells/well (respectively) and cultured for 7 days until fully confluent. 
Cells were then incubated for 24 hours with EHEC (1.2 x 108 bacteria in 24-well 
plates or 5.4 x 108 bacteria in 6-well plates) or IL-1β (10 ng/ml). Bacteria were killed 
1 hour post-infection using gentamicin (200 µg/ml). 
 
2.3 | In vitro organ culture (IVOC) of intestinal biopsies 
2.3.1 | Preparation of IVOC medium 
IVOC medium was prepared by mixing the following ingredients in 90 mL ddH20: 
NCTC-135 (0.94 g), sodium bicarbonate (0.22 g) and D-(+)-Mannose (1 g). This 
solution was sterilised using a 0.45 µm syringe filter (Sartorius Stedim), after which 
DMEM containing 4500 mg/L glucose and sodium bicarbonate (90 mL) and 
newborn calf serum (20 mL) were added. IVOC medium was stored at 4 °C. 
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2.3.2 | Collection of intestinal biopsies 
Biopsy samples were supplied through the Partners in Cancer Research Human 
Tissue Bank (NRES reference number 10/H0310/21) in collaboration with the 
Gastroenterology Department, Norfolk and Norwich University Hospital. The study 
was approved by the University of East Anglia Faculty of Medicine and Health 
Ethics Committee (reference number 2010/11-030). Recruited patients were 
undergoing routine colonoscopy for intestinal disorders and gave their written 
consent for donation of biopsies before the procedure (see Appendix 1 for a copy of 
The Norwich Biorepository Consent Form version 15). 
Up to 8 biopsies were taken from the transverse colon and/or terminal ileum of 35 
adult patients aged between 24-77 years and 2 paediatric patients (aged 9 and 13 
years) by medically trained staff using grasp capture forceps. Biopsy collection was 
not pursued in patients who showed macroscopic pathology in the region of interest 
during colonoscopy. Biopsies were collected in 5 mL plastic bijoux (Ramboldi) 
containing 2 ml IVOC medium for transportation to the lab and were used 
immediately upon arrival. Biopsies were examined under a dissecting microscope 
(Zeiss Stem SV8) and cut in half to yield samples with a mucosal surface area of ~5 
mm2. 
 
2.3.3 | IVOC 
IVOC was performed as described previously (Knutton et al., 1987). Biopsies were 
mounted mucosal-side upwards onto a 1 cm2 foam support (Simport) placed inside a 
12-well culture plate. IVOC medium was added to a level that enabled saturation of 
the support without submerging the biopsy (~1 mL) to prevent epithelial shedding. 
For infection, 25 µL bacterial overnight culture or LB alone (i.e. non-infected 
control) was applied directly to the mucosal surface of the biopsy and the culture 
plate was placed in a plastic box filled with a 5% CO2/air mixture (BOC). Samples 
were then incubated for 8 hours at 37°C on a rocking platform. For a small subset of 
experiments, samples were incubated with 5% CO2 in oxygen, rather than air. To 
prevent bacterial overgrowth, medium was exchanged at 4 and 6 hours post-
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inoculation. At the end of infection, biopsies were washed vigorously in 2 mL PBS 
to remove mucus and non-adherent bacteria. 
 
2.3.4 | Polarised IVOC of colonic biopsies 
This protocol is based on the published method for small intestinal pIVOC (Schüller 
et al., 2009), amended for colonic biopsies. Biopsies were mounted mucosal-side 
upwards onto a circular Perspex disk (manufactured by the Faculty of Science 
Mechanical Workshop, University of East Anglia) lined with a nitrocellulose filter (3 
µM pore, Whatman), as shown in Figure 2.2. The disks contain a small central 
aperture (measuring 2 mm in diameter) and the biopsy was positioned in alignment 
with this. A second ‘apical’ disk was placed on top of the first ‘basal’ disk, enclosing 
the biopsy in a sandwich-like arrangement with the epithelium exposed through the 
apical aperture. The apical disk was coated in Histoacryl tissue glue (Braun Medical) 
before placing onto the sandwich in order to fix it onto the biopsy and thereby 
prevent bacterial access to non-epithelial tissue. The sandwich was then mounted 
onto a Snapwell support (polycarbonate, Corning), with its apical side facing into the 
Snapwell chamber. The Snapwell was placed into a 6-well plate and IVOC medium 
was added to both the apical and basal compartments (180 µL and 3 mL, 
respectively). Biopsies were then inoculated with 20 µL bacterial overnight culture 
or LB alone (i.e. non-infected control) and incubated at 37 °C with 5% CO2/air on a 
rocking platform. 
To prevent bacterial overgrowth, the inoculum was removed after 2 hours and the 
apical compartment was rinsed once in 200 µL IVOC medium. Two drops (~25 µL) 
fresh IVOC medium were then added to the edge of the apical compartment, with 
care taken not to submerge the biopsy, and incubation was resumed for up to 5 hours. 
 
2.4 | Quantification of bacterial colonisation 
At the end of infection, cell monolayers were rinsed three times in PBS to remove 
non-adherent bacteria and lysed through incubation in Triton X-100 (1% in PBS) for 
10 minutes. Lysates were then serially diluted in 1 mL PBS and 100 µL of  
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Figure 2.2. pIVOC system (adapted from Schüller et al., 2009). Biopsies were 
sandwiched between 2 perspex disks and installed into Snapwell supports, leaving 
only the epithelium accessible for experimental treatment. 
 
appropriate dilutions (containing 50-500 colony forming units (CFU)) was plated 
onto LB agar plates. After overnight incubation at 37°C, the number of CFU was 
counted. This process was also performed on the bacterial inoculum immediately 
after inoculation. To calculate the percentage colonisation level, the CFU count for 
cell lysates was divided by that of the inoculum and multiplied by 100. 
 
2.5 | Immunofluorescence staining 
2.5.1 | Cell monolayers and whole biopsies 
Cell monolayers and biopsies were rinsed twice in PBS and fixed with 3.7% 
formaldehyde (in PBS) for 20 minutes. Samples were then permeabilised and 
blocked by incubation in 1% Triton X-100 and 0.5% bovine serum albumin (BSA) in 
PBS for 20 minutes. 
When staining for occludin, cells were pre-extracted in 0.2% Triton X-100 in PBS 
for 2 minutes on ice, fixed in 3.7% formaldehyde for 20 minutes, and permeabilised/ 
blocked in 0.05% Triton X-100 and BSA in PBS for 5 minutes on ice according to 
the manufacturer’s instructions. 
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Table 2.2 | List of primary antibodies used for fluorescence microscopy in this 
study. All antibodies are polyclonal. 
 
Samples were rinsed in PBS before staining. All stains and antibodies were diluted in 
0.5% BSA in PBS to reach their working concentrations. 
A list of primary antibodies (Abs) used for immunofluorescence staining is presented 
in Table 2.2. All primary Ab incubations were conducted for 1 hour at room 
temperature except for anti-hBD2, which was incubated at 4°C overnight. Samples 
were washed in PBS on a seesaw rocker for 10 minutes between primary and 
secondary Ab incubation steps. All secondary Abs were Alexa Fluor-conjugated 
(Life Technologies) and were administered to cells for 30 minutes at a dilution of 
1:400. To label cell nuclei, cells were counterstained with 4',6-diamidino-2-
phenylindole (DAPI; Roche), which was administered during the last secondary Ab 
incubation step at a dilution of 1:5000. 
To visualise filamentous actin, samples were incubated with fluorescein 
isothiocyanate (FITC)-conjugated phalloidin at a dilution of 1:200 for 20 minutes. If 
used in conjunction with fluorescent antibodies, FITC-phalloidin was administered 
after the last secondary Ab step. 
Samples were washed for 2 x 30 minutes after the final staining step. Cells were 
mounted onto glass microscope slides (R & L Slaughter) in a drop of Vectashield 
mounting medium (Vector Laboratories) and covered with a cover slip (Agar 
Scientific). When mounting intestinal biopsies, cover slips were secured to the 
Ab name Host Species Working conc. Source 
E. coli Goat 1:200 abcam 
EspA Rabbit 1:500 G. Frankel, Imperial College, UK 
hBD2 Rabbit 1:200 abcam 
Occludin  Rabbit 1:20 Life Technologies 
Stx 204 Rabbit 1:1000 A. Kane, Tufts Medical Centre, USA 
Tir Mouse 1:500 J. Leong, Tufts University, USA 
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microscope slide by sealing the edges with transparent nail varnish. Samples were 
imaged using a standard fluorescence (Zeiss Axiovert 200M) or confocal (Zeiss 
LSM510 Meta) microscope.  
 
2.5.2 | Biopsy cryosections 
Biopsies were fixed in 3.7% formaldehyde in PBS for 30 minutes. After washing 
three times in 2 mL PBS, samples were submerged in 15% sucrose in PBS, chilled to 
4°C. Samples were left until fully saturated (approximately 10 minutes), indicated by 
their sinking to the bottom of the tube. Samples were submerged in chilled 30% 
sucrose until saturated. After blotting on a paper towel to remove excess moisture, 
samples were transferred to cryotubes and submerged within a drop of OCT 
compound (Sakura). Samples were snap frozen by submerging cryotubes in ethanol 
chilled to -80°C using dry ice and transferred to a -80°C freezer. Frozen samples 
were cut into 7 µm sections using a Microm HM550 cryostat (Thermo Scientific) 
and transferred onto poly L-lysine -coated glass slides (Agar Scientific). Sections 
were left for 30 minutes to adhere to the slide before transferring to a -80°C freezer. 
For staining, sections were thawed at room temperature for ~10 minutes and blocked 
in 0.5% BSA in PBS for 20 minutes. Sections were then stained and imaged as 
described in section 2.5.1. 
 
2.6 | Scanning electron microscopy (SEM) 
At the end of infection, samples were washed twice in 2 mL PBS and fixed in 2.5% 
glutaraldehyde (Agar Scientific) in PBS at 4°C for at least 12 hours. After 2 further 
washes in 2 mL PBS, samples were dehydrated through a series of 15 minute 
incubations in acetone of increasingly higher concentrations (30%, 50%, 70%, 90% 
and 2 x 100%) in ddH20 on a rocker. Samples were then dried in tetramethylsilane 
for 10 minutes on a rocker and air-dried for approximately 10 minutes or until all 
liquid had disappeared from the sample. 
Dried samples were mounted onto aluminium stubs (TAAB Laboratory Equipment 
Ltd.) under a dissecting microscope. For cell monolayers grown on cover slips or 
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Transwell membranes, these were placed cell-side up onto stubs lined with adhesive 
carbon conductive tabs (TAAB Laboratory Equipment Ltd.). Biopsies were mounted 
onto the stubs in a drop of silver paint (Agar Scientific), taking care not to submerge 
the epithelium. Mounted samples were then sputter-coated with gold (Polaron 
SC7640 sputter coater, Quorum Technologies) and imaged with a JEOL JSM 4900 
LV or Zeiss Supra 55 VP FEG scanning electron microscope. 
To quantify bacterial colonisation of biopsies by SEM, biopsy epithelia were 
apportioned into fields of view (~250 per sample), and the presence or absence of 
bacteria within each was noted. The number of bacteria-positive fields was divided 
by the total number fields counted to calculate the colonisation level, expressed as a 
percentage. Quantification was conducted at 2700x magnification. 
 
2.7 | Transmission electron microscopy 
Samples were fixed in 2.5% glutaraldehyde in 0.1M PIPES buffer at 4°C for at least 
12 hours and sent to Kathryn Cross (Electron Microscopy Facility, IFR) for 
processing and imaging, as described below. Samples were post-fixed in 1% aqueous 
osmium tetroxide for 1 hour and dehydrated through a graded ethanol series (10, 20, 
30, 40, 50, 60, 70, 80, 90 and 3 x 100% in ddH20) with 15-minute incubations. 
Embedding then took place through incubation in increasing concentrations of LR 
White medium grade resin (1 hour in 50%, 66%, 75%, 100%; 2 x 8 hours in 100%) 
in ethanol. Samples were then mounted in embedding capsules with fresh resin and 
allowed to polymerise overnight at 60°C. Semi-thin tissue sections (1 µM) were cut 
using an ultramicrotome (Ultracut E, Reichert-Jung) with a glass knife and collected 
on glass slides. Sections were stained with toluidine blue and imaged using an 
Olympus BX60 light microscope to locate adherent bacteria. Areas of interest were 
cut into 90 nm ultra-thin sections, mounted onto film/carbon copper grids, and 
stained sequentially with uranyl acetate and lead citrate. Sections were imaged with a 
Tecnai G2 20 Twin transmission electron microscope (FEI) at 200 kV. 
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2.8 | Gene expression analysis 
2.8.1 | RNA isolation and DNase treatment 
Total RNA was isolated from cells and biopsies using the RNeasy Mini kit (Qiagen). 
Cell and biopsies were lysed in buffer RLT supplemented with 1% β-
mercaptoethanol. To homogenise cell monolayers, buffer RLT was flushed over the 
monolayer until cells had detached from the membrane, transferred to an RNase-free 
microcentrifuge tube (Sarstedt) and vortexed for 10 seconds. To homogenise 
biopsies, samples were transferred into a microcentrifuge tube and broken down 
using a homogenising pestle (Kimble Chase) before being vortexed for 45 seconds. 
Samples were immediately frozen at -80°C for at least 12 hours. After thawing on 
ice, lysates were transferred into Qiagen spin columns, and RNA was isolated 
according to the manufacturer’s instructions (section entitled ‘Purification of Total 
RNA from Animal Cells using Spin Technology’). Genomic DNA was degraded by 
on-column digestion with RNase-free DNase (Qiagen), according to the 
manufacturer’s instructions. 
RNA quantity and purity were determined using a Nanodrop ND-1000 
spectrophotometer (Thermo Scientific). Samples were considered pure within 
acceptable limits if the 260/230 nm ratio (measures presence of salt contaminants) 
ranged between 1.5 and 2.0, and the 260/280 nm ratio (measures presence of protein 
contaminants) was ≥1.8. 
RNA integrity was analysed by agarose gel electrophoresis. RNA was labelled with 
DNA nontox dye (PanReac AppliChem) and samples were separated on a 1.5% 
agarose gel in Tris-borate-EDTA (TBE). TBE stock solution (10x) was prepared by 
adding 108 g Tris, 55 g boric acid and 40 mL 0.5 M EDTA pH 8.0 and adjusting to a 
final volume of 1 L with ddH20. A 1x working solution was prepared by diluting 
1:10 in ddH20. Gels were run at 100 V (constant) for ~45 minutes (Consort E863) 
and RNA was visualised under UV light using a U:Genius gel imager (Syngene). 
RNA integrity was considered acceptable if two distinct bands were visible 
(indicating the presence of 28S and 18S rRNA) with the former appearing stronger 
than the latter (Figure 2.3). 
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Figure 2.3. Representative image of intact RNA, as determined by agarose gel 
electrophoresis. Each column represents an individual sample. 
 
2.8.2 | cDNA synthesis 
RNA was converted to cDNA by using the qScript cDNA supermix (Quanta 
Biosciences). Reaction mixes were prepared by mixing 4 µL supermix with 1 µg 
RNA (volume dependent on concentration of RNA solution) and water up to a total 
volume of 20 µL. To control for the presence of residual DNA in the RNA samples, 
which could interfere with downstream applications, a reaction mix was prepared 
without addition of qScript cDNA supermix (RT-control) for each cDNA synthesis 
procedure. 
cDNA synthesis was conducted according to qScript instructions using a thermal 
cycler (Biometra Professional Trio) set to the following conditions: 5 minutes at 
25°C, 30 minutes at 42°C, 5 minutes at 85°C. cDNA was diluted 1:2 in filter-
sterilised milli-Q water and stored short-term at 4°C or long-term at -20°C. 
 
2.8.3 | Quantitative PCR 
Quantitative PCR (qPCR) reaction mixtures were prepared by mixing 5 µL 2x SYBR 
Green Jumpstart Taq Readymix, 0.1 µL internal reference dye, 1 µL forward/reverse 
primer (10 µM), cDNA (1 µL for cells and 2 µL for biopsies) and water (3 µL for 
cells and 2 µL for biopsies) up to a total volume of 10.1 µL. For analysis of hBD2 or 
LL-37 mRNA levels, 4 µL cDNA and no water was added to reaction mixes. 
Reaction mixes were also prepared using the RT-negative control sample. To ensure 
that none of the reagents were contaminated with DNA, no template (NT) control 
reaction mixes were prepared containing water in place of cDNA for each primer 
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pair. Reaction mixes were loaded in duplicate into 96-well PCR plates (Sarstedt) on 
ice. Cling film was placed beneath the plates whilst on ice to prevent accumulation of 
water and dirt. Plates were sealed with transparent sealing film (Sarstedt) and spun in 
a swing rotor centrifuge at 2000 x g for 1 minute to collect reagents at the base of the 
wells. Plates were loaded into an ABI 7500 qPCR machine and subjected to the 
following cycling program: 
 Stage 1: 2 minutes at 95°C 
 Stage 2: 30 seconds at 95°C, 30 seconds at 60°C, 35 seconds at  
72°C (repeat for 40 cycles) 
 Stage 3: 5 minutes at 72°C 
 Dissociation stage: 15 seconds at 95°C, 60 seconds at 60°C,  
15 seconds at 95°C, 15 seconds at 60°C 
At the end of the run, cycle threshold (Ct) values and dissociation curves were 
generated using ABI7500 software and exported for further analysis.  
 
2.8.4 | Primer design and validation 
Primers used are presented in Table 2.3. Primer sequences were either obtained from 
published studies or designed using PrimerBLAST software 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/). Whole gene sequences were 
obtained from ENSEMBL (http://www.ensembl.org/index.html). Primers were 
selected only if they met the following parameters: the GC content ranged between 
30% and 70%, the self-complementarity score was <8, and the amplified sequence 
was 60-150 base pairs (bp) in length and spanned an intron. All primer melting 
temperatures were ~60°C. Lyophilised primers were purchased from Sigma-
Genosys, reconstituted in 10 mM Tris (pH 8.0) to obtain a 100 µM stock solution, 
and stored at -20°C. Working solutions were prepared by diluting stock solution 1:10 
in filter-sterilised milliQ water.  
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Table 2.3 | List of primers used in this study 
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To confirm primer specificity, dissociation curve analysis of qPCR products was 
performed (single peak) and qPCR product size was determined by agarose gel 
electrophoresis. To test amplification efficiency, two-fold serial dilutions of cDNA 
were prepared and run with each primer. After the run, the Ct values for each dilution 
were log transformed and plotted onto a scatter graph. The slope of the graph was 
used to calculate primer efficiency, according to the following formula: (10^(-
1/slope)-1)*100. Primer efficiencies ranging between 95 and 130% were considered 
acceptable. 
 
2.8.5 | Relative quantification 
To confirm that Ct values represented levels of converted mRNA (i.e cDNA) and not 
contaminant DNA, values for the NT- and RT-controls were compared with those for 
standard samples. The amount of contaminating DNA was considered acceptably 
low if control samples yielded Ct values that were >5 higher than standard samples 
(equivalent to a >32-fold difference in transcript levels). 
Ct values for the gene of interest were normalised by subtracting the geometric mean 
Ct for two housekeeper genes, glyceraldehyde 3-phosphate dehydrogenase (GAPDH) 
and RNA polymerase II (POLR2A). Fold expression values for the gene of interest 
were calculated in treated samples relative to matched untreated samples using the 
formula 2–ΔCt, where ΔCt represents the product of subtracting the normalised Ct 
value of the untreated sample from that of the treated sample. 
 
2.9 | Enzyme-linked immunosorbent assay (ELISA) 
All ELISAs were performed in Nunc Maxisorb immunoassay 96-well plates 
(Thermo Fisher Scientific). Washes were conducted using 200 µL PBS/0.05% 
Tween. Optical density (OD) readings were taken using a Benchmark Plus 
Microplate Spectrophotometer (BioRad) and standard curves generated using 
Microplate Manager 5.2.1 software. 
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2.9.1 | Sample collection 
Culture medium was collected in pre-chilled microcentrifuge tubes and spun at 
18,000 x g for 5 minutes at 4°C to pellet cell debris and bacteria. To harvest protein 
located within cells, T84 monolayers or biopsies were lysed in 1% ice-cold Triton X-
100 in PBS supplemented with protease inhibitor cocktail (0.5%). Cells were left to 
lyse for 5 minutes on ice before being disrupted with a pipette tip (T84 cells) or 
homogenizing pestle (biopsies), transferred to a microcentrifuge tube, and spun at 
18,000 x g for 15 minutes at 4°C to pellet insoluble proteins. Supernatants were 
stored at -80°C until required. 
When preparing samples for hBD2 ELISA, all centrifuge steps were conducted in 
LoBind microcentrifuge tubes (Eppendorf). To concentrate hBD2, samples were 
loaded into pre-chilled Amicon ultra centrifugal filter units with a molecular weight 
cut-off of 3 kDa (Millipore) and spun at 2,000 x g at 4 °C until sample volume had 
reduced to the desired amount. 
 
2.9.2 | ELISA for Stx2 
Plates were coated in 100 µL Stx binding agent diluted in a coating buffer (1.59 g/L 
sodium carbonate, 2.93 g/L sodium bicarbonate and 0.2 g/L sodium azide in water) 
for 3 hours. Either P1 glycoprotein or polyclonal rabbit α-Stx 204 (Anne Kane, Tufts 
Medical Centre), NIH, USA) was used as a binding agent at a dilution of 1:5000 or 
1:500, respectively. This was followed by a 2-hour blocking step in 300 µL 
powdered milk (5% in coating buffer). After 5 washes in PBS/Tween, duplicate 
wells were loaded with 100 µL sample (diluted 1:5 in DMEM/F12) or DMEM/F12 
alone (blank wells). Two-fold serial dilutions of purified Stx2 standard (Anne Kane, 
Tufts Medical Centre), ranging from 40 to 0.31 ng/ml, were also added to wells in 
triplicate.Wells were incubated for 1 hour, washed 5 times in PBS-Tween, and 
subjected to the following incubation steps (interspersed with 5x washing): 20 
minutes in monoclonal mouse α-Stx2 NR846 (1:2500 in PBS/Tween, BEI resources), 
20 minutes in goat α-mouse IgG conjugated with alkaline phosphatase (1:2000 in 
PBS/Tween), and 30 minutes in phosphatase substrate dissolved in diethanolamine 
buffer (prepared in 11 mL batches by mixing 9.7 mL diethanolamine, 1 mL 50 mM 
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magnesium chloride, 0.2 g sodium azide and adjusted to pH 9.8 using concentrated 
hydrochloric acid). The OD at wavelength 405 nm (OD405) was then measured, with 
baseline wavelength set at 605 nm. To remove any signal caused by non-specific 
binding of antibodies, OD405 readings from the blank wells were subtracted from 
those containing samples. Stx2 concentrations were calculated from the standard 
curve. Stx levels released by each bacterial strain were normalised according to the 
level of bacterial growth within the sample (measured by OD600) using the following 
formula: ng/ml ÷ OD600 0.1. 
 
2.9.3 | ELISA for IL-8 and hBD2 
IL-8 and hBD2 were quantified using commercial human ELISA kits (PeproTech), 
according to the manufacturer’s instructions. When using the hBD2 ELISA kit, the 
following amendments were made: the blocking step was increased to 2 hours, the 
sample incubation step was increased to 2.5 hours, and the detection antibody step 
was reduced to 1.5 hours. For biopsies, IL-8 levels were normalised against total 
tissue protein. Total tissue protein was measured using the DC protein assay (Bio-
Rad). The DC protein assay was performed according to manufacturer’s instructions, 
except that the volume of sample used was 40 µl rather than 100 µl. A 2-fold dilution 
of BSA (in lysis buffer) was used to construct the standard curve, ranging from 94 to 
1500 µg/ml. 
 
2.10 | Statistical analyses 
Statistical analysis was performed using GraphPad Prism Version 6 software. For 
comparison of two groups, parametric students t-test (cell line experiments) or non-
parametric Mann-Whitney test (biopsy experiments) was used. Comparisons of three 
or more groups were performed using parametric analysis of variance (ANOVA) 
with Tukey’s post-hoc test (cell lines) or non-parametric Kruskal-Wallis with Dunn’s 
post-hoc test (biopsies). All gene expression data were log10 transformed before 
statistical analysis was performed. A P value of <0.05 was considered significant. 
Degrees of statistical significance are presented as follows: *=P<0.05, **=P<0.01, 
***=P<0.001.  
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CHAPTER THREE 
 
EHEC COLONISATION                      
AND A/E LESION FORMATION 
 
 
 
 
 
 
Based on publication: 
Lewis, S.B., Cook, V., Tighe, R. and Schüller, S. (2015) Enterohemorrhagic 
Escherichia coli colonization of human colonic epithelium. Infection and Immunity 
83, 942-949 (see Appendix 2) 
 
Collaborative work: 
Biopsies provided by Vivienne Cook, Richard Tighe and Graham Briars 
TEM performed by Kathryn Cross 
SEM support provided by Bertrand Lézé 
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3.1 | Introduction 
EHEC colonisation of IECs is considered critical for pathogenesis in humans 
(Croxen et al., 2013). Colonisation is associated with the formation of attaching and 
effacing (A/E) lesions, which are characterised by intimate bacterial attachment to 
the IEC surface, localised microvillous effacement, and polymerised actin beneath 
the site of attachment (Lai et al., 2013). The mechanisms underlying EHEC 
adherence to IECs have been characterised in detail using in vitro infection models 
based on cultured epithelial cell lines, and the following sequence of events has been 
established (Figure 1.4). Initially, EHEC bacteria loosely adhere to the host cell 
surface using one or more adhesins, including fimbriae, pili and flagella (Table 1.1). 
Subsequently, the bacterium inserts a type III secretion system (T3SS) into the host 
cell (Ebel et al., 1998), through which effector proteins such as the translocated 
intimin receptor (Tir) are transported (DeVinney et al., 1999). Tir inserts into the 
host plasma membrane, where it binds to and clusters with intimin on the bacterial 
outer membrane, thereby conferring an intimate attachment (Touzé et al., 2004). Tir 
then triggers a signalling cascade that leads to recruitment of polymerised actin to the 
attachment site  (DeVinney et al., 1999), which collects to form a pedestal-like 
structure beneath the bacterium (Knutton et al., 1989). The adherence process also 
leads to the localised effacement of microvilli, although the direct cause of this 
phenomenon remains unclear. 
EHEC adherence to the intestinal epithelium has also been examined in vivo using 
animal models. Infection of gnotobiotic piglets, infant rabbits and neonatal calves 
leads to A/E lesion formation in the small intestine and the colon (Dean-Nystrom et 
al., 1997; Francis et al., 1986; Pai et al., 1986; Tzipori et al., 1986). However, 
examination of intestinal biopsy tissue from EHEC-infected humans has revealed no 
signs of bacterial colonisation, despite showing damage to colonic mucosa (Griffin et 
al., 1990; Kelly et al., 1987; Malyukova et al., 2009; Shigeno et al., 2002). This has 
cast doubt on whether EHEC colonises the human intestinal epithelium in vivo, 
although clinical samples are generally taken at a progressed stage of disease at 
which point colonisation may have diminished or be obscured by damaged tissue. 
EHEC adherence to human intestinal tissue has been investigated experimentally 
using in vitro organ culture (IVOC), a model that involves ex vivo infection of human 
104 
 
endoscopic biopsies. Human IVOC studies using Stx-negative EHEC strains have 
detected A/E lesions on terminal ileal but not colonic IECs (Chong et al., 2007; 
Phillips et al., 2000). Therefore, it remains unclear whether EHEC colonise human 
colonic epithelium and whether colonisation has any relevance for onset of colonic 
pathology during infection of humans. 
In this study, we re-examined EHEC colonisation of human colonic epithelium ex 
vivo using wild-type EHEC strains. Previous studies have shown that Shiga toxin 
(Stx) produced by EHEC enhances adherence to HeLa cells and colonisation in mice 
(Robinson et al., 2006). Therefore, we hypothesised that Stx produced by wild-type 
EHEC strains may facilitate adherence to human colonic biopsy epithelium. In 
addition, we also characterised EHEC colonisation of T84 human colonic carcinoma 
cells, which are widely used as an in vitro model of EHEC infection. 
The objectives of this study were to: 
1. Determine whether EHEC colonise human colonic epithelium ex vivo 
2. Characterise the adherence phenotype ex vivo (if any) and in vitro 
3. Identify bacterial factors influencing colonisation ex vivo (if any) and in vitro  
105 
 
3.2 | Results 
3.2.1 | EHEC adherence phenotype on T84 human colon 
carcinoma cells is dependent on polarisation status 
T84 human colonic carcinoma cells were used to characterise EHEC adherence to 
colonic epithelial cells in vitro. These cells resemble colonic crypt cells and form a 
polarised cell monolayer in culture, evidenced by their columnar shape, apical brush 
border, high transepithelial electrical resistance (TER), and tight junctions between 
cells (Madara et al., 1987; Tran et al., 2014). Unlike most other carcinoma cell lines, 
T84 cells do not express the Shiga toxin (Stx) receptor globotriaosylceramide (Gb3) 
on their surface and are therefore resistant to Stx cytotoxicity, which mimics the 
situation in the human intestine (Björk et al., 1987; Miyamoto et al., 2006; Philpott 
et al., 1997; Schüller et al., 2004). This makes T84 cells a suitable model for 
studying adherence of EHEC. Cells were seeded onto coverslips at a low cell density 
and cultured for 7 days to promote growth of a confluent monolayer (Gobert et al., 
2007). Monolayers were infected with Stx-negative EHEC strains TUV 93-0, 85-170 
and Sakai for 5 hours, and cell morphology was visualised by immunofluorescence 
staining and scanning electron microscopy (SEM). 
Upon examination of T84 monolayers, it was noted that cells exhibited two types of 
morphology: cells in central areas showed signs of polarisation such as an actin-rich 
brush border, whereas those in marginal areas appeared non-polarised with few 
microvilli (Figure 3.1; data shown for TUV 93-0). The majority of EHEC bacteria 
were found on non-polarised cells, with a relatively small number on polarised cells. 
EHEC bound to non-polarised cells were associated with polymerised actin beneath 
attachment sites (Figure 3.1A), indicating that actin recruitment had taken place. In 
contrast, actin was not observed beneath bacteria on polarised cells. Consistent with 
these findings, SEM analysis revealed formation of actin pedestals beneath bacteria 
attached to non-polarised, but not polarised, cells (Figure 3.1B). Interestingly, 
polarised cells displayed microvillous effacement around bacterial attachment sites, 
whilst microvillous effacement on non-polarised cells could not be examined due to 
the lack of a thick brush border on these cells (Figure 3.1B). 
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Figure 3.1. EHEC adherence phenotype differs on polarised vs. non-polarised 
T84 cells. Confluent cells on coverslips were infected with EHEC strain TUV 93-0 
for 5 hours. (A) Immunofluorescence staining for actin (green) and E. coli (red). Top 
images show merged channels; bottom images show actin channel alone. Scale bars 
= 10 µm. (B) Scanning electron micrographs showing EHEC-associated microvillous 
effacement (white arrows) on polarised cells and actin pedestal formation (black 
arrows) on non-polarised cells. Images represent those from two independent 
experiments performed in duplicate. Scale bars = 2 µm 
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Figure 3.2. EPEC induce actin recruitment in polarised and non-polarised T84 
cells. Confluent cells on coverslips were infected with EPEC strain E2348/69 for 3 
hours and immunostained for actin (green) and E. coli (red). Top images show 
merged channels; bottom images show actin channel alone. Images represent those 
from two independent experiments performed in duplicate. Scale bars = 10 µm. 
 
To determine whether actin recruitment in polarised cells was impaired or obscured 
by the actin-rich brush border, infections were performed using the related A/E 
pathogen, EPEC. Flourescent actin staining (FAS) revealed the presence of 
polymerised actin beneath EPEC adhered to both polarised and non-polarised cells, 
as shown in Figure 3.2. 
Put together, this data shows that confluent monolayers of T84 cells seeded out on 
coverslips were displaying different stages of polarisation. In cells that appeared 
polarised, EHEC triggered microvillous effacement but no actin polymerisation. This 
suggests that EHEC may not induce typical A/E lesions in polarised T84 cells.  
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3.2.2 | Establishment of fully polarised T84 cell culture 
In order to obtain fully polarised T84 cell monolayers for EHEC adherence studies, a 
modified cell culture method was adopted using collagen-coated permeable 
Transwell inserts (Madara et al., 1987). Cells were seeded onto inserts at a high cell 
density (5 x 105 cells/insert) and cultured for an extended period (up to 14 days), 
whilst monitoring the TER at regular intervals. By day 7-10 post-seeding, 
monolayers had developed a TER of above 1500 Ω x cm2 and displayed other 
hallmarks of polarisation when examined by microscopy, such as column-shaped 
morphology, apical brush border and tight junctions between adjacent cells (Figure 
3.3). In addition, these cells appeared morphologically identical to the centrally-
located cells previously grown on coverslips (Figure 3.4). These monolayers were 
considered fully polarised, and the Transwell culture method was used for all 
subsequent T84 cell experiments. 
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Figure 3.3. T84 cells exhibiting hallmarks of polarisation. Cells were cultured in 
Transwell inserts for up to 14 days. (A) Transepithelial electrical resistance (TER) 
was monitored every two days from day 4 post-seeding. Data are shown as means ± 
SE of four experiments performed in triplicate. (B) Immunofluorescence image 
showing the tight junction protein occludin in between cells. (C) Scanning electron 
micrograph showing a dense microvillous brush border on the apical cell surface. (D) 
XZ-scan confocal image of actin-stained cells exhibiting a column-shaped 
morphology. (B, C, D) Images represent those from at least two independent 
experiments performed in duplicate. Scale bars = 10 µm. 
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3.2.3 | EHEC do not induce typical A/E lesions on polarised T84 
cells 
In order to examine the adherence phenotype of EHEC on fully polarised T84 cells, 
infections were repeated using cells grown in Transwell inserts. Infection assays 
were extended to include wild-type strains EDL933 and Walla-1, as well as Stx-
negative TUV 93-0. No signs of actin recruitment in polarised T84 cells were 
observed beneath adherent bacteria following infection for 5-9 hours with any of the 
three strains (Figure 3.4), indicating that neither wild-type nor Stx-negative EHEC 
strains recruit actin during colonisation of polarised T84 cells. However, actin 
recruitment was detected beneath bacteria bound to extruding cells that had lost 
polarity, and bacterial colonisation of these cells was high in comparison to non-
extruding cells (data not shown). 
Actin recruitment is mediated by Tir upon its translocation into the host cell via the 
T3SS (DeVinney et al., 1999). Tir insertion into the plasma membrane and clustering 
by intimin is indicative of intimate bacterial attachment, another A/E lesion hallmark. 
To determine whether EHEC translocates Tir into polarised T84 cells, monolayers 
were immunostained for Tir and EspA (component of the T3S translocation tube) 
following infection with EDL933 and Walla-1 for 6 hours. Figure 3.5A shows that 
Tir was not detected beneath bacteria adhered to polarised T84 cells. This was not 
attributable to the absence of a functional T3SS, as EspA-rich translocation tubes 
were seen protruding the surface of adherent EHEC (Figure 3.5C). Furthermore, Tir 
translocation was evident beneath EHEC bound to extruding cells that appeared to 
undergo apoptotic cell death (Figure 3.5B). Put together, these findings indicate that 
EHEC adherence to polarised T84 cells does not involve actin recruitment or 
intimate attachment, and therefore does not lead to formation of typical A/E lesions. 
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Figure 3.4. EHEC do not induce actin recruitment in polarised T84 cells. 
Polarised cells were infected with EHEC strains TUV 93-0, EDL933 and Walla-1 for 
9 hours and immunostained for actin (green) and E. coli (red). Left images show 
merged channels; right images show actin channel alone. Images represent those 
from two independent experiments performed in duplicate. Scale bars = 10 µm.  
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Figure 3.5. EHEC adhered to polarised T84 cells do not associate with 
translocated Tir. Cells were infected with EHEC strain EDL933 for 6 hours and 
immunostained for Tir (top; green), EspA (bottom; green) and E. coli (red). (A) 
Bacteria adhered to polarised cells with no visible signs of Tir. (B) Bacteria adhered 
to extruding cell (indicated by fragmented nucleus shown after staining with DAPI 
(blue)) with Tir visible beneath attachment site. (C) Adherent bacteria with EspA 
filaments protruding from their surface. Images represent those from two 
independent experiments performed in duplicate. Scale bars = 5 µm. 
 
3.2.4 | EHEC colonise human colonic biopsies and induce A/E 
lesions 
In vitro organ culture (IVOC) enables the study of EHEC adherence to human 
intestinal epithelium ex vivo. Previous IVOC infection studies using Stx-negative 
EHEC strains have reported adherence to terminal ileal but not colonic biopsy 
epithelium (Chong et al., 2007; Phillips et al., 2000). We utilised the IVOC model in 
order to characterise adherence of wild-type EHEC strains to human intestinal 
epithelium. Biopsies taken from the terminal ileum and transverse colon of adults 
were infected with EHEC strains EDL933, Walla-1 and H07184 for 8 hours and 
colonisation was examined by scanning electron microscopy (SEM). 
All three EHEC strains extensively colonised both ileal and colonic biopsy 
epithelium (Figure 3.6; data shown for EDL933). In agreement with published  
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Figure 3.6. EHEC colonise human ileal and colonic biopsies. Endoscopic biopsies 
from the terminal ileum and transverse colon were infected with EHEC strain 
EDL933 for 8 hours and adherence was examined by scanning electron microscopy. 
(Top) EHEC adhered to ileum were surrounded by elongated microvilli, whereas 
those bound to the colon were associated with a zone of microvillous effacement 
(white arrows). (Bottom) Bacteria on terminal ileal and colonic biopsies localised 
around villus tips and crypt openings, respectively (black arrows). Images represent 
those from three independent experiments performed in duplicate. Scale bars = 2 µm 
(Top) or 20 µm (Bottom) 
 
findings (Fitzhenry et al., 2002; Phillips et al., 2000), terminal ileal biopsies 
harboured elongated microvilli at sites of bacterial adherence. No signs of 
microvillous elongation were found on colonic biopsies but a zone of microvillous  
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Figure 3.7. EHEC form A/E lesions on human colonic biopsies. Biopsies were 
infected with EHEC strain EDL933 for 8 hours. Immunostaining was performed for 
EspA (A) and Tir (B) in green and E. coli in red. (C) Transmission electron 
micrograph showing intimate attachment of bacteria to host cell membrane and 
microvillous effacement. Images represent those from two independent experiments 
performed in duplicate. Scale bars = 2 µm (A, B) and 0.5 µm (C).  
 
effacement was evident around adherent bacteria, similar to that observed in 
polarised T84 cells. Colonisation on ileal samples was predominantly localised 
towards the tips of villi, whilst bacteria on colonic biopsies were most often found on 
the surface epithelium located between crypts (Figure 3.6). 
To further characterise the adherence phenotype of EHEC bound to colonic 
epithelium, biopsies were immunostained for Tir and EspA following infection with 
EDL933 and Walla-1 strains. In contrast to findings from T84 cell infections, EHEC 
on colonic biopsies were associated with translocated Tir beneath sites of attachment 
(Figure 3.7B; data shown for EDL933). EspA filaments were also detected on 
adherent bacteria (Figure 3.7A). Transmission electron microscopy (TEM) revealed 
adherent bacteria in close contact with the IEC membrane and surrounded by a zone 
of microvillous effacement (Figure 3.7C). Put together, these studies demonstrate 
that EHEC colonise the human colonic epithelium ex vivo and induce formation of  
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Figure 3.8. Stx-negative EHEC colonise human colonic biopsies. Colonic biopsies 
were infected with EHEC strains TUV 93-0 and 85-170 for 8 hours and colonisation 
was examined by scanning electron microscopy. Images represent those from two 
independent experiments performed in duplicate. Scale bars = 2 µm. 
 
typical A/E lesions, characterised by Tir translocation, intimate attachment and 
effacement of microvilli. 
 
3.2.5 | EHEC colonisation of the human colonic epithelium is not 
affected by Stx production 
Previous IVOC studies using Stx-negative EHEC strains have reported that EHEC is 
unable to colonise colonic epithelium (Chong et al., 2007; Phillips et al., 2000). As a 
previous study by Robinson et al. (2006) has shown that Stx enhances adherence to 
HeLa human cervical carcinoma cells and intestinal colonisation in mice, we decided 
to investigate whether Stx plays a role in EHEC colonisation of human colonic 
epithelium. To determine whether Stx production is required for EHEC colonisation 
of colonic biopsies, IVOC was performed using Stx-negative strains TUV 93-0 and 
85-170 used in previous studies. As shown in Figure 3.8, both Stx-negative EHEC 
strains colonised colonic biopsies, displaying a similar adherence phenotype to that 
observed following wild-type infection. This indicates that Stx is not the determining 
factor for EHEC colonisation of colonic biopsies during IVOC. 
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Figure 3.9. Stx production does not affect EHEC colonisation of human colonic 
epithelial cells. (Left) Human colonic biopsies were infected with wild-type (WT) 
EHEC strain EDL933 or an isogenic Stx deletion mutant (Δstx) for 8 hours. Samples 
were viewed by scanning electron microscopy and colonisation was quantified by 
recording the presence or absence of adherent bacteria in approximately 250 fields of 
view. Colonisation is expressed as the percentage of fields of view containing 
adherent bacteria. Data are shown as means ± standard error (SE) from two 
independent experiments performed in triplicate. (Right) Polarised T84 cells were 
infected with wild-type EDL933 or EDL933 Δstx for 6 hours. Colonisation was 
quantified by plating serial dilutions of cell lysates and determining the numbers of 
colony-forming units. Colonisation is expressed as the percentage of adherent 
bacteria relative to the inoculum. Data are shown as means ± SE from five 
independent experiments performed in duplicate. 
 
In addition, colonic biopsies and T84 cells were infected with a wild-type (WT) 
EHEC strain EDL933 or an isogenic Stx deletion mutant (Δstx) for 8 and 6 hours, 
respectively. SEM-based analysis of biopsies revealed no significant difference in the 
proportion of epithelium colonised between the two strains (Figure 3.9). Similarly, 
both strains colonised polarised T84 cells to a similar degree. These data indicate that 
Stx does not have a significant effect on EHEC colonisation of human colonic 
epithelium in vitro or ex vivo. 
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3.2.6 | Intimin and the T3SS are essential for EHEC colonisation 
of human colonic biopsies but not T84 cells 
Intimin and the T3SS play essential roles in EHEC adherence to HeLa cervical 
carcinoma cells and colonic epithelium of some animals (Dean-Nystrom et al., 
1998b; Donnenberg et al., 1993; Ebel et al., 1998; McKee et al., 1995; Ritchie et al., 
2003). To investigate whether intimin and T3S are required for human colonic 
colonisation by EHEC, biopsies and polarised T84 cells were infected with EHEC 
strain EDL933 or isogenic mutant strains with deletions in intimin (eae), EspA 
(espA) or EscN (escN, cytoplasmic ATPase of T3SS). SEM analysis revealed no 
adherent bacteria on biopsies infected with any of the mutant strains, whilst the wild-
type (WT) strain showed good colonisation (Figure 3.10A). Quantification analysis 
confirmed these observations, with WT colonising 26.0% ± 7.2% of biopsy 
epithelium, compared to 0% for each of the mutant strains (Figure 3.10B). In 
contrast, all deletion mutants colonised polarised T84 cells (Figure 3.11) to a level 
comparable with that of the WT strain. Put together, these data suggest that 
expression of intimin and T3S are essential for EHEC colonisation of colonic 
biopsies but not T84 cells. 
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Figure 3.10. EHEC colonisation of human colonic biopsies is dependent on 
intimin and the T3SS. Colonic biopsies were infected with wild-type (WT) EHEC 
strain EDL933 or isogenic deletion mutants lacking EspA, EscN or intimin (eae) for 
8 hours. (A) Biopsies were viewed by scanning electron microscopy and (B) 
colonisation was quantified by recording the presence or absence of adherent bacteria 
in approximately 250 fields of view. Colonisation is expressed as the percentage of 
fields of view containing adherent bacteria. Data are shown as means ± SE from four 
independent experiments performed in duplicate. Scale bars = 10 µm. 
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Figure 3.11. EHEC colonisation of polarised T84 cells is not dependent on 
intimin or T3S. Polarised T84 cells were infected with wild-type EHEC strain 
EDL933 or isogenic deletion mutants lacking functional EspA, EscN or intimin (eae) 
for 6 hours. Colonisation was quantified by plating serial dilutions of cell lysates and 
determining the numbers of colony-forming units. Colonisation is expressed as the 
percentage of adherent bacteria relative to the inoculum. Data are shown as means ± 
SE from four independent experiments performed in duplicate. 
 
3.2.7 | EHEC colonise human paediatric colonic biopsies 
As our data showing EHEC colonisation of colonic biopsies contrasted with those 
reported previously by Phillips and colleagues (Phillips et al., 2000; Chong et al., 
2007), we compared the experimental methodology employed in each study. It was 
noted that previous studies had performed IVOC experiments using biopsies from 
paediatric patients, whilst our study used biopsies from adults. To determine whether 
EHEC colonic colonisation ex vivo was restricted to adult biopsies, a limited set of 
infections was performed using biopsies obtained from children aged 9 and 13 years. 
SEM analysis revealed that both EHEC strains EDL933 and Walla-1 colonised 
paediatric colonic biopsies and exhibited a similar adherence phenotype to bacteria 
bound to adult biopsies (Figure 3.12). This indicates that age is not a determining 
factor for EHEC colonisation of human colonic epithelium during IVOC. 
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Figure 3.12. EHEC colonise human paediatric colonic biopsies. Paediatric colonic 
biopsies were infected with EHEC strains EDL933 and Walla-1 for 8 hours, and 
colonisation was examined by scanning electron microscopy. Images represent those 
from two independent experiments performed in duplicate. Scale bars = 2 µm 
 
3.2.8 | High oxygen levels suppress EHEC colonisation of colonic 
biopsies 
Another difference between previously published IVOC studies and ours is the 
oxygen concentration used: whilst Phillips and colleagues performed IVOC at high 
oxygen concentrations (5% CO2 + 95% O2) (Chong et al., 2007; Phillips et al., 
2000), the IVOC experiments in our study were performed in atmospheric oxygen 
concentrations (5% CO2 + air). As it has recently been reported that EHEC 
colonisation of T84 cells is enhanced by microaerobiosis in a T3S-dependent manner 
(Schüller and Phillips, 2010), we decided to test the effect of oxygen on EHEC 
colonisation of human colonic biopsies during IVOC. Infections with EHEC strain 
EDL933 were performed under atmospheric (5% CO2 + air) or oxygen-rich (5% CO2 
+ 95% O2) conditions and colonisation was quantified by SEM. As shown in Figure 
3.13, infections performed in 95% oxygen resulted in a significantly reduced level of 
EHEC colonic colonisation compared with those performed in air (3.1 ± 0.7% vs. 
43.1 ± 8.0%), indicating that high oxygen levels suppress EHEC colonic colonisation 
during IVOC. 
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Figure 3.13. EHEC colonisation of human colonic biopsies is inhibited in 
oxygen-rich conditions. Colonic biopsies were infected with EHEC strain EDL933 
and IVOC was performed for 8 hours under high (oxygen) or atmospheric (air) 
oxygen levels. Samples were viewed by scanning electron microscopy and 
colonisation was quantified by recording the presence or absence of adherent bacteria 
in approximately 250 fields of view. Colonisation is expressed as the percentage of 
fields of view containing adherent bacteria. Data are shown as means ± SE from two 
independent experiments performed in triplicate. * = P < 0.05 
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3.3 | Discussion 
EHEC is considered a colonic pathogen (Croxen and Finlay, 2010). Disease is 
associated with haemorrhagic colitis (HC), with inflammation and ulcer-like lesions 
found predominantly in the ascending and transverse colon, respectively (Griffin et 
al., 1990; Shigeno et al., 2002). Studies using cultured cell lines and animal models 
have linked pathogenesis with EHEC adherence and A/E lesion formation on IECs 
(reviewed in Croxen et al., 2013), and it is postulated that EHEC A/E lesions on 
colonic epithelium contribute to disease during infection of humans. However, 
clinical evidence of EHEC binding to human intestinal epithelium is lacking (Kelly 
et al., 1987; Malyukova et al., 2009), and an ex vivo model system using human 
intestinal tissue and Stx-negative EHEC has failed to demonstrate EHEC binding to 
the colon (Chong et al., 2007; Phillips et al., 2000). In this study, we conducted an 
in-depth assessment of EHEC adherence to colonic epithelium using physiologically 
relevant models of human intestinal infection, with the aim of improving our 
understanding of EHEC-IEC interactions in the colon. 
 
3.3.1 | A/E lesion formation in vitro 
The T84 human colonic carcinoma cell line has been widely used in the study of 
EHEC as it forms a polarised monolayer of colonic crypt-like cells in culture 
(Madara et al., 1987) that do not express the Stx receptor Gb3 on their surface, in 
line with the situation in vivo (Schüller et al., 2004). We used this cell line to 
examine EHEC adherence to human colonic epithelial cells in vitro. 
In this study, we found that EHEC did not induce typical A/E lesions on polarised 
T84 cells. Although bacteria colonised these cells and induced microvillous 
effacement, adherence sites were not associated with actin pedestal formation or Tir 
translocation into the plasma membrane. This is consistent with previous studies, 
which have reported EHEC adherence to polarised T84 cells with no discernible 
recruitment of actin (Ismaili et al., 1995; Li et al., 1999). Since actin recruitment is 
dependent on the action of Tir within the host cell (reviewed in Frankel and Phillips, 
2008), it seems likely that the observed lack of pedestals occurs as a direct result of 
the failure of EHEC to translocate Tir and/or failure of Tir to insert into the host cell 
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membrane. Interestingly, previous studies have found that EHEC bacteria adhered to 
T84 cells are able to subvert host cell signal processes such as epithelial barrier 
function and ion transport (Ismaili et al., 1995; Li et al., 1999; Philpott et al., 1998). 
Modulation of barrier function and ion transport by EHEC and EPEC has been 
attributed to the action of bacterial effector proteins such as EspF, EspFU, Map, Tir 
and NleA (Dean et al., 2006; Hodges et al., 2008; McNamara et al., 2001; 
Viswanathan et al., 2004), suggesting that bacteria adhered to polarised T84 cells are 
able to secrete effectors into the host cytosol. In agreement with this, we found EspA 
filaments protruding from adherent bacteria, indicating expression of the T3SS. Put 
together, these findings suggest that EHEC are able to adhere to polarised T84 cells, 
translocate effector proteins and modulate host cell signal transduction pathways 
independently of actin pedestal formation and Tir insertion into the plasma 
membrane. 
Despite their failure to translocate Tir or recruit actin, adherent EHEC bacteria did 
induce microvillous effacement. This is in agreement with transmission electron 
micrographs presented by Li et al. (1999), which show a lack of microvilli on T84 
cells loosely associated with EHEC bacteria at the plasma membrane. Furthermore, 
studies on EPEC adherence to human biopsies ex vivo have reported the presence of 
partial A/E lesions displaying two or fewer of its hallmarks: ex vivo infection of 
human intestinal biopsies with an intimin-deficient EPEC mutant caused 
microvillous effacement with no signs of intimate adherence (Shaw et al., 2005), and 
EPEC strains of the pathogenic serotype O125:H6 have been shown to induce 
microvillous effacement and Tir translocation on biopsies without recruiting actin 
(Bai et al., 2008). Our findings, together with published data, suggest that 
microvillous effacement occurs as the result of a distinct subversive pathway from 
that conferring intimate attachment and actin pedestal formation, highlighting the 
multiplicity of subversive elements involved in A/E lesion formation. 
The bacterial factors responsible for microvillous effacement during EHEC infection 
are unknown, and studies with EPEC Tir have yielded conflicting results depending 
on the model system used. Whilst EPEC-associated microvillous effacement appears 
to be dependent on the Tir-intimin interaction in Caco-2 cells (Dean et al., 2006; 
Dean et al., 2013), Tir was not required for the same phenotype following human or 
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porcine IVOC (Girard et al., 2005; Shaw et al., 2005). Our data on EHEC suggest 
that Tir insertion into the plasma membrane is not required for microvillous 
effacement, although we cannot rule out the possibility that Tir is present at low 
levels in the cytosol and able to induce microvillous effacement from this location. It 
would be necessary to confirm this by comparing microvillous effacement in T84 
cells following infection with wild-type and Tir-deficient mutant EHEC strains. 
EspF, Map and EspH have also been implicated in EPEC-mediated microvillous 
effacement (Dean et al., 2006; Shaw et al., 2005), and so it would be interesting to 
examine the role of these proteins during EHEC infection. 
In contrast to what was seen on polarised T84 cells, EHEC formed actin pedestals 
and translocated Tir on non-polarised cells located in marginal areas or extruding 
from monolayers. We also observed a greater number of adherent bacteria on these 
cells compared with polarised cells, suggesting that EHEC preferentially binds to 
non-polarised T84 cells. Consistent with our findings, Li et al. (1999) also observed 
actin recruitment by EHEC only on T84 cells in marginal areas of the monolayer that 
did not appear polarised. The reason for this polarisation-dependency may lie in 
differences in the availability of binding receptors on the plasma membrane. For 
example, EHEC has been shown to preferentially bind to the phospholipid 
phosphatidylethanolamine (PE) (Barnett Foster et al., 1999), which becomes 
available in epithelial (including T84) cell membranes during apoptosis and cell 
shedding (Barnett Foster et al., 2000; Cotton, 1972). It is therefore possible that PE 
acts as a receptor for EHEC adherence to non-polarised, but not polarised, T84 cells; 
thereby promoting formation of A/E lesions. This could be tested by infecting T84 
cells with EHEC following treatment with a PE inhibitor and assessing bacterial 
adherence to non-polarised cells. It would also be useful to compare PE levels and 
distribution on the surface of polarised vs. non-polarised cells in our model system. 
To date, it is not known which EHEC protein is responsible for the observed 
interaction with PE, but it could be one of several putative adhesins that have been 
identified (see section 3.9.3). 
Unlike EHEC, EPEC readily colonised polarised T84 cells and induced actin 
pedestals. This was also observed in Li et al.’s study (1999) and suggests that these 
two pathotypes use different receptors for initial binding. EPEC is known to produce 
125 
 
two adhesins not found in EHEC: bundle-forming pili (Bfp), which bind to PE; and 
type I fimbriae, which bind to D-mannose-containing glycoproteins (Girón et al., 
1993; Giron et al., 1991; Roe et al., 2001). As PE also acts as an EHEC adherence 
receptor (Barnett Foster et al., 2000; Barnett Foster et al., 1999), it is unlikely that 
Bfp is responsible for the difference in adherence phenotype observed between 
EPEC and EHEC. It has been postulated that EHEC may interact with D-mannose-
containing glycolipids via its long polar fimbriae (Lpf) (Farfan et al., 2011), which 
show some sequence homology to EPEC type I fimbriae (Torres et al., 2005b). 
However, no effect of D-mannose on Lpf-mediated EHEC adherence to HeLa cells 
was demonstrated in a recent study (Torres et al., 2008). Therefore, it is possible that 
EPEC may adhere to polarised T84 cells through binding of its type I fimbriae to D-
mannose-containing glycolipids. Alternatively, adherence may be mediated by some 
as-yet unidentified adhesin-receptor interaction. 
 
3.3.2 | A/E lesion formation ex vivo 
In vitro organ culture (IVOC) of human intestinal biopsies represents the current 
gold standard method for studying EHEC-IEC interactions. A major advantage of 
IVOC over cell lines is that the former uses healthy native epithelium comprising all 
of the major cell types (e.g. enterocytes, goblet cells, autoendocrine cells), together 
with an in-tact mucus layer and microbiota (reviewed in Fang et al., 2013). The 
IVOC model has been used by Phillips and colleagues to examine EHEC 
colonisation of paediatric intestinal epithelium using Stx-negative EHEC strains 
(Chong et al., 2007; Phillips et al., 2000). They reported EHEC adherence to IECs on 
terminal ileal but not colonic biopsies. Similarly, examination of intestinal tissue 
from EHEC-infected patients has not revealed evidence of bacterial adherence, 
despite finding severe colonic histopathology (Kelly et al., 1987). In contrast, in vivo 
and ex vivo infection of gnotobiotic piglets, infant rabbits and neonatal calves 
resulted in colonisation of the colonic epithelium as well as other intestinal sites 
(Dean-Nystrom et al., 1997; Francis et al., 1986; Pai et al., 1986; Tzipori et al., 
1986), creating a disparity between studies using human and animal tissue. These 
studies have called into question the role of A/E lesion formation in inducing colonic 
pathology during EHEC infection of humans. 
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As previous IVOC studies were conducted using Stx-negative EHEC strains (Chong 
et al., 2007; Phillips et al., 2000), and because Stx has been implicated in EHEC 
adherence (Robinson et al., 2006), we decided to re-investigate EHEC adherence to 
human colonic epithelium using wild-type EHEC. All strains colonised both terminal 
ileal and colonic epithelia, indicating that EHEC is able to adhere to human colonic 
IECs and likely does so in vivo. The reason why clinical samples from infected 
patients have failed to show EHEC colonic adherence is unclear, but it may be due to 
the fact that infections have often reached an advanced stage by the time 
colonoscopy takes place, by which time colonisation may have diminished or 
become obscured by the damaged mucosa. Collection of biopsy samples from 
infected patients at earlier time-points would clarify this point; however, such studies 
are ethically unsound due to the risk of perforation associated with performing 
endoscopy on HC sufferers (Nataro and Kaper, 1998). 
It was noted that the distribution of EHEC colonies on the epithelium was not equal. 
Bacteria appeared to be predominantly localised to the surface epithelium between 
crypt openings on colonic samples and at villus tips on ileal samples. Bacteria were 
rarely observed deep within colonic crypts or on the lower half of ileal villi. These 
more luminal regions may confer the advantage of being positioned furthest away 
from antimicrobial peptides, which are present at high concentrations in crypts 
(reviewed in Cunliffe and Mahida, 2004). 
EHEC adhered to colonic biopsies were associated with typical A/E lesions, 
characterised by intimate attachment, microvillous effacement and Tir translocation. 
This contrasts with our in vitro data on polarised T84 cells (Section 3.9.1), indicating 
that distinct interactions between EHEC and colonic IECs are taking place in each 
model. A similar disparity between in vitro and ex vivo model systems was reported 
during an EPEC study, in which Tir phosphorylation mutants were able to recruit 
actin in human intestinal biopsies but not in HeLa cells (Schüller et al., 2007). This 
data highlights the risk associated with relying on cell culture models only. 
While terminal ileal IECs displayed elongated microvilli at EHEC adherence sites, as 
shown previously (Chong et al., 2007; Phillips et al., 2000), colonic IECs did not 
harbour this phenotype. This has also been observed following colonic bovine IVOC 
with EHEC (Girard et al., 2007) and porcine IVOC with EPEC (Mundy et al., 2007), 
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and most likely reflects differences in brush border composition between intestinal 
sites. Put together, our data indicate that EHEC adhered to human colonic epithelium 
subvert host processes and form A/E lesions ex vivo, which likely leads to the onset 
of colonic pathology during infection of humans. 
 
3.3.3 | Role of bacterial proteins in colonisation 
A previous study by Robinson and colleagues identified a role for Stx in EHEC 
colonisation (Robinson et al., 2006). EHEC adherence to HeLa cells and colonisation 
of mice was significantly lower following infection with Stx-negative EHEC 
compared with wild-type, which was attributed to Stx-mediated enhancement in 
expression of surface nucleolin, a host-derived intimin-receptor. As previous human 
IVOC studies using Stx-negative EHEC failed to demonstrate EHEC adherence to 
colonic biopsies (Chong et al., 2007; Phillips et al., 2000), we tested the hypothesis 
that Stx is required for EHEC adherence to human colonic epithelium. Infection of 
both colonic biopsies and polarised T84 cells with an Stx deletion mutant resulted in 
comparable colonisation to that of the wild-type strain, suggesting that Stx does not 
influence EHEC colonisation of colonic IECs in vitro or ex vivo. The reason why Stx 
appears to influence EHEC colonisation of mice and HeLa cells but not T84 cells or 
human biopsy epithelium is unclear, but it should be noted that an enhancing effect 
of Stx on intestinal epithelial nucleolin surface levels has not yet been reported. It 
would therefore be interesting to investigate the effect of Stx on nucleolin 
redistribution in HeLa vs. T84 cells and/or intestinal biopsies in order to clarify the 
role of this phenomenon in EHEC adherence. 
Intimin was the first bacterial protein shown to play a role in A/E bacterial 
adherence, with the discovery that deletion of the gene encoding intimin (eae) 
inhibited EPEC attachment and pedestal formation on HeLa cells (Jerse et al., 1990). 
Intimin mediates adherence via binding to Tir, which is translocated into the host cell 
through the T3SS (reviewed in Frankel and Phillips, 2008). EHEC adherence to 
HeLa cells has been shown to be dependent on expression of intimin, Tir and the 
T3SS (DeVinney et al., 1999; Ebel et al., 1998; McKee et al., 1995), and an essential 
role for intimin during in vivo infection of infant rabbits, gnotobiotic piglets and 
neonatal calves has also been demonstrated (Dean-Nystrom et al., 1998b; 
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Donnenberg et al., 1993; Ritchie et al., 2003). Furthermore, human IVOC studies 
have shown that intimin and Tir are essential for EHEC binding to small intestinal 
epithelium (Fitzhenry et al., 2002; Schüller et al., 2007). We therefore determined 
the role of intimin and T3S in EHEC colonisation of human colonic biopsies and 
polarised T84 cells. Colonic biopsies infected with mutant EHEC strains carrying 
deletions in eae, espA or escN showed no evidence of bacterial adherence or A/E 
lesions, confirming that intimin and T3S are essential for EHEC colonisation of 
human colonic epithelium. 
In addition to Tir, it has been shown that two host-derived receptors also interact 
with intimin in vitro. EPEC intimin binds β1-integrin (Frankel et al., 1996), which is 
usually restricted to the basolateral membrane of IECs but is redistributed apically in 
T84 cells during infection-mediated disruption of epithelial barrier function (Muza-
Moons et al., 2003). The second host molecule, nucleolin, has been shown to bind 
EHEC intimin, and competitive inhibition of nucleolin activity reduces EHEC 
adherence to HeLa cells (Sinclair and O'Brien, 2002). Although we did not look 
specifically at the role of host-derived intimin receptors in our IVOC model, the fact 
that the T3SS is required for adherence and that Tir is present beneath adherent 
bacteria suggests that intimin-dependent EHEC adherence occurs through binding to 
a translocated bacterial receptor (i.e. Tir) rather than a host receptor. 
In contrast to what was found ex vivo, colonisation of polarised T84 cells was 
unaffected in EHEC strains lacking functional intimin and the T3SS apparatus, 
compared with that of the wild type. This suggests that EHEC adhere to polarised 
T84 cells via a different mechanism to that used during colonisation of colonic 
biopsies; one which does not involve intimin or T3S and does not lead to the 
formation of typical A/E lesions (see section 3.9.1). It is possible that T84 cells 
express a receptor on their surface that is not expressed on colonic IECs in vivo and 
confers adherence via an adhesin other than intimin. A number of putative adhesins 
have been described in EHEC O157:H7, which are listed in Table 1.1. Although the 
identity of host-derived receptors for most of these adhesins is currently unknown, 
binding to extracellular matrix proteins has been demonstrated for Lpf1, ELF, HCP, 
F9, EhaB and EhaJ (Easton et al., 2011; Farfan et al., 2011; Low et al., 2006; 
Samadder et al., 2009; Wells et al., 2009; Xicohtencatl-Cortes et al., 2009). 
129 
 
However, the role of these putative adhesins in EHEC adherence to polarised T84 
cells has not been investigated. 
 
3.3.4 | Role of host age and oxygen on colonisation 
Since the use of Stx-positive vs. Stx-negative EHEC strains did not explain the 
discrepancy in colonic colonisation seen between previous human IVOC studies 
(Chong et al., 2007; Phillips et al., 2000) and our own, we sought to ascertain which 
other factors might be responsible. Whereas Phillips and colleagues performed IVOC 
on biopsies from paediatric patients and in 95% oxygen, our IVOCs used adult 
biopsies and atmospheric oxygen concentrations. We first examined the role of host 
age on EHEC colonic colonisation during IVOC. Infection of paediatric colonic 
biopsies with strains EDL933 and Walla-1 resulted in colonisation, with an 
adherence phenotype indistinguishable from that observed following IVOC of adult 
biopsies. This is consistent with a published IVOC study using EPEC, which 
reported no difference in bacterial colonisation on adult vs. paediatric biopsies 
(Humphries et al., 2009). Our findings indicate that host age was not the determining 
factor for EHEC colonisation in our model system. 
IVOC is traditionally performed in an oxygen-rich atmosphere (95%) in order to 
facilitate gas exchange in the tissue and thereby maximise survival (Deschner et al., 
1963; Fang et al., 2013). However, oxygen concentrations in the intestinal lumen are 
much lower, with levels estimated at 1.4% of atmospheric pressure in the mouse 
colon (He et al., 1999). A recent bovine IVOC study found that EHEC infections 
performed at atmospheric oxygen concentrations (21%) yielded colonisation with no 
detrimental effects on tissue integrity, whilst no colonisation was observed following 
IVOC at 95% oxygen concentrations (Girard et al., 2007). We tested the effect of 
oxygen in our human IVOC model by performing EHEC infections in either 95% 
oxygen or air and comparing the degree of colonisation. We found a significant 
reduction in colonisation during IVOCs performed in 95% oxygen compared with 
air, with the former condition almost completely suppressing colonisation. These 
data indicate that oxygen inhibits EHEC adherence to colonic biopsies, and implicate 
high oxygen levels as the inhibitory factor for EHEC colonisation in past IVOC 
studies (Chong et al., 2007; Phillips et al., 2000). 
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Oxygen has also been shown to affect EHEC adherence to colonic IECs in vitro. By 
performing infections in a vertical diffusion chamber system, which enables the 
generation of separate apical and basolateral environments, Schüller and Phillips 
(2010) demonstrated that microaerobiosis (1-1.7% oxygen) enhanced EHEC 
colonisation of T84 cells compared with aerobiosis. Adherent bacteria produced 
higher amounts of Tir and EspA under microaerobic conditions compared with 
aerobic. Similarly, Ando and colleagues (2007) have shown that EHEC grown in 
anaerobic conditions secrete higher levels of Tir and EspB compared with those 
grown in aerobic conditions. Therefore, it seems likely that microaerobic conditions 
in the gut favour EHEC colonisation of colonic IECs by promoting T3S and A/E 
lesion formation. Unfortunately, it is not possible to investigate EHEC adherence to 
colonic biopsies in microaerobic conditions as epithelial cell integrity is 
compromised by the lack of oxygenation (Schüller, personal communication). To 
date, the molecular mechanisms underlying oxygen-mediated inhibition of adherence 
have not been investigated. Expression of LEE genes (involved in A/E lesion 
formation) are known to be controlled by a number of regulatory systems, including 
the Pch proteins, QS signalling proteins, and the acid stress regulator GadE 
(Connolly et al., 2015; Figure 1.9). These systems are responsive to external 
conditions such as pH and the presence of host hormones and bacterial metabolites. 
Therefore, it would be interesting to determine whether any of these regulatory 
systems are involved in oxygen-mediated inhibition of EHEC adherence. 
Interestingly, previous IVOC studies using high oxygen levels reported EHEC 
colonisation of distal small intestinal biopsies but not the colon (Chong et al., 2007; 
Phillips et al., 2000), suggesting that the inhibitory effects of oxygen are not felt or 
are less potent in the former compared with the latter. Colonisation was largely 
restricted to the follicular associated epithelium (FAE) of Peyer’s patches (Fitzhenry 
et al., 2002; Phillips et al., 2000), although additional colonisation of villi adjacent to 
Peyer’s patches was seen in one study (Chong et al., 2007). In contrast, our IVOC 
experiments using atmospheric oxygen levels resulted in extensive colonisation of 
villi regardless of their proximity to FAE, suggesting that oxygen does suppress 
adherence to small intestinal biopsies, albeit not as efficiently as to colonic biopsies. 
One possible explanation is that EHEC colonises FAE via a mechanism distinct from 
that used in other regions, one that is unaffected by oxygen. Alternatively, the small 
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intestinal epithelium may be easier to colonise than the colon, perhaps due to the 
thinner mucus layer and less microbiota, which may permit bacterial adherence even 
in the presence of inhibitory oxygen levels. 
 
3.3.5 | Summary 
In this study, we have demonstrated for the first time that EHEC colonises human 
colonic biopsies ex vivo and forms A/E lesions, which likely contribute to colonic 
pathogenesis during in vivo infection. Colonisation was dependent on intimin and 
T3S, and was suppressed by high oxygen levels traditionally used in IVOC. In 
contrast, EHEC adherence to polarised T84 cells did not lead to Tir translocation into 
the host cell membrane and was mediated by factors other than T3S and intimin. Our 
findings highlight the disparities that can arise between experiments on cultured cell 
lines and human tissue, and emphasise the importance of using physiologically 
relevant model systems such as IVOC to study EHEC-IEC interactions. 
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CHAPTER FOUR 
 
INNATE IMMUNE RESPONSE TO 
EHEC INFECTION 
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4.1 | Introduction 
EHEC infection is associated with a moderate inflammatory response in the intestinal 
mucosa, characterised by recruitment of neutrophils to the site of infection (Griffin et 
al., 1990; Kelly et al., 1990; Kelly et al., 1987). In addition, infected patients 
suffering from haemolytic uraemic syndrome (HUS) have been shown to harbour 
elevated circulatory levels of neutrophil chemoattractant interleukin-8 (IL-8) 
compared with healthy controls (Fitzpatrick et al., 1992; Murata et al., 1998), 
suggesting that this cytokine plays an important role in the innate immune response 
to infection. Accordingly, in vitro studies have demonstrated that intestinal 
carcinoma cells express IL-8 in response to EHEC infection (Berin et al., 2002; 
Dahan et al., 2002). This response has been shown to depend primarily on expression 
of flagellin (Berin et al., 2002; Zhou et al., 2003), although other bacterial factors 
such as Shiga toxins (Stxs), long polar fimbriae (Lpf) and haemorrhagic coli pili 
(HCP) have also been implicated (Farfan et al., 2013; Ledesma et al., 2010; Thorpe 
et al., 2001; Yamasaki et al., 1999). To date, the IL-8 response to EHEC infection 
has been studied only in carcinoma cell lines and not in human colonic epithelium. 
In addition to secretion of cytokines, intestinal epithelial cells (IECs) are also known 
to produce antimicrobial peptides (AMPs) and proteins (e.g. lysozyme). These short 
cationic peptides constitute an important part of the innate immune system, 
performing direct bactericidal functions as well as regulating various inflammatory 
processes (Muniz et al., 2012). AMPs known to be produced by colonic epithelium, 
the site of EHEC colonisation, include human β-defensins (hBDs) 1-4, the 
cathelicidin LL-37, and lysozyme (Fahlgren et al., 2003, 2004; Hase et al., 2002). 
Expression of several AMPs appears to be modulated during infection with enteric 
bacteria and/or inflammation. hBD2-4 and lysozyme expression is enhanced in 
inflammatory bowel disease (IBD) sufferers compared with healthy controls, and 
hBD2 is also stimulated upon infection with invasive and non-invasive bacteria 
including Salmonella, Campylobacter, Shigella, and enteropathogenic and 
enteroinvasive E. coli (EPEC; EIEC) (Hase et al., 2002; Khan et al., 2008; O'Neil et 
al., 1999; Ogushi et al., 2001; Zilbauer et al., 2005). Conversely, expression of hBD1 
and LL-37 has been shown to decrease following infection with Shigella spp., 
enterotoxigenic E. coli (ETEC) and Vibrio cholerae, which is thought to represent a 
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bacterial attempt to dampen the innate immune response and thereby increase the 
chance of survival (Chakraborty et al., 2008; Islam et al., 2001; Sperandio et al., 
2008). As yet, the influence of EHEC infection on AMP expression in human colonic 
epithelium has not been examined. 
In this study, we sought to characterise the innate immune response to EHEC 
infection in human colonic epithelium using physiologically relevant IEC models. In 
our previous study, we demonstrated that EHEC colonise human colonic epithelium 
during IVOC (Chapter 3; Lewis et al., 2015). Schuller et al. (2009) have previously 
developed a polarised version of the IVOC model (pIVOC) to study the IL-8 
response to enteropathogenic E. coli (EPEC) in human duodenal biopsy epithelium. 
pIVOC restricts bacterial access to the epithelium and away from immune cells in the 
lamina propria, thus allowing examination of the epithelial immune response in 
biopsies. Therefore, we adapted this model for use with EHEC and colonic biopsies. 
We also determined the innate immune response in vitro using polarised T84 human 
colonic carcinoma cells, which are widely used in EHEC infection studies. 
The objectives of this study were to: 
1. Determine whether EHEC infection affects expression of AMPs and IL-8 in 
human colonic epithelium in vitro and ex vivo 
2. Identify which bacterial proteins influence the innate immune response 
3. Ascertain which inflammatory signalling pathways are involved 
4. Determine the direction of IL-8 and AMP secretion 
  
135 
 
4.2 | Results 
4.2.1 | Selection of EHEC strains 
In order to obtain a representative overview of the innate immune response to EHEC, 
we included several EHEC strains in our study. To aid in the selection of suitable 
strains, eight wild-type EHEC strains were screened for their ability to colonise 
epithelial cells and produce Stx. This set of strains included the widely-used 
prototypes EDL933 and Walla-1, the enteroaggregative/enterohaemorrhagic hybrid 
strain (H1121) responsible for the 2011 German outbreak, and five other O157:H7 
clinical isolates from cases in the UK (Table 2.1). All strains express Stx2(a) only 
except for EDL933, which also releases Stx1(a) but to a much lesser extent (Tran et 
al., 2014). Stx2-producing strains were selected due to the fact that Stx2 is more 
closely associated with severe disease in humans compared with Stx1 (Boerlin et al., 
1999; Werber et al., 2003). Infections were performed on cultured Vero African 
green monkey kidney cells, as these are easily colonised by EHEC and readily 
internalise Stx (Konowalchuk et al., 1977). Following infection, Stx2 levels in 
culture medium were quantified by enzyme-linked immunosorbent assay (ELISA), 
and cells were examined for internalised Stx2 and bacterial colonisation by 
immunofluorescence staining. 
As shown in Figure 4.1A, the amount of Stx2 released into culture medium during 
infection varied between EHEC strains. Prototype strain EDL933 and H07184 
released the highest levels of Stx2, while significantly lower levels were released by 
all other strains. Infection with H09374 resulted in an intermediate level of Stx2 
release, significantly lower than EDL933 and H07184 but higher than other strains. 
The amount of internalised Stx2 in Vero cells mirrored this pattern, with Stx2 clearly 
visible inside cells that had been infected with EDL933 and H07184 but not with 
other strains (Figure 4.1B, data shown for E1353). 
Colonisation levels also varied between strains. As shown in Figure 4.2 and Table 
4.1, strain H1121 colonised most extensively and displayed an aggregative adherence 
phenotype distinct from the loose-localised pattern exhibited by the other strains. In 
addition, H1121 was not associated with polymerised actin beneath the site of 
attachment, in line with the fact that the genome of this strain is of primarily EAEC 
origin and does not contain genes necessary for A/E lesion formation (e.g. eae)  
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Figure 4.1. Level of Stx2 produced by EHEC differs between strains during 
infection of Vero cells. Cells on coverslips were infected with EHEC strains or 
exposed to purified Stx2 for 4 hours. (A) Stx protein levels in culture medium were 
measured by ELISA. Stx levels were normalised relative to bacterial growth, 
determined by measuring optical density (OD600) of culture medium. Data shown as 
means ± SE from two independent experiments performed in duplicate. Letters 
above bars indicate groups of significant differences. (B) Cells were immunostained 
for Stx2 (red), actin (green) and nuclei (blue). Images represent those from two 
independent experiments performed in duplicate. Scale bars = 5 µm. 
137 
 
 
Figure 4.2. EHEC colonisation of Vero cells. Cells on coverslips were infected 
with EHEC strains for 4 hours. Cells infected with Walla-1, EDL933 and H07184 
were immunostained for E. coli (red), actin (green) and nuclei (blue), whilst those 
infected with H1121 were stained for nuclei (blue) only. Images represent those from 
two independent experiments performed in duplicate. Scale bars = 10 µm. 
 
(Bielaszewska et al., 2011; Rasko et al., 2011). Of the remaining EHEC strains, 
Walla-1 showed the highest level of colonisation, followed by EDL933. Intermediate 
levels of colonisation were observed following infection with E1353, H07184 and 
H07462, whilst very few adherent bacteria were found on cells infected with H10354 
and H09374. Interestingly, the relative ability of strains to colonise epithelial cells 
did not appear to correlate with the ability to produce Stx2, indicating that expression 
of the two phenotypes is mutually exclusive. 
Consequently, three strains were selected for further analysis that together 
encompassed the various extremes in phenotype expression: EDL933 as a high 
coloniser and high Stx producer; Walla-1 as a high coloniser and low Stx2 producer, 
and H07184 as an intermediate coloniser and high Stx2 producer. 
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Table 4.1. EHEC colonisation of Vero cells differs between strains. Cells on 
coverslips were infected with EHEC strains for 4 hours. The relative colonisation 
level of each strain was determined by visually assessing the amount of adherent 
bacteria following immunostaining for E. coli, actin and nuclei (see Figure 4.2 for 
images). Number of + symbols indicates the extent of bacterial colonisation. 
 
We next examined virulence trait expression during infection of human colonic 
epithelial cells, the primary target cells of EHEC. Polarised T84 cells grown in 
Transwell inserts (as described in section 3.2.2) were infected with EDL933, Walla-1 
or H07184 for 9 hours. Bacterial overgrowth and loss of epithelial integrity was 
prevented by removal of the inoculum after 3 hours and subsequent hourly medium 
exchange. After infection, Stx2 release and colonisation levels were quantified. 
Release of Stx2 followed a similar pattern to that seen during infection of Vero cells, 
with EDL933 releasing the highest amount, followed by H07184, then Walla-1 
(Figure 4.3A). The ability of strains to colonise T84 cells was also similar to that 
seen with Vero cell infections, with EDL933 and H07184 showing high and low 
levels (respectively) (Figure 4.3B). These data indicate that the virulence trait 
expression profile of each strain is distinct during infection of polarised T84 cells, 
and therefore these strains were used to investigate the effect of EHEC on AMP 
expression in human colonic epithelium. 
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Figure 4.3. Stx2 production and colonisation by EHEC strains during infection 
of polarised T84 cells. Cells were apically infected with EHEC strains EDL933, 
Walla-1 and H07184 for 9 hours. (A) Stx2 protein levels in culture medium were 
measured by ELISA and normalised relative to bacterial growth in culture medium, 
determined by measuring OD600 after 1 hour. (B) Colonisation was quantified by 
plating serial dilutions of cell lysates and determining numbers of colony-forming 
units. Colonisation is expressed as the percentage of adherent bacteria relative to the 
inoculum. Data are shown as means ± SE of four (A) or five (B) independent 
experiments performed in duplicate. Asterisks denote significant differences. * = P < 
0.05 
 
4.2.2 | Apical EHEC infection of polarised T84 cells induces 
hBD2 and IL-8 gene expression 
To determine whether EHEC influences innate immune gene expression in human 
colonic epithelium, polarised T84 cells were infected for 9 hours with EHEC strains 
EDL933, Walla-1 or H07184. To prevent loss of epithelial barrier function due to 
bacterial overgrowth and acidification of culture medium, medium was exchanged at 
3 hours post-infection (PI) and hourly thereafter. Barrier function was monitored by 
measuring the TER at regular intervals. Following infection, total RNA was 
harvested and expression of hBD1-4, LL-37, lysozyme and IL-8 in infected 
monolayers was determined relative to non-infected (NI) controls by quantitative 
PCR (qPCR) analysis. Primers for each gene of interest (Table 2.3) were validated 
for specificity and amplification efficiency before use in qPCR assays (Figure 4.4). 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) and RNA polymerase II 
(POLR2A) were used to normalise qPCR data, as expression of these genes in T84 
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Figure 4.4. Validation of primer specificity and amplification efficiency. (A) 
Dissociation curves were generated for each primer pair. Primers were deemed 
specific when curves consisted of only one peak. Curves are representative of those 
generated with every qPCR performed. (B) Agarose gel electrophoresis analysis of 
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qPCR product size. Image is representative of data from two independent 
experiments. (C) Amplification efficiency of each primer pair. Two-fold serial 
dilutions of cDNA were prepared and run in a qPCR assay with each primer. Cycle 
threshold (Ct) values were plotted onto a scatter graph and the slope was used to 
calculate the primer efficiency. Efficiencies ranging from ~95 to 130% were 
considered acceptable. Data are representative of those from 2 independent 
experiments. 
 
cells was unaffected by EHEC infection (Figure 4.5B). Figure 4.5A shows that the 
TER of T84 cell monolayers was not significantly affected by infection with any of 
the EHEC strains compared with non-infected (NI) cells. As shown in Figure 4.5C, 
all three EHEC strains induced a significant increase in expression of hBD2 (21.5 ± 
9.1 fold for EDL933, 70.4 ± 21.8 fold for Walla-1, and 31.5 ± 2.0 fold for H07184) 
and IL-8 (6.0 ± 1.6 fold for EDL933, 8.3 ± 2.4 fold for Walla-1, and 8.2 ± 3.9 fold 
for H07184) mRNA compared with NI controls, whereas no change was observed 
for hBD1, hBD3, LL-37 or lysozyme. No amplification product was detected for 
hBD4. No obvious correlation between IL-8/hBD2 expression and colonisation or 
Stx2 production was observed. 
In order to determine the kinetics of hBD2 and IL-8 induction, T84 cells were 
infected with EHEC strain EDL933 for 3-12 hours. Results in Figure 4.6 show that 
expression of both hBD2 and IL-8 was significantly induced from 6 hours PI, and 
this induction increased in magnitude up to 12 hours PI. Although induction levels 
were highest after 12-hour infections, practical factors favoured a shorter protocol, 
and so an infection time of 9 hours was selected for subsequent experiments. 
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Figure 4.5. Innate immune gene expression in polarised T84 cells following 
EHEC infection. Cells were apically infected with EHEC or left uninfected (NI) for 
9 hours. (A) Transepithelial electrical resistance (TER) of monolayers following 
infection, expressed as a percentage relative to before infection. (B) GAPDH and 
POLR2A mRNA levels in non-infected (NI) and EDL933-infected cells, as 
determined by qPCR. Data are shown as mean Ct values (arbitrary) ± SE of six 
biological replicates. (C) Fold changes in innate immune gene expression in T84 
cells infected with EDL933, Walla-1 or H07184, relative to NI controls, calculated 
from qPCR data using the ΔΔCt method. Data are shown as means ± SE of four 
independent experiments performed in duplicate. Asterisks denote significant 
differences from NI. * = P <0.05; ** = P < 0.01; *** = P < 0.001. 
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Figure 4.6. Kinetics of hBD2 and IL-8 gene expression in EHEC-infected T84 
cells. Cells were apically infected with EHEC strain EDL933 for 3–12 hours, or left 
NI for 12 hours. Fold mRNA expression in infected cells was quantified relative to 
NI controls using qPCR. Data represents means ± SE of duplicate samples from a 
single experiment. Asterisks denote significant differences from non-infected cells. * 
= P <0.05; ** = P < 0.01; *** = P < 0.001. 
 
4.2.3 | Development of human colonic polarised IVOC 
To examine the IL-8 and AMP response to EHEC in human colonic epithelium ex 
vivo, we established a polarised in vitro organ culture (pIVOC) model for human 
colonic biopsy tissue. This method was based on a previously published pIVOC 
method used to investigate the IL-8 response to EPEC in paediatric duodenal 
biopsies (Schüller et al., 2009), and is designed to restrict bacterial access to the 
mucosal surface and away from immune cells in the submucosa. Colonic biopsy 
samples were sandwiched between two perspex disks with part of the mucosal 
surface exposed through a central aperture. Samples were then mounted into 
Snapwell supports (Figure 2.2) and apically infected with EHEC strain EDL933 for 
either 5 or 7 hours. Samples showing bacterial leakage into the basolateral medium, 
indicated by increasing acidification and turbidity, were excluded from analysis. 
After infection, tissue integrity and bacterial colonisation were assessed by scanning 
electron microscopy (SEM). Figure 4.7 shows preserved epithelium on tissue located 
within the central aperture at 7 hours PI. Colonisation of epithelium was observed 
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Figure 4.7. Development of colonic pIVOC. Human colonic biopsies were 
sandwiched between two Perspex disks and mounted into Snapwell supports, 
restricting bacterial access to the mucosal side. Biopsies were infected with EHEC 
strains EDL933, Walla-1 or H07184, or given LB alone, for 7 hours and examined 
by scanning electron microscopy (SEM). (A) Biopsy tissue exposed through the 
central aperture (area within white circle) showed preserved epithelium. Scale bar = 
200 µm. (B) Intact colonic surface epithelium at higher magnification. Scale bar = 50 
µm (C) EHEC strain EDL933 colonised epithelium. Scale bar = 2 µm. Images 
represent those from three independent experiments performed in duplicate. 
 
following infections lasting both 5 and 7 hours, but was most widespread after the 
latter time point (Figure 4.7C). Therefore, subsequent pIVOC infections were 
performed for 7 hours. 
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4.2.4 | Apical EHEC infection of human colonic biopsies results 
in increased hBD2 and IL-8 gene expression 
The influence of EHEC on innate immune gene expression in human colonic 
epithelium ex vivo was investigated using pIVOC. Polarised biopsies were apically 
infected with EHEC strains EDL933, Walla-1 and H07184 for 7 hours and gene 
expression was determined by qPCR. As shown in Figure 4.8, EHEC infection 
resulted in a significant increase in hBD2 (median fold increase = 8.1 for EDL933 
and 5.7 for H07184) and IL-8 (median fold increase = 6.6 for EDL933, 5.2 for 
Walla-1, and 4.8 for H07184) mRNA expression compared with NI controls. 
Conversely, no effect of infection on hBD1, LL-37 or lysozyme expression was 
observed. Transcript levels of hBD3 and hBD4 were often below the detection 
threshold, which precluded analysis of these genes. However, transcripts of 
corresponding size were detected within some samples, thereby confirming 
functionality of the qPCR assay (data not shown). In line with results from T84 cell 
experiments, the level of hBD2 and IL-8 induction by all three EHEC strains was 
comparable. 
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Figure 4.8. Innate immune gene expression in human colonic biopsies following 
apical EHEC infection. Biopsies were infected with EHEC strains EDL933, Walla-
1 and H07184, or given LB alone (NI control), for 7 hours. Fold mRNA expression 
of select innate immune genes in infected biopsies was quantified relative to NI 
controls using qPCR. Each data point represents an individual biopsy from a total of 
six patients. Medians are indicated by a line. Asterisks denote significant differences 
from NI controls. * = P < 0.05, ** = P < 0.01. 
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4.2.5 | EHEC induction of hBD2 and IL-8 gene expression in 
human colonic IECs is dependent on flagellin 
To ascertain which EHEC proteins were responsible for the observed induction of 
hBD2 and IL-8 in human colonic epithelium, polarised T84 cells were infected with 
wild-type (WT) EHEC strain EDL933 or isogenic deletion mutants unable to express 
either fliC (encoding flagellin, the main constituent of the flagellum), escN (EscN, 
ATPase of the T3SS) or stx (Stx). Infection for 9 hours with these strains did not 
affect epithelial barrier function, as determined by TER (data not shown). Expression 
of hBD2 and IL-8 mRNA was then quantified by qPCR. Whilst infection with WT, 
ΔescN and Δstx resulted in significant induction of hBD2 (48.6 ± 12.3 fold for WT, 
60.5 ± 15.6 fold for ΔescN, and 41.5 ± 8.3 fold for Δstx) and IL-8 (5.6 ± 1.3 fold for 
wt, 7.5 ± 1.2 fold for ΔescN, and 4.9 ± 0.3 fold for Δstx) expression relative to NI 
controls, no significant induction was observed following infection with the ΔfliC 
mutant (Figure 4.9A). It has been shown that flagellin plays a role in EHEC binding 
to bovine intestinal epithelium and mucus (Erdem et al., 2007; Mahajan et al., 2009). 
To ascertain whether the lack of hBD2 and IL-8 gene induction in the ΔfliC mutant 
was attributable to grossly impaired binding to IECs, immunofluorescence staining 
was performed on infected T84 cells. As shown in Figure 4.9B, colonisation of T84 
cells by the ΔfliC mutant was comparable to that of the WT strain. 
We then determined the role of EHEC proteins on induction of colonic epithelial 
hBD2 and IL-8 expression ex vivo. Apical infection of human colonic biopsies with 
EDL933 WT, ΔescN and Δstx strains resulted in a significant induction of hBD2 
(median fold increase = 15.9 for wt, 14.3 for ΔescN, and 17.8 for Δstx) and IL-8 
(median fold increase = 3.6 for wt, 3.1 for ΔescN, and 4.9 for Δstx) expression vs NI 
controls. In contrast, no change in hBD2 and IL-8 expression was observed in ΔfliC-
infected epithelium (Figure 4.10A). As seen with T84 cells, the ΔfliC mutant 
displayed no marked impairment of colonisation to colonic biopsies when examined 
using SEM (Figure 4.10B). 
As it has been reported that long polar fimbriae (Lpf) and the haemorrhagic coli pilus 
(HCP) trigger innate immune gene expression in T84 cells during EHEC infection 
(Farfan et al., 2013; Ledesma et al., 2010), we investigated whether these factors  
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Figure 4.9. EHEC induction of hBD2 and IL-8 gene expression in T84 cells is 
dependent on flagellin. (A) T84 cells were apically infected for 9 hours with wild-
type (WT) EHEC strain EDL933 or isogenic mutants lacking either fliC, escN or stx; 
or left uninfected. Fold mRNA expression in infected monolayers was quantified 
relative to uninfected controls using qPCR. Data are presented as means ± SE from 
three independent experiments performed in duplicate. Asterisks denote significant 
differences from uninfected cells. *** = P < 0.001. (B) T84 cells were apically 
infected with WT EDL933 or an isogenic fliC deletion mutant for 6 hours. 
Colonisation was visualised by immunofluorescence staining for E. coli (red) and 
actin (green). Images represent those from two independent experiments performed 
in duplicate. Scale bars = 5 µm. 
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Figure 4.10. Flagellin is required for EHEC induction of hBD2 and IL-8 gene 
expression in human colonic biopsies. (A) Biopsies were infected for 7 hours with 
wild-type (WT) EHEC strain EDL933 or isogenic mutants lacking either fliC, escN 
or stx; or given LB alone (NI control). Fold mRNA expression in infected biopsies 
was quantified relative to NI control biopsies using qPCR. Each data point represents 
an individual biopsy from a total of 4 patients. Medians are indicated by a line. 
Asterisks denote significant differences from NI control biopsies. * = P < 0.05, ** = 
P < 0.01; *** = P < 0.001. (B) Biopsies were infected with EHEC strain EDL933 or 
an isogenic fliC deletion mutant for 8 hours and colonisation was visualised by SEM. 
Images represent those from two independent experiments performed in duplicate. 
Scale bars = 5 µm. 
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Figure 4.11. Lpf and HCP are not involved in EHEC induction of hBD2 and IL-
8 gene expression in T84 cells. T84 cells were apically infected for 9 hours with 
wild-type (WT) EHEC strain 85-170 or isogenic mutants lacking either lpfA1 or hcp; 
or left uninfected. Fold mRNA expression in infected monolayers was quantified 
relative to uninfected controls using qPCR. Data are presented as means ± SE from 
three independent experiments performed in duplicate. Asterisks denote significant 
differences from uninfected cells. *** = P < 0.001. 
 
played a role in the IL-8 and hBD2 response to EHEC in our system. Polarised T84 
cells were infected for 9 hours with wild-type (WT) EHEC strain 85-170 or isogenic 
deletion mutants unable to express either lpfA1 or hcp. As shown in Figure 4.11, 
infection with wild type and both mutant strains induced a significant increase in 
expression of hBD2 (195.9 ± 50.1 fold for WT, 168.6 ± 40.4 fold for Δhcp, and 
163.4 ± 26.8 fold for ΔlpfA1) and IL-8 (84.3 ± 21.8 fold for WT, 157.5 ± 45.7 fold 
for Δhcp, and 88.4 ± 28.0 fold for ΔlpfA1) compared with NI controls, suggesting 
that neither Lpf nor HCP are required for the hBD2 and IL-8 response to EHEC in 
colonic IECs. 
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4.2.6 | Purified EHEC flagellin induces hBD2 and IL-8 gene 
expression in human colonic IECs 
To ascertain whether exposure of human colonic IECs to flagellin is sufficient to 
induce hBD2 and IL-8 gene expression, polarised T84 cells were incubated with 
EHEC strain EDL933 or various concentrations of purified LPS-free monomeric H7 
flagellin (kindly donated by David Gally, University of Edinburgh, UK) for 9 hours. 
Epithelial barrier function was monitored by measuring TER throughout the 
procedure and no effect from any condition was observed (data not shown). Analysis 
of mRNA expression levels by qPCR revealed a dose-dependent hBD2 response to 
purified flagellin, with induction levels for 1 µg/ml flagellin approximating those 
observed for infection with EDL933 (101.5 ± 24.0 fold for flagellin and 99.0 ± 23.0 
fold for EDL933). In contrast, induction of IL-8 by flagellin was not strictly dose-
dependent and did not reach levels observed following infection with EDL933 
(Figure 4.12A). To determine whether the IL-8 response to flagellin peaked at an 
earlier time-point, a kinetic assay was performed whereby cells were incubated with 
flagellin for 1-9 hours. Results in Figure 4.12B show that, whilst expression of hBD2 
was highest after 6-9 hours of exposure to flagellin, IL-8 expression levels peaked 
much earlier at 1-3 hours post-exposure. Subsequently, IL-8 induction by flagellin 
was re-examined at the revised time point of 2 hours post-exposure, and a dose-
sensitive response was observed with similar induction levels for 1 µg/ml flagellin 
and EDL933 infection (62.6 ± 8.9 fold for flagellin and 80.8 ± 10.5 fold for EDL933) 
(Figure 4.12C). 
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Figure 4.12. Purified flagellin is sufficient to induce hBD2 and IL-8 gene 
expression in T84 cells. Cells were apically exposed to purified H7 flagellin, 
infected with EHEC strain EDL933, or left untreated, and mRNA expression was 
determined by qPCR. (A) Incubation with flagellin for 9 hours induced a dose-
sensitive increase in hBD2 expression, whereas IL-8 was induced to a lesser extent, 
and induction was not strictly dose-dependent. Data are shown as means ± SE of 
three independent experiments performed in duplicate. (B) Kinetics of hBD2 and IL-
8 induction after exposure to 0.1 µg/ml flagellin. Data are shown as means ± SE of 
two independent experiments performed in duplicate. (C) Dose-sensitive increase in 
IL-8 expression following exposure to flagellin for 2 hours. Data are shown as means 
± SE of two independent experiments performed in duplicate. Asterisks denote 
significant differences from untreated cells. * = P < 0.05; ** = P < 0.01; *** = P < 
0.001. 
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Figure 4.13. Purified flagellin induces hBD2 and IL-8 gene expression in human 
colonic biopsies. Biopsies were apically exposed to 1 µg/ml purified H7 flagellin or 
given LB alone (NI control) for 7 hours. Fold mRNA expression in treated vs. NI 
control samples was determined by qPCR. Each data point represents an individual 
biopsy from a total of 4 patients. Medians are indicated by a line. Asterisks denote 
significant differences from untreated cells. * = P < 0.05; ** = P < 0.01. 
 
We next sought to determine whether flagellin had an effect on hBD2 and IL-8 gene 
expression in colonic biopsy epithelium ex vivo. Following exposure to 1 µg/ml 
purified flagellin for 7 hours, colonic biopsies expressed significantly higher levels 
of hBD2 (median fold increase = 5.3) and IL-8 (median fold increase = 2.2) mRNA 
compared with NI controls (Figure 4.13). 
 
4.2.7 | Involvement of NF-κB and MAPK signalling pathways in 
the hBD2 and IL-8 response to EHEC 
To elucidate the regulatory mechanisms underlying the hBD2 and IL-8 response to 
EHEC in colonic IECs, NF-κB and mitogen-activated protein kinase (MAPK) 
pathways (Figure 1.14) were inhibited in T84 cells prior to treatment with purified 
H7 flagellin. This was achieved by using chemical inhibitors targeting NF-κB (MG-
132) and the MAPKs p38 (SB20358), JNK (SP600125), and ERK1/2 (PD98059). 
TER was measured before and after the procedure, and expression of hBD2 and IL-8 
was quantified using qPCR. As shown in Figure 4.14A, cells treated with the NF-κB 
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Figure 4.14. Involvement of NF-κB and MAPK signalling pathways in the hBD2 
and IL-8 response to purified flagellin. T84 cells were apically and basolaterally 
exposed to 25 µM MG-132 (NF-κB inhibitor), SB203580 (p38 kinase inhibitor), 
SP600125 (JNK inhibitor) or PD98059 (ERK1/2 inhibitor), or left untreated (non-
treated (NT) and control) for 1 hour. Purified H7 flagellin (0.1 µg/mL) was then 
added apically to all wells except NT for 6 hours. (A) TER of cell monolayers 
following treatment, expressed as a percentage relative to TER before treatment. 
Asterisks denote significant differences before vs. after treatment. (B) Fold mRNA 
expression in treated monolayers was quantified relative to NT cells using qPCR. 
Data are presented as means ± SE from three independent experiments performed in 
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duplicate. Asterisks denote significant differences from control cells. *** = P < 
0.001. 
 
inhibitor exhibited a significant reduction in TER, whilst the other inhibitors had no 
detectable effect. Figure 4.14B shows that flagellin-treated cells expressed 
significantly higher amounts of hBD2 (757.2 ± 97.7% increase) and IL-8 (873.3 ± 
202.6% increase) mRNA when pre-exposed to the NF-κB inhibitor compared with 
non-treated controls. In contrast, pre-exposure to p38 and JNK inhibitors 
significantly attenuated the hBD2 response to flagellin (73.5 ± 3.5% decrease for 
p38, 76.3 ± 3.4% decrease for JNK), and inhibition of ERK1/2 caused a less-
pronounced suppressive effect (33.1 ± 7.1% decrease). Similarly, IL-8 expression 
was markedly reduced in flagellin-treated cells pre-exposed to all three MAPK 
inhibitors (59.9 ± 10.7% decrease for p38, 47.7 ± 8.8% decrease for JNK, 63.6 ± 
5.2% decrease for ERK1/2), although this did not reach significance (Figure 4.14B). 
These data suggest that MAPK signalling, particularly the p38 and JNK pathways, is 
involved in the hBD2 response to EHEC infection. 
 
4.2.8 | Effect of EHEC on IL-8 protein expression in T84 cells 
Having demonstrated EHEC induction of IL-8 mRNA expression, we next sought to 
determine whether this effect extended to the protein level. Polarised T84 cells were 
apically infected with EHEC strain EDL933 or incubated with the IL-8 inducer 
interleukin (IL)-1β (10 ng/ml) for 24 hours. To prevent cell death and loss of 
epithelial barrier function due to bacterial overgrowth and acidification of culture 
medium, gentamicin (200 µg/ml) was added to the culture medium after 1 hour. This 
treatment reduced the rate of bacterial growth to a level that did not compromise 
epithelial barrier function after 24 hours, as determined by TER (data not shown). At 
the end of the incubation, IL-8 protein levels were determined in cell lysates and in 
apical and basolateral culture media by ELISA. As shown in Figure 4.15A, apical 
EDL933 infection was associated with a significant increase in IL-8 levels in apical 
media (240.9 ± 27.4 vs 32.0 ± 6.1 pg/well in NI controls) and to a lesser extent in 
cell lysates (88.9 ± 21.5 vs 16.6 ± 1.4 pg/well in NI controls) but not in basolateral  
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Figure 4.15. IL-8 protein secretion in T84 cells following EHEC infection. (A) 
Cells were apically exposed to EHEC strain EDL933, IL-1β (10 ng/ml), or left 
untreated (NI), for 24 hours. Protein levels in apical and basolateral media, and in 
cell lysates, were determined by ELISA. Data are shown as means ± SE of three 
independent experiments performed in duplicate. (B) Cells were exposed apically 
(AP) or basolaterally (BL) to EHEC strain EDL933, purified H7 flagellin (1 µg/ml), 
or left untreated (NI), for 24 hours. Protein levels in apical (white columns) and 
basolateral (black bars) media were determined by ELISA. Data are shown as means 
± SE of two independent experiments performed in triplicate. Asterisks denote 
significance differences from NI samples. ** = P < 0.05; *** = P < 0.001. 
 
media. IL-1β treatment also enhanced IL-8 levels in apical media (102.3 ± 14.8 vs 32 
± 6.1 pg/well in NI controls) but not in cell lysates or basolateral media. 
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As previous studies have reported basolateral IL-8 secretion by polarised T84 cells 
following basolateral stimulation (Ruchaud-Sparagano et al., 2007; Zhou et al., 
2003), our experiments were extended to include basolateral stimulation. Polarised 
monolayers were incubated with EDL933 or purified flagellin (1 µg/ml) on the apical 
or basolateral side for 24 hours and IL-8 protein levels in apical and basolateral 
media were quantified. Results in Figure 4.16B show that apical exposure of T84 
monolayers to EDL933 and flagellin significantly induced IL-8 secretion into apical 
media (569.5 ± 46.2 or 7612 ± 8.5 vs 108.2 ± 16.8 pg/well in NI controls, 
respectively) but did not affect IL-8 secretion into basolateral media. Conversely, 
basolateral exposure to EDL933 and flagellin resulted in significantly enhanced 
secretion into basolateral media (506.6 ± 103.2 or 1119 ± 181.4 vs 128.6 ± 8.05 
pg/well in NI controls, respectively) but not apical media. These data indicate that 
EHEC-induced secretion of IL-8 in polarised T84 cells is both vectorial and directed 
towards the side of exposure. 
 
4.2.9 | Effect of EHEC on hBD2 peptide expression in T84 cells 
To determine the influence of EHEC on hBD2 peptide expression in vitro, polarised 
T84 monolayers were apically incubated with EDL933, purified flagellin (1 µg/ml) 
or the hBD2 inducer IL-1β (Schlee et al., 2007) (10 ng/ml) for 24 hours, and hBD2 
peptide in cell lysates, apical and basolateral media was measured using ELISA. No 
hBD2 was detected in cell lysates or in culture media (data not shown). This lack of 
hBD2 detection was not attributable to low functionality of the ELISA, as hBD2 was 
detected in culture medium of Caco-2 cells following incubation with IL-1β (Schlee 
et al., 2007) for 24 hours (Figure 4.16). Suspecting that hBD2 peptide secreted by 
T84 cells may have been below the level required for detection, larger-scale 
experiments were conducted using a 20-fold greater number of cells per sample. Cell 
monolayers cultured to confluency in 75cm2 culture flasks were incubated with IL-1β 
for 24 and 48 hours. Culture medium and cell lysates were then collected and 
proteins were concentrated 40-fold using Amicon ultra filtration units. No hBD2 was 
detected in any of the concentrated samples at either time-point tested (data not 
shown). We then changed the detection method to immunofluorescence staining in 
an attempt to visualise hBD2 protein within cells. Returning to the initial infection  
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Figure 4.16. hBD2 peptide secretion in Caco-2 cells. Cells grown in 6-well plates 
were incubated with IL-1β (10 ng/ml) or left untreated (control) for 24 hours and 
hBD2 peptide levels in culture medium and cell lysates were quantified by ELISA. 
Data are shown as means ± SE of duplicate samples. ND = none detected. 
 
protocol, polarised T84 cells grown on permeable Transwell inserts were incubated 
with EDL933, purified flagellin or IL-1β for 24 hours. As shown in Figure 4.17, 
positive staining for hBD2 was detected in a subset of T84 cells. No difference in 
hBD2 levels within cells was observed between treatments, indicating that hBD2 
protein expression was not influenced by EHEC infection or exposure to flagellin 
and IL-1β. In order to confirm specificity of the hBD2 antibody, 
immunofluorescence staining was also performed on Caco-2 cells following 
incubation with EDL933 and IL-1β for 24 hours. Images in Figure 4.18 show a 
marked induction of hBD2 protein within cells treated with IL-1β and to a lesser 
extent with EDL933, compared with NI control cells. 
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Figure 4.17. hBD2 peptide expression in T84 cells is unaffected by EHEC 
infection. Cells were apically exposed to EHEC strain EDL933, purified H7 flagellin 
(1µg/ml), IL-1β (10 ng/ml), or left untreated (NI), for 24 hours. Immunofluorescence 
staining was performed to visualise hBD2 (red) and actin (green). Right images show 
merged channels; left and central images show hBD2 and actin channels, 
respectively. Images represent those from two independent experiments, performed 
in duplicate. Scale Bars = 10 µm. 
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Figure 4.18. hBD2 peptide production in Caco-2 cells. Cells grown on coverslips 
were exposed to EHEC strain EDL933, IL-1β (10 ng/ml), or left untreated (NI), for 
24 hours. Immunofluorescence staining was performed to visualise hBD2 (red) and 
cell nuclei (DAPI; blue). Right images show merged channels; left and central 
images show hBD2 and DAPI channels, respectively. Images represent those from 
duplicate samples. Scale Bars = 10 µm. 
 
4.2.10 | Effect of EHEC on hBD2 and IL-8 protein expression in 
human colonic biopsies 
To determine the influence of EHEC on hBD2 and IL-8 protein expression ex vivo, 
pIVOC was performed on human colonic biopsies incubated with EDL933 or 
purified flagellin (1 µg/ml) for 7 hours. After the procedure, hBD2 peptide 
expression within cells was analysed by immunofluorescence staining. Images in 
Figure 4.19 show that, whilst hBD2 peptide expression was low in non-infected  
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Figure 4.19. hBD2 peptide expression in human colonic biopsies is up-regulated 
during EHEC infection. Biopsies were apically exposed to EHEC strain EDL933, 
purified H7 flagellin (1 µg/ml), IL-1β (10 ng/ml), or given LB alone (NI), for 8 
hours. Cryosections were stained with anti-hBD2 (green) and counterstained with 
DAPI (blue) to label cell nuclei. Right images show merged channels; left and 
central images show hBD2 and DAPI channels, respectively. Images represent those 
from two independent experiments performed in duplicate. Scale bars = 10 µm. 
 
biopsies, considerably higher hBD2 expression was evident in epithelium from 
biopsies treated with EDL933 or flagellin. This indicates that exposure to EHEC and 
flagellin enhances hBD2 peptide expression in human colonic biopsy epithelium, in 
contrast to T84 cells. IL-8 protein levels in biopsy lysates were also analysed by 
ELISA. As shown in Figure 4.20, no effect of EDL933 infection or flagellin on IL-8 
protein levels was observed relative to NI controls, suggesting that EHEC does not 
enhance IL-8 protein expression in human colonic biopsies at this time point. 
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Figure 4.20. IL-8 protein expression in human colonic biopsies. Biopsies were 
apically exposed to EHEC strain EDL933, purified H7 flagellin (1 µg/ml), or given 
LB alone (NI), for 7 hours. Protein levels in biopsy lysates were determined by 
ELISA. Each data point represents an individual biopsy from a total of 3 patients. 
Medians are indicated by a line. 
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4.3 | Discussion 
The intestinal epithelium is the first line of defence against enteric pathogens, 
together with the mucus layer and resident microbiota. In addition to forming a 
physical barrier between the external environment and the internal milieu, IECs 
secrete antimicrobial peptides (AMPs), which directly kill bacteria and recruit 
various immune cells to the site of infection (Dommett et al., 2005; Muniz et al., 
2012). Despite the important role for AMPs in epithelial defence, expression of these 
peptides by IECs during EHEC infection has not been examined. In addition to 
AMPs, IECs are also able to secrete cytokines that trigger inflammation. Studies 
using T84 and Caco-2 human intestinal carcinoma cell lines have shown that EHEC 
induces epithelial secretion of IL-8 (Berin et al., 2002; Dahan et al., 2002), a 
chemokine that promotes infiltration of neutrophils into the intestinal mucosa. 
However, the influence of EHEC on IL-8 expression by normal human colonic 
epithelium has not been investigated. In this study, we developed a polarised IVOC 
model for human colonic biopsies in order to determine the AMP and IL-8 response 
to EHEC infection in human colonic epithelium ex vivo. As previous studies of 
EHEC-immune interactions have been performed in vitro using intestinal carcinoma 
cell lines, we extended our investigation to include polarised T84 human colonic 
carcinoma cells. 
 
4.3.1 | Influence of EHEC infection on AMP expression 
In the human colon, IECs have been shown to secrete hBD1-4, LL-37 and lysozyme 
(Fahlgren et al., 2003, 2004; Hase et al., 2002; Zilbauer et al., 2010), and so we 
tested whether EHEC infection influences expression of these AMPs. Our results 
show that infection of both T84 cells and human colonic biopsies with EHEC 
resulted in increased expression of hBD2. The extent of hBD2 induction was 
comparable for all EHEC strains tested, despite these strains exhibiting differences in 
levels of Stx production and colonisation. This indicates that hBD2 expression in 
response to EHEC infection does not appear to be influenced by the amount of Stx 
produced or extent of colonisation. hBD2 is capable of directly killing E. coli by 
breaking down the bacterial cell membrane (Estrela et al., 2013). In addition, hBD2 
has pro-inflammatory properties, acting as a chemoattractant for neutrophils, 
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immature dendritic cells (DCs) and T cells via binding to CC-chemokine receptor 6 
(CCR6) (Niyonsaba et al., 2004; Vongsa et al., 2009; Yang et al., 1999); for 
monocytes by binding to CCL2 (Röhrl et al., 2010); and for mast cells via an as-yet 
unidentified receptor (Niyonsaba et al., 2002; Niyonsaba et al., 2001). Accordingly, 
intestinal hBD2 expression is elevated in inflammatory bowel disease (IBD) patients 
vs. healthy individuals (Fahlgren et al., 2003; Wehkamp et al., 2002; Zilbauer et al., 
2010), and inflamed tissue contains higher levels of hBD2 compared with non-
inflamed areas in ulcerative colitis (UC) sufferers (Wehkamp et al., 2003). Thus, 
hBD2 is of great clinical relevance to intestinal health and may have the potential to 
influence the outcome of EHEC infection if used as a therapeutic agent. Future work 
in this area should include an analysis of whether EHEC colonisation and 
pathogenesis is reduced in the presence of hBD2, before assessing its potential 
contribution to therapies. 
Several other enteric species have been shown to stimulate hBD2 expression by 
human intestinal epithelial cells. These include enteroinvasive Salmonella spp., S. 
flexneri and dysenterae, EIEC and C. jejuni (Hase et al., 2002; O'Neil et al., 1999; 
Ogushi et al., 2001; Zilbauer et al., 2005); non-invasive EPEC (Khan et al., 2008); 
and even probiotic E. coli Nissle 1917 (Schlee et al., 2007; Wehkamp et al., 2004). 
However, it should be noted that the majority of these findings were garnered by 
performing infections on human carcinoma cell lines such as Caco-2 and HT-29, 
with very few studies utilising native human intestinal tissue. Recently, a model for 
growing human intestinal xenografts in mice has been developed, enabling the study 
of the innate immune response in vivo. Using this model system, Sperandio and 
colleagues (2008) reported no change in hBD2 expression by human intestinal 
xenograft tissue inoculated with S. flexneri compared with NI controls, despite noting 
significant up-regulation of hBD2 in infected HT-29 and TC7 carcinoma cell lines. 
This suggests that the hBD2 response to infection may differ depending on the model 
system used. To the best of our knowledge, our study is the first to examine the AMP 
response to bacterial infection using IVOC of intestinal tissue explanted from 
humans. We found that, although both human colonic biopsies and polarised T84 
cells showed enhanced hBD2 mRNA expression following EHEC infection, a 
concurrent increase in hBD2 peptide expression was detected only in the former 
model system and not the latter. It is unclear why hBD2 was induced at the mRNA 
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but not protein level in T84 cells. One possible explanation is that translation of 
hBD2 was inhibited in T84 cells, perhaps by the action of microRNAs, which target 
mRNA for degradation (Cai et al., 2009). Alternatively, hBD2 may have undergone 
a post-translational modification, such as ubiquitylation, that resulted in its 
degradation or a change in its antigenic properties (Popovic et al., 2014), thereby 
rendering it undetectable using antibody-based methods. In any case, the observed 
differences in results obtained from colonic biopsies vs. T84 cells highlights the 
importance of confirming findings in physiologically relevant model systems. 
In addition to hBD2, we determined the influence of EHEC on colonic epithelial 
expression of several other AMPs: hBD1, 3 and 4; LL-37 and lysozyme. Whilst 
hBD1 is constitutively expressed by IECs and is largely unresponsive to bacterial or 
inflammatory stimuli (Fahlgren et al., 2003; O'Neil et al., 1999; Ou et al., 2009; 
Sperandio et al., 2008; Zilbauer et al., 2010), a few bacterial species such as Shigella 
ssp., ETEC and V. cholerae have been shown to down-regulate its expression. 
(Chakraborty et al., 2008; Islam et al., 2001; Sperandio et al., 2008). Inhibition of 
LL-37 expression by the same pathogens was also reported in these studies, although 
up-regulated expression has also been demonstrated following infection with 
Salmonella spp. (Chakraborty et al., 2008; Hase et al., 2002). Inhibition of AMP 
production by enteric pathogens likely represents a survival strategy to avoid direct 
harm or immunodetection. Expression of hBD3, hBD4 and lysozyme by colonic 
epithelium is thought to occur at low levels but is enhanced in IBD patients 
(Fahlgren et al., 2003, 2004; Zilbauer et al., 2010), suggesting inducible regulation 
that is linked with the inflammatory response. Little is known about the influence of 
pathogens on expression of these AMPs, although C. jejuni has been shown to 
enhance hBD3 production in Caco-2 and HT-29 cells (Zilbauer et al., 2005). We 
found no evidence for EHEC induction of hBD1, hBD3, LL-37 or lysozyme during 
infection of human colonic epithelium, suggesting that they are not involved in the 
immune response to EHEC. However, we cannot rule out the possibility that their 
induction is inhibited by EHEC, as several EHEC effector proteins have been shown 
to dampen host innate immune pathways (reviewed in Santos and Finlay, 2015). It 
would be interesting to determine human colonic epithelial expression of these 
AMPs during infection with a mutant EHEC strain deficient in T3S to ascertain 
whether EHEC subverts the AMP response. 
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During our study, we were unable to consistently detect hBD3 and hBD4 mRNA in 
human colonic biopsies, meaning that we could not determine whether EHEC affects 
expression of these AMPs ex vivo. This is likely due to the fact that hBD3 and 4 are 
expressed at low levels compared with other AMPs in the colon (Fahlgren et al., 
2003, 2004), which were likely below those required for detection by our qPCR 
assay. This highlights a limitation of the IVOC model system, which requires the use 
of biopsy tissue that may be insufficiently small for some applications. One possible 
way to increase the mRNA signal of poorly expressed genes may be to pool biopsy 
samples during analysis. However, this will impact on the size of experiments due to 
ethical restrictions on the number of biopsies available from any one patient. Another 
solution may be to use an alternative model system, such as intestinal xenografts 
grown on severe combined immuno-deficiency (SCID) mice (Golan et al., 2011; 
Miyamoto et al., 2006). This model is less restricted by sample size but has other 
disadvantages such as a lack of human commensal microflora and limited access to 
tissue, which derives from aborted foetuses. 
 
4.3.2 | Influence of EHEC infection on IL-8 expression 
EHEC infection triggers a moderate inflammatory response in the human intestine, 
characterised by transmigration of neutrophils into the colonic mucosa (Griffin et al., 
1990; Kelly et al., 1990; Kelly et al., 1987). Since the discovery of IL-8 as the 
primary tissue-derived chemoattractant for neutrophils (Baggiolini and Clark-Lewis, 
1992), expression of this cytokine in human colonic epithelium has been shown to be 
responsive to a range of enteric pathogens including S. typhimurium, C. jejuni, Vibrio 
spp., EPEC and EAEC (Chakraborty et al., 2008; Harrington et al., 2005; 
McCormick et al., 1993; Zhou et al., 2003; Zilbauer et al., 2005). In addition, studies 
on EHEC have demonstrated infection-mediated induction of IL-8 in cultured 
intestinal carcinoma cell lines Caco-2, HT-29 and T84 (Dahan et al., 2002; Jung et 
al., 1995). In our study, we examined the IL-8 response to EHEC in human colonic 
epithelium during pIVOC of human colonic biopsies and in vitro infection of 
polarised T84 cells. In line with published findings on non-polarised T84 cells, we 
found that EHEC stimulated expression of IL-8 by polarised T84 cells. Importantly, 
ex vivo infection of human colonic biopsies with EHEC yielded similar results, 
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demonstrating for the first time EHEC induction of IL-8 expression in explanted 
human colonic epithelium. 
 
4.3.3 | Role of bacterial proteins in EHEC induction of hBD2 and 
IL-8 
Several EHEC proteins have been shown the affect innate immune processes in 
human IECs. Studies examining the IL-8 response to EHEC in carcinoma cell lines 
and human colonic xenografts have identified flagellin, the main constituent of 
flagella, as the main factor responsible for induction (Bellmeyer et al., 2009; Berin et 
al., 2002; Miyamoto et al., 2006; Zhou et al., 2003). However, deletion of fliC, the 
gene encoding flagellin, did not completely abrogate IL-8 induction by EHEC in one 
study (Bellmeyer et al., 2009), suggesting that flagellin is not solely responsible for 
the observed response. Aside from flagellin, other factors such HCP and Lpf have 
been implicated in the IL-8 response to EHEC (Farfan et al., 2013; Ledesma et al., 
2010). In particular, the role of Stx has been examined in some detail. Whilst some 
studies have found that Stx induces IL-8 expression in carcinoma cell lines 
(Bellmeyer et al., 2009; Thorpe et al., 2001; Yamasaki et al., 1999), others have 
found no evidence of a stimulatory role for the toxin (Berin et al., 2002; Miyamoto et 
al., 2006). Conversely, a down-regulatory effect was demonstrated during EHEC 
infection of T84 cells (Gobert et al., 2007), and so the role of Stx in EHEC induction 
of IL-8 expression remains controversial. Interestingly, inhibiting the type III 
secretion system (T3SS) in EHEC and EPEC has been shown to enhance the IL-8 
response to infection in HeLa and Caco-2 cells (Hauf and Chakraborty, 2003; 
Ruchaud-Sparagano et al., 2007; Sharma et al., 2006). Recent functional analysis of 
secreted effector proteins has revealed that many inhibit inflammatory signal 
transduction (NleE, NleB, NleH1, NleC, NleD and Tir) (Baruch et al., 2011; Gao et 
al., 2009; Nadler et al., 2010; Newton et al., 2010; Ruchaud-Sparagano et al., 2011; 
Sham et al., 2011), whereas only two appear to stimulate it (EspT and NleH2) (Gao 
et al., 2009; Raymond et al., 2011). Whilst no studies have examined EHEC 
stimulation of hBD2 expression, it has been demonstrated that the hBD2 response to 
EPEC in Caco-2 cells can be abrogated or enhanced by deletion of fliC or T3S, 
respectively (Khan et al., 2008).  
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Based on this research, we sought to determine whether flagellin, T3S, Stx, HCP and 
Lpf were involved in EHEC stimulation of hBD2 and IL-8 in human colonic 
epithelium in vitro and ex vivo. We found that a fliC-negative EHEC deletion mutant 
was unable to stimulate expression of both hBD2 and IL-8 by polarised T84 cells and 
human colonic biopsies. In contrast, mutant strains deficient in T3S, Stx, HCP and 
Lpf were able to stimulate comparable hBD2 and IL-8 responses to those observed 
following infection with the wild-type strain. We also demonstrated that exposure to 
purified EHEC flagellin was sufficient to induce hBD2 and IL-8 expression in both 
of our model systems. These data suggest that flagellin is the primary factor 
responsible for the inflammatory response in human colonic epithelium during 
EHEC infection, and that T3S and Stx are not involved. Our results are the first to 
demonstrate a role for flagellin in the colonic epithelial hBD2 response to EHEC 
infection, and the first to show flagellin-mediated induction of IL-8 during IVOC of 
human colonic biopsies. Flagellin has also been implicated in the innate immune 
response to other enteric bacteria: flagellin-dependent hBD2 expression has been 
reported during infection with EPEC, S. serotype Enteritidis and E. coli Nissle (Khan 
et al., 2008; Ogushi et al., 2001; Schlee et al., 2007), whilst induction of IL-8 by 
EPEC, EAEC, Salmonella spp. and commensal E. coli has also been attributed to 
flagellin (Bambou et al., 2004; Gewirtz et al., 2001b; Ruchaud-Sparagano et al., 
2007; Steiner et al., 2000; Zhou et al., 2003). Our data on EHEC infection, together 
with findings from other bacterial infection studies, implicates flagellin as a crucial 
microbe-associated molecular pattern (MAMP) used in innate immune recognition of 
a broad range of enteric bacteria. 
In addition to triggering inflammation via flagellin, it has been shown that EHEC and 
EPEC dampen the IL-8 response through the action of T3S effector proteins (Hauf 
and Chakraborty, 2003; Nadler et al., 2010; Sharma et al., 2006; Yen et al., 2010). A 
similar suppressive effect of the T3SS on hBD2 expression during EPEC infection 
has also been demonstrated (Khan et al., 2008). These studies were conducted on the 
cervical HeLa and/or the small intestinal Caco-2 cell line. Interestingly, we did not 
detect a significant inhibitory effect of the T3SS on IL-8 or hBD2 expression during 
EHEC infection of polarised T84 cells or human colonic biopsies. Whilst our study is 
the first to examine the role of the T3SS on innate immune responses in human 
intestinal tissue, Ruchaud-Sparagano and colleagues have also failed to detect an 
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inhibitory effect of T3SS on the IL-8 response in T84 but not Caco-2 cells (Ruchaud-
Sparagano et al., 2007). Put together, these results suggest that EHEC-mediated 
suppression of the innate immune response may be delayed or absent in colonic 
epithelium, in contrast to the small intestine. To clarify this issue, it would be 
necessary to examine the influence of the T3S on the colonic and small intestinal 
innate immune response over an extended period of time. 
 
4.3.4 | Flagellin recognition by IECs 
Flagellin is recognised by Toll-like receptor-5 (TLR5) on the IEC surface membrane, 
and blocking TLR5 activity in intestinal carcinoma cell lines inhibits the 
inflammatory response to flagellin from S. dublin and E. coli (Bambou et al., 2004; 
Eaves-Pyles et al., 2011). Therefore, it is likely that the hBD2 and IL-8 response to 
EHEC infection is triggered by binding of flagellin to TLR5 on the colonic IEC 
surface. 
Given that flagella are a common feature of both pathogenic and commensal 
bacteria, there is uncertainty as to how detection of flagellin by IECs can serve as an 
indication of the presence of a pathogen. This problem was first addressed by 
Gewirtz and co-workers (2001a), who demonstrated that flagellin from Salmonella 
induced an IL-8 response in polarised T84 cells when administered basolaterally but 
not apically, and that TLR5 was expressed only on the basolateral surface of 
polarised T84 cells. Based on their findings, the authors postulated that IECs only 
detect flagellin that has crossed the epithelium and binds to TLR5 on their basolateral 
surface, which generally only occurs as a result of pathogen activity (i.e. invasion of 
the epithelium or subversion of epithelial barrier function). However, this hypothesis 
has been called into question by subsequent studies reporting apical TLR5 
localisation and/or flagellin responsiveness in T84, Caco-2 and HCA-7 cells (Berin 
et al., 2002; Miyamoto et al., 2006; Ruchaud-Sparagano et al., 2007; Zhou et al., 
2003). Furthermore, examination of human mucosal tissue by TLR5 
immunofluorescence has shown positive staining on the apical and basolateral side of 
epithelium from duodenum and colon (Cario and Podolsky, 2000; Schüller et al., 
2009). 
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In our study, we found that apical exposure of polarised T84 cells and human colonic 
biopsies to purified EHEC flagellin was sufficient to induce hBD2 and IL-8 
expression. This is in line with a study on EPEC flagellin, which reported apical 
induction of IL-8 expression in human duodenal biopsies (Schüller et al., 2009). Our 
attempts to determine TLR5 localisation in T84 cells and colonic biopsies were 
unsuccessful, hindered by the well-documented lack of high-affinity antibodies 
(Steiner, 2007). Nevertheless, our data support the theory that basolateral access to 
flagellin is not required for induction of the innate immune response in human 
colonic epithelium. It is worth noting that C. jejuni flagellin does not induce IL-8 
expression in T84 cells (Johanesen and Dwinell, 2006), nor does flagellin from 
commensal E. coli strains ATCC 259922 and JM109 (Schlee et al., 2007). This 
suggests that IECs do not respond to flagellin from all bacteria indiscriminately, and 
that variations in flagellar structure or composition may instead be important in 
distinguishing between pathogenic vs. non-pathogenic bacterial species. 
 
4.3.5 | Regulation of the hBD2 and IL-8 response to EHEC 
infection 
Stimulation of TLR5 on IECs triggers a regulatory cascade that involves both the 
NF-κB and mitogen-activated protein kinase (MAPK) signal transduction pathways 
(Figure 1.14) (Steiner, 2007). Accordingly, the IL-8 response to EHEC infection in 
T84 and Caco-2 cells is abrogated by inhibition of NF-κB and the MAPKs p38 and 
ERK1/2 (Berin et al., 2002; Dahan et al., 2002). Similarly, we found that inhibition 
of p38, ERK1/2 and JNK MAPKs in polarised T84 cells suppressed the IL-8 
response to flagellin. In addition, the hBD2 response was significantly reduced by 
inhibition of p38 and JNK, and of ERK1/2 to a lesser extent. These data are in line 
with published studies showing that the hBD2 response to to E. coli Nissle 1917, 
Lactobacillus spp. and IL-1α involves the same MAPK pathways, in addition to NF-
κB (O'Neil et al., 1999; Schlee et al., 2008; Schlee et al., 2007). Surprisingly, we 
found that inhibition of NF-κB signalling using the inhibitor MG-132 resulted in a 
significant increase in the hBD2 and IL-8 response to flagellin compared with non-
treated control cells. This might be explained by the loss of epithelial barrier function 
incurred after exposure to MG-132, which is likely to permit translocation of 
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flagellin from the apical to the basolateral surface of IECs and enhance its 
stimulatory effect on hBD2 and IL-8 expression. Different experimental approaches, 
such as DNA binding or nuclear translocation assays, would be necessary to 
determine NF-κB activity after apical flagellin exposure. In this study, we have 
shown for the first time that the hBD2 response to EHEC infection in human colonic 
T84 cells involves MAPK signalling. An important next step would be to confirm 
these findings in colonic pIVOC. 
 
4.3.6 | Vectorial IL-8 secretion 
Whilst analysing the influence of EHEC on IL-8 protein expression in polarised T84 
cells, we discovered that IL-8 secretion was vectorial: apical exposure to EHEC and 
flagellin led to secretion of IL-8 in an apical but not basolateral direction, whereas 
basolateral exposure triggered basolateral but not apical secretion. Whilst IL-8 
secretion in polarised T84 cells during EHEC infection has not been examined 
before, studies using EPEC have reported an increase in basolateral IL-8 secretion 
when cells were stimulated basolaterally but not apically (Ruchaud-Sparagano et al., 
2007; Zhou et al., 2003). Very few studies consider apical IL-8 secretion by IECs 
during bacterial infection as it is generally assumed that IL-8 is secreted basolaterally 
into the lamina propria to mediate recruitment of neutrophils to the epithelium. In 
line with this theory, predominantly basolateral IL-8 secretion has been demonstrated 
in Caco-2 cells apically infected with EPEC and by HCA-7 cells stimulated with 
EHEC flagellin (Berin et al., 2002; Ruchaud-Sparagano et al., 2007). In contrast, our 
data showing apical IL-8 secretion by T84 cells contradict these findings, and 
indicate that IL-8 may be secreted apically during EHEC infection in vivo. This 
theory is supported by a recent study, which reported apical IL-8 secretion in Caco-2 
cells following apical exposure to flagellin (Rossi et al., 2013). Moreover, IL-8 has 
been detected in luminal contents sampled from the colon of humans and IL-8 levels 
were higher in UC patients compared with healthy controls (Keshavarzian et al., 
1999), further suggesting that IL-8 is secreted into the lumen as part of the 
inflammatory response. The reason(s) why IL-8 may be secreted into the intestinal 
lumen is open to conjecture. One possible explanation is that apical IL-8 secretion 
promotes neutrophil migration across the epithelium and into the lumen 
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(Keshavarzian et al., 1999). Neutrophils are often found in the lumen of patients 
suffering from colonic inflammation (Fournier and Parkos, 2012), and their presence 
at this site likely represents an immune strategy for killing pathogens before they 
colonise the epithelium. Alternatively, apical IL-8 secretion by IECs could serve a 
role other than neutrophil recruitment. IL-8 is a ligand for the G-protein-coupled 
receptor CXCR1, which is expressed on the apical surface of explanted human 
intestinal epithelium, and so it is possible that IL-8 may perform some as-yet 
unidentified autocrine function (Rossi et al., 2013). 
Unfortunately, it was not feasible to determine the direction of IL-8 secretion in 
colonic biopsies due to the mucus layer and mucosal tissue blocking cytokine 
diffusion into the medium. However, it was possible to analyse the influence of 
EHEC on intracellular IL-8 production by measuring protein levels in biopsy lysates. 
In order to prevent bacterial overinfection and detachment of the biopsy epithelium, 
the length of infection was restricted to 7 hours. We were unable to detect an effect 
of EHEC or flagellin on IL-8 production using this infection protocol. Given that 
protein production in IECs is generally analysed after 18+ hours of infection with 
A/E  pathogens (Farfan et al., 2013; Gobert et al., 2007; Khan et al., 2008), it is 
probable that our ex vivo experiments were not conducted for long enough to allow 
adequate time for induction of protein expression to take place. Therefore, it is 
possible that EHEC infection does indeed trigger an increase in colonic biopsy IL-8 
protein production, but this takes place at a time-point later than 7 hours. To test this 
theory, it would be necessary to develop a method for prolonged infection of colonic 
biopsies that does not compromise tissue integrity and enables analysis of IL-8 
protein expression at later time-points. Alternatively, prolonged exposure of colonic 
biopsies to purified flagellin may be sufficient to induce IL-8 protein expression 
without affecting tissue preservation. 
 
4.3.7 | Summary 
In this study, we have demonstrated that EHEC infection triggers expression of 
hBD2 and IL-8 in polarised T84 cells and human colonic biopsies. Flagellin was 
found to be both necessary and sufficient for induction of both genes. Basolateral 
exposure to EHEC or flagellin was not necessary for induction of this response, 
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indicating that flagellin is recognised upon contact with the apical surface of IECs. 
The hBD2 and IL-8 response to flagellin was dependent on p38, JNK and ERK1/2 
MAPK activity. Whilst EHEC induction of hBD2 expression extended from gene to 
protein level in human colonic biopsies, no effect of EHEC was seen on peptide 
expression in T84 cells. This highlights the importance of using native human tissue 
rather than cancer-derived cell lines when analysing the innate immune response in 
IECs. Finally, we found that apical exposure to EHEC and flagellin stimulated apical 
and not basolateral secretion of IL-8 by polarised T84 cells, suggesting that this 
cytokine may be secreted into the lumen during in vivo infection. 
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CHAPTER FIVE 
 
CONCLUSION 
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The aim of this PhD project was to elucidate the interactions between EHEC and the 
human colonic epithelium. To this end, the first half of the study focussed on EHEC 
colonisation and attaching and effacing (A/E) lesion formation on intestinal epithelial 
cells (IECs), whilst the second half characterised the innate immune response to 
infection. In this section, the main findings from this thesis are summarised, and their 
contribution to current knowledge is discussed. In addition, important areas for future 
research are proposed. 
 
5.1 | EHEC colonisation and A/E lesion formation 
Despite a wealth of in vitro studies indicating the importance of EHEC adherence to 
IECs in disease pathogenesis, its clinical relevance has been put into question by the 
lack of evidence for EHEC adherence to human intestinal tissue. Colonic biopsies 
from EHEC-infected individuals exhibit signs of mucosal damage but not bacterial 
adherence, and experimental infection of human colonic tissue with EHEC using the 
in vitro organ culture (IVOC) model has not resulted in adherence or A/E lesion 
formation. In this study, we revisited the IVOC model and successfully demonstrated 
for the first time that EHEC adhere to human colonic mucosa and form typical A/E 
lesions at this site. Accordingly, colonisation was dependent on expression of 
proteins involved in A/E lesion formation (i.e. intimin, EspA, EscN). These data 
verify the hypothesis that EHEC causes colonic pathology by forming A/E lesions on 
IECs, and thereby highlights A/E proteins as important therapeutic targets in the 
search for a treatment for EHEC infection. 
Our discovery that EHEC colonises human colonic tissue during IVOC contrasted 
with previous reports (Chong et al., 2007; Phillips et al., 2000), and this prompted us 
to investigate the cause of this disparity. We found that IVOC conducted under high 
oxygen levels, as used in previous studies, severely reduced EHEC colonisation of 
colonic biopsies compared with atmospheric oxygen concentrations. Therefore, 
through modification of the existing IVOC protocol to incorporate reduced oxygen 
levels, we have established a reproducible ex vivo model for investigating EHEC 
interactions with the human colonic mucosa. This optimised IVOC method can now 
be used to examine other less well-defined aspects of the A/E process, such as the 
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molecular interactions underlying initial attachment and microvillous effacement, 
which have so far been confounded by contrasting data from cell line experiments. 
Our IVOC data suggest that oxygen may negatively regulate EHEC adherence to 
human colonic epithelium in vivo, which complements a recent study showing that 
microaerobiosis enhances T3S and A/E lesion formation relative to aerobic 
conditions (Schüller and Phillips, 2010). Given that oxygen levels in the GI lumen 
are markedly lower than those in the external environment, it is likely that exposure 
to lower oxygen concentrations upon entry into the gut serves as an environmental 
cue for EHEC A/E genes expression and subsequent colonisation of the colonic 
epithelium. Several regulatory pathways have been shown to modulate A/E gene 
expression (e.g. quorum sensing, acid resistance, Pch signalling), and it would be 
interesting to ascertain whether any of these are influenced by oxygen. In addition, 
other environmental factors (e.g. butyrate, biotin, pH, adrenaline, noradrenaline, AI-
3, host cell contact) have been shown to affect EHEC adherence to cultured epithelial 
cells in vitro, and IVOC can now be used to verify their influence ex vivo. 
We also examined EHEC adherence to the widely-used T84 human colonic epithelial 
cell line. In contrast to human biopsy tissue, EHEC adherence to polarised T84 cells 
was not dependent on A/E genes and did not result in formation of typical A/E 
lesions. This suggests that EHEC adherence to T84 cells is conferred by an A/E-
independent mechanism. There are a number of potential EHEC adhesins that may 
mediate adherence to T84 cells, and this would be an interesting area of research to 
pursue. It would also be interesting to investigate why Tir is not translocated in 
polarised T84 cells, as this may lead to development of a method for blocking A/E 
lesion formation during infection. Importantly, our data demonstrates that EHEC 
interacts differently with IECs depending on the intestinal model used, and therefore 
highlights the importance of using physiologically relevant experimental systems. 
Whilst published results have indicated a role for Stx in EHEC adherence to HeLa 
cells and colonisation of mice (Robinson et al., 2006), we did not detect a significant 
effect of Stx on adherence to polarised T84 cells or human colonic biopsies. This 
suggests that Stx is not required for EHEC colonisation of human colonic epithelium 
in vivo. 
177 
 
5.2 | Innate immune response to EHEC infection 
EHEC infection is associated with moderate colonic inflammation characterised by 
infiltration of neutrophils. In vitro studies have attributed this to production of the 
neutrophil chemoattractant, interleukin-8 (IL-8), by IECs in response to detection of 
EHEC flagellin. In addition to recruitment of innate immune cells, IECs have been 
shown to produce a range of antimicrobial peptides (AMPs) in response to pathogen 
attack, although this response has not been investigated during EHEC infection. In 
this part of our study, we developed a polarised colonic IVOC model (pIVOC) and 
used it to determine the influence of EHEC infection on expression of AMPs and IL-
8. The advantage of pIVOC over IVOC is that it restricts bacterial access to the 
mucosal biopsy surface and thus prevents cross-stimulation of the immune cells in 
the lamina propria. We found that EHEC induced expression of human β-defensin-2 
(hBD2) and IL-8 in a flagellin-dependent manner. This data provides the first 
example of EHEC regulation of innate immune gene expression in a human intestinal 
tissue model, and the first evidence of hBD2 induction by EHEC in any model. 
Whilst the IL-8 response to EHEC is known to be mediated by the NF-κB and 
MAPK signal transduction pathways, the mechanisms underlying the hBD2 response 
to EHEC are unknown. We have shown that EHEC induction of hBD2 in T84 cells is 
mediated by the p38 and JNK MAPK signalling pathways, and possibly the ERK1/2 
MAPK pathway to a lesser extent. An important next step would be to confirm these 
findings using colonic pIVOC. Our investigation into the role of NF-κB signalling in 
the hBD2 response to EHEC was inconclusive due to compromised epithelial barrier 
function caused by the chemical inhibitor. Therefore, it would be necessary to 
explore this further using different experimental approaches before any conclusions 
can be made. 
hBD2 has potent bactericidal capabilities and is produced in response to a range of 
bacterial species, indicating an important role for this AMP in innate immune 
defence. Accordingly, several research groups are investigating the feasibility of 
utilising hBD2 and other AMPs as therapeutic agents against intestinal pathogens 
(Mukherjee and Hooper, 2015). Based on our findings, it would seem possible that 
any such hBD2-based strategy has the potential to successfully combat EHEC 
infection. In addition to its ability to directly kill bacteria, hBD2 has been shown to 
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act as a signalling molecule for lymphocytes. Given the prominent role of neutrophil 
recruitment in EHEC-induced inflammation, future work should focus on 
determining the influence of hBD2 on neutrophil migration during EHEC infection. 
Whilst it has been shown that EHEC dampens the innate immune response in 
cervical HeLa and small intestinal Caco-2 cell lines (Hauf and Chakraborty, 2003; 
Khan et al., 2008), we did not observe a significant inhibitory effect of the T3SS on 
IL-8 or hBD2 expression in human colonic tissue or polarised T84 cells. Further 
work is needed in order to ascertain whether EHEC-mediated suppression of the 
innate immune response is delayed or absent during infection of human colonic 
epithelium. 
Whilst examining protein production, we discovered that IL-8 is secreted apically by 
T84 cells following apical stimulation by EHEC or flagellin. This raises the 
possibility that the cytokine may be secreted into the lumen rather than the lamina 
propria, as generally assumed. Polarised secretion of cytokines by intestinal cell lines 
is well-documented in the literature, although most studies show that the direction is 
basolateral rather than apical. Therefore, at present we cannot rule out the possibility 
that the secretion pattern observed in T84 cells represents an artefact of the 
experimental system used, and it is necessary to verify this phenomenon using other 
intestinal models. Unfortunately, pIVOC could not be utilised for this purpose, as it 
is technically unfeasible to quantify IL-8 in the mucus and lamina propria. This was a 
major limitation of our study. Luminal secretion of IL-8 may mediate neutrophil 
migration across the epithelium, an event for which the causal factors have not been 
fully defined. In addition, the cellular mechanism for polarised secretion by IECs is 
currently unknown, and future research should focus on elucidating this process. 
Development of the colonic pIVOC system has enabled the study of EHEC-IEC 
immune interactions ex vivo, and other interesting areas of research that may benefit 
from this model include the effect of EHEC infection on mucus production and the 
resident microflora. 
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5.3 | Evaluation of the IVOC model 
IVOC/pIVOC can be considered a gold-standard model to study EHEC-IEC 
interactions, as it is the only human intestinal model that includes a preserved lamina 
propria, mucus layer and microbiota. However, IVOC does have some inescapable 
limitations. For example, it is not possible to simulate the microaerobic environment 
in the gut due to the need for tissue oxygenation. In addition, the use of explant 
material implies that only localised interactions between EHEC and the host can be 
studied, thus excluding the adaptive immune response and other systemic 
manifestations. The short lifespan of biopsy tissue limits the length of IVOC 
experiments, thus preventing the study of prolonged EHEC-IEC interactions. Finally, 
different genetic backgrounds of patients may result in high variation of results and 
require a higher number of experimental repeats compared with cell culture models. 
This can prove particularly challenging, as practical and ethical restrictions can 
hinder access to biopsy samples. Despite its limitations, and given the lack of a 
suitable alternative animal model, IVOC represents a major improvement over the 
use of cultured cell lines and has the potential to greatly inform our understanding of 
EHEC infection biology. 
One of the most important findings from the colonic IVOC studies presented in this 
thesis is that, despite the range of adherence factors implicated in EHEC colonisation 
from studies using cell lines and other models, colonisation during IVOC was 
completely dependent on a very small set of genes found on the LEE – intimin and 
those encoding T3SS proteins. It is striking how dependent this bacterium is on a 
single genetic island for virulence, despite belonging to a species that has evolved to 
thrive in the human gastrointestinal environment for millions of years. Our findings 
raise the hope that it will soon be possible to develop a drug or vaccine capable of 
targeting EHEC-specific colonisation factors to combat infection without harming 
the gastrointestinal microbiota. 
Secondly, our examination of IL-8 and AMP expression during colonic IVOC 
revealed that the innate immune response to EHEC infection was relatively weak. 
Although IL-8 and hBD2 expression was upregulated in response to EHEC infection, 
expression of the other four AMPs tested was unaffected. Furthermore, we saw no 
evidence for T3SS-mediated suppression of the innate immune response, in contrast 
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to previous published data showing enhanced responses to EHEC upon disablement 
of the T3SS (Hauf and Chakraborty, 2003; Khan et al., 2008). These findings suggest 
a less prominent role for the innate immune response than previously thought. It is 
possible that EHEC possess other non-T3SS-associated mechanisms for evading host 
immune detection, which could account for the relatively weak response. 
Alternatively, it may be that EHEC colonisation of the colonic epithelium per se 
does not stimulate a particularly pronounced response, perhaps due to the fact that 
the bacterium is non-invasive. Further investigation into the molecular interactions 
between EHEC and primary colonic tissue during IVOC would undoubtedly inform 
our understanding of the role of the host innate immune system in disease 
presentation and outcome. 
 
5.4 | Summary 
In summary, work from this PhD project has demonstrated for the first time that 
EHEC colonise the human colonic epithelium ex vivo and induces typical A/E 
lesions dependent on intimin and T3S. This process was inhibited by oxygen and not 
affected by Stx. In addition, apical EHEC infection induced expression of hBD2 and 
IL-8 in vitro and ex vivo, and flagellin was both necessary and sufficient for this 
response. We also present preliminary evidence of apical IL-8 secretion during 
infection. Marked differences in EHEC-IEC interactions were evident between the in 
vitro and ex vivo system used, which highlights the risks associated with relying 
solely on cell culture models. The development of the colonic IVOC and pIVOC 
systems in this study should help to accelerate the progression of EHEC research by 
providing a human intestinal experimental model that more closely resembles the in 
vivo situation.                                      
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